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Abstract
Health insurance design influences whether a person will receive health services,
including colorectal cancer (CRC) screening, although how insurance design
influences utilization is not fully explained. By disaggregating types of insurance
into discrete organizational and financial features, specific influential factors may
be identifiable.
This study evaluated insurance features as predictors of CRC screening using
data from the 2009, 2010, and 2011 Medical Expenditure Panel Survey. Studied
insurance features included three organizational features: whether a person’s
insurance defined a provider network (DPN), used gatekeeping, and restricted
coverage to a DPN; and two financial features: whether a person had a Flexible
Spending Account (FSA) and categories of cost-sharing experience during the
survey year. The primary outcome studied was whether a person was up-to-date
with United States (US) Preventive Services Task Force (USPSTF)-
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recommended CRC screening. In sensitivity analyses, any previous-year CRC
screening was evaluated as an alternative outcome to assess if insurance
features more strongly affected short-term screening than longer-term USPSTF
screening. Multivariate logistic regression models were devised to separately
evaluate each insurance feature. In smaller samples of the Western US,
secondary analyses evaluated if insurance features differentially affected CRC
screening among Hispanic versus non-Hispanic whites.
In the logistic models of the full US samples, organizational insurance features
did not significantly predict the USPSTF outcome. A significant, >3% point,
increase in any previous-year CRC screening was predicted by having two
features, gatekeeping and coverage restricted to a DPN. The third organizational
feature, having coverage restricted to a DPN, had a non-significant positive
effect.
In the Western US analyses, each organizational feature predicted a more
favorable change in screening likelihood for Western Hispanic whites than nonHispanic whites suggesting a possible effect of reducing disparate CRC
screening among Hispanics.
For the financial features in the full and Western US analyses, having a FSA had
a large positive effect in unadjusted models, although the effect did not remain
significant in fully-adjusted models. Cost-sharing categories predicted
substantial variation in screening likelihood, which was largely mitigated in fullyadjusted models. Further research is needed using causal study designs and
datasets with richer detail about insurance design.
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Chapter 1
Introduction

Colorectal cancer (CRC) is one of the largest US cancer burdens. In 2013, there
were an estimated 142,820 new CRC cases and 50,830 CRC deaths making it
the second leading cause of cancer death for men and women combined
(Surveillance, Epidemiology, and End Results Program 2013). An average-risk
individual has a 4.8% risk of being diagnosed with CRC at some point in their
lifetime. CRC incidence and mortality have generally declined continuously since
the mid-1980s (Edwards 2009), although use of CRC screening still lags behind
other highly effective cancer screening tests (Klabunde 2012).
CRC screening is highly effective and cost-effective at reducing CRC incidence
and mortality (Whitlock 2008; Maciosek 2010; Maciosek 2006). From 19752000, CRC screening explained 53% of the observed decline in CRC mortality,
while changes in risk factors explained 35% of the decline and improvements in
treatment explained 12% (Edwards 2009). The US Preventive Services Task
Force (USPSTF) recommends that average risk adults aged 50-75 receive CRC
screening by any of three strategies: 1) colonoscopy every ten years, 2) flexible
sigmoidoscopy (FSIG) every five years with high-sensitivity fecal occult blood test
(FOBT) every three years, or 3) annual FOBT (US Preventive Services Task
Force 2008), which is generally consistent with other prominent guidelines (Rex
2009; McFarland 2008)). While CRC screening use increased recently from 54%
up-to-date with recommended screening in 2002 to 65% up-to-date in 2012
(Klabunde 2013), CRC screening use remains low relative to screened
percentages for other highly effective cancer screening tests, notably 72.4% for
mammography for breast cancer screening and 83.0% for pap smears for
cervical cancer screening (Klabunde 2012).
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The likelihood of being up-to-date with CRC screening varies depending on many
factors including age, sex/gender, race, Hispanic ethnicity, education, income,
having health insurance and having a usual source of health care (Shapiro
2012). Improving the health of all groups and eliminating disparities/achieving
health equity are overarching goals of the US government’s HealthyPeople
campaign (Healthy People 2013). For the first time in 2012, equivalent
percentages of whites (65.9%) and blacks (63.1%) were up-to-date with CRC
screening in the Behavioral Risk Factor Surveillance Survey (BRFSS) (Klabunde
2013) the Centers for Disease Control and Prevention (CDC). Also for the first
time, CRC screening use did not significantly differ between Asians/Pacific
Islanders (63.2%) and whites or blacks. Screening differences persist though
between Hispanics (53.1%), American Indians/Alaskan Natives (AIANs) (54.5%)
and non-Hispanics (66.4%).
Many factors contribute to racial/ethnic CRC screening differences. In multiple
studies, lower use of CRC screening among Hispanics has been largely or
entirely mitigated statistically after adjusting for lower socioeconomic status
(SES) and worse health care access (Gonzales 2012; Cokkinides 2011). Other
factors include whether a physician recommended CRC screening (Yepes-Rios
2006; Jo 2008; Kelly 2007; Cronan 2008), immigration status and time lived in
the US (Shih 2008), and geographic area-level poverty (Lian 2008). For
receiving colonoscopy specifically, an intuitive, but non-obvious, factor found to
strongly influence whether underserved individuals followed through with a
scheduled colonoscopy was having a “next of kin” (spouse, family, or friend)
available as a chaperone after the procedure because of the sedation (Anderson
2011).
Many approaches can be considered in the effort to increase CRC screening use
nationally and reduce inequities. Screening promotion can use culturally
appropriate messages to target particular groups, and other policy and practice
2

reforms can address the underlying fundamental social causes of inequities.
Demographic and socioeconomic factors that are the root causes of inequities
are not easy to modify, so health care system factors, such as organizational and
financial factors that can influence preventive services use, may be a more
suitable focus for strategies aiming to increase screening among vulnerable
populations and may be more amenable to policy action. It has been noted that
health insurance may be particularly well suited for influencing preventive
services use because of insurer’s organizational and financial connections to
both providers and patients (Tye 2004).
The National Committee for Quality Assurance’s (NCQA) produces the
Healthcare Effectiveness Data and Information Set (HEDIS) that measures
health plan performance on CRC screening as the percentage of adults aged 5075 who are up-to-date with appropriate screening. Since the early 2000s, HEDIS
CRC screening performance has steadily improved within each Health
Maintenance Organizations (HMOs) and Preferred Provider Organizations
(PPOs) (the two predominant types of health insurance) in the commercial and
Medicare markets (National Committee for Quality Assurance 2013). In 2012,
the HEDIS CRC screening performance measure indicated that HMOs have
consistently achieved higher CRC screening rates than PPOs in the commercial
and Medicare markets since the measures began reporting on all health plan
types in 2005. HEDIS performance shows that the gap in CRC screening use
between HMOs and PPOs has narrowed with a jump in CRC screening use
among PPOs from 2010 to 2011, 47.6 to 54.6% for commercial PPOs and 41.0
to 55.2% for Medicare PPOs.
Variation in CRC screening use across types of health insurance has limited
implications if there are not meaningful distinctions between health insurance
types. Insurers exert influence on utilization in multiple ways and insurance
characteristics may vary within a type of insurance as much as between types
3

(McGlynn 1998). Deconstructing health insurance types into discrete features is
a means to more finely examine the effects of insurance characteristics on being
up-to-date with recommended CRC screening.
By deconstructing health insurance types into discrete features, the features fit in
Andersen and colleagues’ frequently used Behavioral Model of Health Services
Use as enabling factors (Andersen 1968; Andersen 1995; Andersen and
Davidson 2007; Andersen 2008; Aday, Andersen, and Fleming 1980). In the
Behavioral Model, individual and contextual characteristics act as predisposing,
enabling and need factors that influence health behaviors and ultimately
outcomes. Factors that stimulate or inhibit use vary depending on the particular
service (Andersen 1995). For instance, an inpatient stay for a life-threatening
illness would be primarily explained by need-based factors, while whether the
whether a person obtains a discretionary preventive service, such as CRC
screening, depends more on predisposing factors such as awareness of the
service and health beliefs about obtaining needed services, and on enabling
factors, such as being financially able to obtain the service and being having time
away from work or other life demands to obtain the service. While it may be
impossible to detect differences in the enabling effect of different health
insurance types, constituent insurance features may act as enabling factors that
influence a person’s ability to obtain CRC screening. For instance, copay
amount would be expected to influence ability-to-pay for CRC screening, and
organizational features might enable an insurer to influence providers to
recommend CRC screening.
A dataset that would permit evaluating insurance feature effects on CRC
screening likelihood is the Medical Expenditure Panel Survey (MEPS) produced
by the Agency for Healthcare Research and Quality (AHRQ) (Agency for
Healthcare Research and Quality 2010). In addition to a survey component
inquiring about a variety of personal characteristics and health behaviors, MEPS
4

collects information on medical events, payments and sources of payments.
MEPS’s unique combination of information includes CRC screening status, some
insurance features, and a large set of potentially relevant covariates
encompassing predisposing, enabling and need factors.
MEPS has been used with conceptual guidance from the Behavioral Model to
evaluate whether insurance characteristics predicted recent screening
mammography (Tye 2004). Primarily using data from the 1996 MEPS, Tye et al.
assigned organizational and financial health insurance characteristics as
individual enabling factors and assessed their influence on mammography use.
Tye et al. created hypotheses for the effects of health insurance characteristics’
by drawing on two main theoretical premises or “causal pathways”: 1) if a health
insurance characteristic increases the insurer’s capacity to manage information
flows, the health insurer will be better able to communicate to providers and
patients about appropriate screening mammography (Galbraith 1973) and 2) if a
health insurance characteristic reduces the effective “price” of screening
mammography to enrollees, demand will increase (Manning 1987). The study
found that mammography use did not differ depending on a woman’s health
insurance plan being labeled managed care or indemnity, although more specific
health plan characteristics did predict use including that having insurance that
defined a provider network and that used gatekeeping were found to predict
greater likelihood of recent mammography (Tye 2004). Additional health plan
characteristics, restricting out-of-network coverage, use of cost containment
strategies, enrollee cost sharing, and breadth of benefit coverage were not found
to influence mammography use.
This study adapted Tye et al.’s approach to accomplish the objective of
assessing insurance features as predictors of CRC screening. To accomplish
the objective, cross-sectional analyses were conducted of pooled data from the
years 2009, 2010, and 2011 of MEPS data. The conceptual framework based on
5

the Behavioral Model of Health Services Use and Tye et al.’s causal pathways
informed specification of analyses using available measures in MEPS.
As previously noted, CRC screening use is known to be inequitable for Hispanics
(Klabunde 2013) and for Hispanics in New Mexico as compared to whites
(Gonzales 2012). Within Hispanics, variation in CRC screening use has been
identified between different states and regions of the country (Pollack 2006) and
based on nation of origin (Gorin and Heck 2005). Those patterns reveal lower
CRC screening among Western US Hispanics and among the prevalent Hispanic
subgroups in the West of Mexican and Central American origin. In Gonzales et
al.’s study of the BRFSS data for New Mexico, having health insurance was
associated with a higher prevalence of up-to-date CRC screening rates for nonHispanics than for Hispanics by ~20% points for both men and women.
Uninsured non-Hispanic white men and women had screening rates ~8% points
less than uninsured Hispanic men and women, respectively, while insured nonHispanic white men and women had CRC screening rates that were 12% and
14% greater than insured Hispanic men and women, respectively. Exploring
insurance feature effects may provide evidence to support a greater benefit to
CRC screening rates from having insurance among non-Hispanic whites than
Hispanics. Because geographic identification of MEPS respondents is limited to
census regions, this subanalysis examined Hispanic and non-Hispanic whites in
the Western US census region. To explore differential insurance feature effects
between non-Hispanic whites and Hispanic whites in the Western US, the
subanalysis repeated the full population analysis with the addition of a mediating
effect for insurance features by Hispanic ethnicity.
The influences of insurance features studied here has a potential to inform health
insurance administration and health policy to increase CRC screening use,
reduce inequities, reduce CRC incidence and mortality, and support the study of
insurance feature effects on utilization of other health services.
6

Specific Aims and Hypotheses

Aim 1. Evaluate the association between insurance features and likelihood
of being up-to-date with USPSTF-recommended CRC screening.
Hypothesis: Higher CRC screening likelihood is predicted by insurance features
that indicate an insurer had greater capacity to communicate about appropriate
CRC screening messages to providers and enrollees or by insurance features
that indicate enrollees experienced lower cost-sharing.
Aim 2. Evaluate the association between insurance features and likelihood
of being up-to-date with USPSTF-recommended CRC screening among
Western US Hispanic and non-Hispanic whites.
Hypothesis: Aim 1’s hypothesized benefits of increased CRC screening use due
to insurance features will be smaller for Western Hispanic whites in comparison
to non-Hispanic whites.

7

Chapter 2
Literature Review

This chapter provides an overview and synthesis of knowledge on topics relevant
to this study. Four content areas were reviewed: 1) CRC Overview: the
population health burden is summarized including incidence, prevalence,
mortality, trends, treatments, and costs; 2) CRCS Trends and Predictors: recent
estimates and trends in CRC screening use are summarized. A formal literature
search was performed to broadly assess factors that predict CRC screening that
will inform covariate specification for multivariate analyses. Specific issues for
Aim 2 are addressed relating to assessing the CRC screening inequity between
non-Hispanic and Hispanic whites in the Western US; 3) Theoretical Framework:
Use of the Behavioral Model of Health Services Use in this study adapted from
Tye et al. is explained; 4) Health Insurance Effects: current enrollment in types of
insurance across the major sources of payment is detailed. How different
insurance types generally affect health services use and CRC screening in
particular is examined. A formal literature search was conducted to identify
evidence regarding the effects of health insurance features on health services
utilization.

Colorectal Cancer Overview

An estimated 1,154,481 people had CRC in the US in 2013 (Surveillance,
Epidemiology, and End Results Program 2013). Incidence was 45.0 cases of
CRC per 100,000 persons, which constitutes 8.6% of all new cancer diagnoses.
The CRC mortality rate was 16.4 per 100,000 persons, which constitutes 8.8% of
8

all cancer deaths. For men and women separately, CRC is the third leading
cause of cancer and third deadliest cancer after lung and prostate cancer and
lung and breast cancer, respectively. CRC incidence and mortality have been
declining since the mid-1980s (Edwards 2009) and have each fallen by nearly
3% per year over the last ten years (Surveillance, Epidemiology, and End
Results Program 2013).
The CRC burden disproportionately affects some groups. CRC risk increases
with older age: the median age at diagnosis is 69, and those aged 65-74 and 7584 each make up 24% of new cases (Surveillance, Epidemiology, and End
Results Program 2013). The median age at death is 74 with those aged 75-84
making up the largest share, 28.2% followed by those aged 65-74, 21.9% of
deaths, and those aged 85 and older, 20.8%. Men in comparison to women
consistently have higher CRC incidence (50.6 vs. 38.2 per 100,000) and mortality
(19.6 vs. 13.9 per 100,000). African American men and women have the highest
CRC incidence and death rates of all racial and ethnic groups by 1.5-2 times the
population average. In comparison to the full population rates, whites have
slightly lower incidence and mortality rates that are just less; non-Hispanics of all
races have slightly higher incidence and mortality rates; and Asians/Pacific
Islanders, Hispanics, and AIANs generally have lower CRC incidence and
mortality by 10-20%, except AIAN women have a 15% higher mortality rate than
the full population.
CRC risk factors include several medical history factors: a family history of CRC
or other hereditary colorectal conditions; a history of ulcerative colitis or Crohn’s
disease; a personal history of colorectal, ovarian, or breast cancer; or a personal
history of polyps (National Cancer Institute 2013a). Lifestyle risk factors include
lack of regular physical activity, a diet low in fruit and vegetables or a low-fiber
and high-fat diet, obesity, excessive alcohol consumption, and cigarette smoking.
Several medications have been evaluated for CRC prevention effects: although
9

evidence is mixed, long-term aspirin use has been found to reduce CRC risk;
evidence is insufficient to conclude if non-aspirin non-steroidal anti-inflammatory
drugs decrease CRC incidence; evidence is mixed or unsupportive regarding
vitamin supplements including vitamin E, antioxidant vitamins, folic acid
supplements, and statin use. Associational benefits of calcium supplements
have been found although the evidence is inconclusive.
From 2003-2009, five-year survival for new cases was 64.9%. There are six
standard treatments for CRC: surgery by local excision within the colon or
resection of the colon with anastomosis or colostomy; chemotherapy; radiation
therapy; radiofrequency ablation; cryosurgery; and targeted therapy with
monocolonal antibodies or angiogenesis inhibitors (National Cancer Institute
2013b). The five-year survival rate is much higher for persons whose cancers
are detected at an earlier stage, greater than 90% for local stage cancers vs.
~10% for distant cancers. The strong rationale for routine CRC screening is due
to earlier detection (Edwards 2009). In 2010, annual medical expenditures for
CRC were estimated to be $14.1 billion and were projected to rise to $17.4 billion
in 2020 (in 2010$) in analyses accounting for only changes in the US population,
with a range of estimates from $14.4 billion to $20.4 billion in different scenarios
varying incidence, survival, and cost assumptions (Mariotto 2011).

Predictors of Colorectal Cancer Screening

A formal literature search was conducted to identify studies evaluating CRC
screening predictors other than health insurance features. A PubMed search
was conducted on 06/03/2013 covering the previous ten years. The search
terms contained three components: 1) National Cancer Institute’s “Cancer Topic
Search” for “Digestive System Cancer: Screening and Prevention” modified to
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exclude non-colorectal cancers (Appendix) (National Cancer Institute ), 2) the
U.S. National Library of Medicine’s health disparities search terms (U.S. National
Library of Medicine ) and 3) any of three words to identify predictors: (predictor*
OR factor* OR determinant*). The search strategy yielded 131 search results,
and 43 articles were reviewed. The most current, original findings from US
settings on unique CRC screening predictors, quantitative and qualitative, were
reviewed to inform the specification of control variables in this study’s analyses.
Evidence from additional applicable sources are included where appropriate
notably an extensive 2010 systematic review of CRC screening use and quality
that was conducted on behalf of AHRQ (Holden 2010a).
Changes in CRC screening Use Over Time
Repeated measures over time using national health surveys including the
National Health Interview Survey (NHIS) and BRFSS show that CRC screening
use has continuously increased over time from the late 1980s to the present
(Klabunde 2013; Cokkinides 2011; Miranda 2012; Shavers 2010; Klabunde 2011;
Bandi 2012; Soneji 2012; Rim 2011; Holden 2010b). In the CRC screening
eligible population of 50-75 year old average-risk persons, nation-wide 65.1%
were up-to-date with USPSTF-recommended CRC screening strategy in a recent
estimate from the 2012 BRFSS (Klabunde 2013). From 2000-2008, the
percentage of the population aged 50-75 that was up-to-date with any
recommended CRC screening strategy increased by 15.9% point (38.6 to 54.5%)
(Klabunde 2011).
Medicare Policies influencing Trends of Different CRC screening Techniques
CRCS trends by screening technique from the early 2000s to the present are a
continuation of trends relating to Medicare policy changes for CRC screening
around the turn of the millennium (Gross 2006). Beginning in January 1998,
Medicare was required by Congress to pay for FOBT, FSIG, double-contrast
11

barium enema (DCBE) screening, and colonoscopy for high-risk persons
according to American Cancer Society recommendations. Coverage was later
expanded to require Medicare to reimburse screening colonoscopy every 10
years for all persons as of July 1, 2001, no longer for just those at high-risk. In a
trend analysis of number of procedures received per 100,000 Medicare
beneficiaries from 1991-2003, it was demonstrated that a switch occurred from
more FSIG use in the early period from 1991-7 to more colonoscopy use after
the first policy change in 1998 (Gross 2006). FSIG peaked at 691.9 procedures
per calendar-year quarter per 100,000 beneficiaries in 1999-2000 before
declining to 267.5 in 2002-2003. Colonoscopy use increased from 284.6
procedures per calendar-year quarter per 100,000 beneficiaries in 1996-1997 to
1918.9 procedures in 2002-2003, an increase by a factor of greater than six.
Colonoscopy use superseded FSIG as the predominant screening technique,
even before the universal colonoscopy coverage expansion in July 2001.
Provider Opinion
Besides reimbursement policy, provider opinion has contributed to the trends in
CRC screening use by different techniques. In the 2006-2007 National Survey of
Primary Care Physicians’ Recommendations and Practices for Breast, Cervical,
Colorectal, and Lung Cancer Screening (Klabunde 2009), 95.3% of primary care
physicians (PCPs) perceived colonoscopy to be effective in reducing mortality,
while only 22.6% of PCPs perceived computed tomography (CT) colonography to
be effective, and less than 20% of PCPs perceived to be effective each of FOBT,
FSIG, DCBE, and fecal DNA testing. Comparing the techniques that PCPs said
that they would recommend in that survey to the previous 1999-2000 survey, the
percentage of PCPs recommending FOBT declined from 95% to 80%, while the
percentage of PCPs recommending each FSIG and colonoscopy more than
switched with a decline for FSIG from 78 to 26% and an increase for
colonoscopy from 38 to 95%.
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CRCS Trends within Racial/Ethnic Groups
Major racial/ethnic groups, African Americans, Hispanics, Asians and nonHispanic whites have generally experienced increasing CRC screening use
consistent with trends in the general population over the same period (Shavers
2010; Klabunde 2011; Bandi 2012; Soneji 2012). The magnitude of trends varies
though: Hispanics have not increased screening use as much as other major
racial/ethnic groups (i.e. disparities have widened) due to a smaller increase in
colonoscopy use, although at the same time Hispanics have also had smaller
declines in FOBT and FSIG (Klabunde 2011; Bandi 2012).
CRC screening adoption has varied among Hispanic subethnicities as well: using
pooled MEPS data from 2000-2007 (Miranda 2012), CRC screening use trends
were studied for Hispanic subethnicities, blacks and whites aged 50 and older.
Puerto Ricans, Cubans, blacks, and whites experienced a similar ≥10% points
gain in combined use of FOBT and/or endoscopy from 2000-2007, although CRC
screening use was essentially flat for Mexicans and declined among “Other
Latinos”. These trends are relevant to this study’s second Aim because Mexican
and Central Americans are heavily represented in the Western US while Puerto
Ricans and Cubans are concentrated in the Eastern US (Ennis 2012).
CRCS Trends by Other Factors
Inequities have also widened relating to other factors, particularly social status
and SES factors: from 2000-2008, smaller gains in CRC screening use were
experienced by those with less income and education, by the disabled, and by
immigrants (Klabunde 2011; Rim 2011). Inequities widened for those with
deficient health care access including those lacking health insurance (Rim 2011),
those having no physician visits in the previous year, and those without a usual
source of care (Klabunde 2011). Among the insured, CRC screening disparities
relating to age subgroups and insurance types have shifted over time (Klabunde
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2011). Among the insured 50-64 age group, the disparity between the publicly
(historically inequitable) and privately insured widened slightly by 5% points. In
the insured 65-75 age group, the CRC screening gap narrowed by more than 5%
points for those having basic Medicare without supplemental insurance
(historically inequitable) in comparison to those with Medicare HMO coverage or
Medicare with private supplemental insurance.
Changes in CRC Screening Over Time Summary
In the context of Medicare’s CRC screening reimbursement expansions in 1998
and 2001 (Gross 2006), and a shift in provider opinions to favor colonoscopy
more and favor FSIG and FOBT less (Klabunde 2009), colonoscopy became the
strongly preferred CRC screening strategy type by the early 2000s. Declining
FSIG and FOBT use has been more than replaced by increasing colonoscopy
use such that overall CRC screening use consistent with recommendations
increased from 38.6% in 2000 to 54.5% in 2008 (Klabunde 2011) and most
recently has been estimated to be 65.1% in 2012 (Klabunde 2013). These gains
have been experienced broadly, although CRC screening use has notably not
increased as much among Hispanics resulting in a widening disparity in
comparison to non-Hispanic whites (Klabunde 2011) and some Hispanic
subgroups (Miranda 2012). Inequities have also widened among those of lower
socioeconomic and social status and those with poorer health care access
(Klabunde 2011; Rim 2011).
Predisposing Factors
Demographics
Age
As age increases above from the recommended start age, 50, CRC screening
use increases (Shapiro 2012; Cokkinides 2011; Miranda 2012) until plateauing at
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70-75 years and gradually declining thereafter (Soneji 2012; Mobley 2010;
O'Malley 2005). In the 50-59, 60-69, and 70-75 age groups in the 2010 NHIS,
50.0, 65.8 and 68.2%, respectively, were estimated to be up-to-date with CRC
screening by any of the USPSTF-recommended strategies (Shapiro 2012). In
the 50-59, 60-69, and 70-75 age groups in the 2010 BRFSS, 55.1, 72.9 and
76.9%, respectively, were estimated to be up-to-date with CRC screening by any
of the USPSTF-recommended strategies (Joseph 2012). The discrepancy
between the estimates from the NHIS and BRFSS is due to survey administration
differences and different response rates: NHIS has a higher response rate, and
since non-responders are less likely to be screened, NHIS has less nonresponse bias than BRFSS, so the NHIS is less likely to overestimate screening
rates (Holden 2010b).
Explanations for the Association with Increasing Age
Many explanations have been proposed for the positive association between
increasing age and CRC screening use including greater awareness of CRC and
CRC screening, elevated concern about CRC, more diagnostic testing for other
gastrointestinal issues, more positive FOBT tests with increasing age that prompt
endoscopy (Ioannou 2003), poorer health that prompts health care system
encounters increasing the likelihood of a CRC screening provider
recommendation, and the removal of health insurance coverage barriers for the
uninsured/underinsured once they receive Medicare at age 65 (although CRC
screening use increases substantially in the 50-64 year olds age group prior to
Medicare eligibility) (Hudson 2012).
Sex/Gender
Men and women are similarly likely to receive CRC screening with many studies
finding no difference in CRC screening use (Cokkinides 2011; Soneji 2012;
Carcaise-Edinboro and Bradley 2008), although some, mostly larger studies,
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have found that women have a small, independently significant, lower likelihood
of CRC screening use (Miranda 2012; Shavers 2010; Rim 2011; Ioannou 2003;
Homayoon 2013). Recent estimates though suggest that if there has historically
been a small gender gap, it may have recently reversed: in the 2010 BRFSS,
women had significantly higher CRC screening use than men (65.0 vs. 63.9)
(Joseph 2012), and in the 2012 BRFSS, women had further gains in CRC
screening use since 2010, while use did not change among men, 66.2% vs.
63.9% (Klabunde 2013). No literature was found pertaining to CRC screening
use among any non-heteronormative genders.
Explanations for Gender Disparities
Explanations for gender differences in CRC screening use include differences in
physician recommendation patterns and differential attitudes and beliefs about
CRC screening. In the Supporting Colorectal Cancer Outcomes Through
Participatory Enhancements (SCOPE) study, a predominantly white, insured, and
higher SES sample visiting primary care practices in New Jersey between 2006
and 2008 (Hudson 2012), men were recommended to receive CRC screening
significantly more often than women, although men and women did not differ in
their likelihood of adhering to a recommendation. Another study though did not
find gender significantly predicted receiving a recommendation for FOBT, FSIG,
colonoscopy, any endoscopy, or any CRC screening among black and white,
North and South Carolina Medicare beneficiaries (Klabunde 2006). In a study
assessing attitudes and beliefs associated with CRC screening use, it was found
that women were more likely than men to report agreement with attitudes and
beliefs that were associated with lower likelihood of being up-to-date with
endoscopy use (Farraye 2004) including being more frightened or embarrassed
about having a FSIG exam, considering having a FSIG to be very inconvenient
with one’s daily schedule, being more willing to have a FSIG if the endoscopist
was the same gender as the respondent, and being less likely to agree that
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having an FSIG every five years after the age of 50 is important for general
health.
Race
Estimates from the 2012 BRFSS indicate that differences in CRC screening use
are not significant between whites, 65.9% up-to-date with recommended
screening; blacks, 65.5%; and Asians/Pacific Islanders, 63.2%; although
screening is still inequitable among AIANs, 54.5% (Klabunde 2013). Those
estimates are a change from estimates two years earlier in the 2010 BRFSS and
2010 NHIS, which indicated that CRC screening use among Asians was lower
than whites and blacks (Shapiro 2012; Joseph 2012).
Hispanic Ethnicity
In recent 2012 BRFSS estimates, Hispanics’ CRC screening use lagged nonHispanics, 53.1% vs. 66.4% (Klabunde 2013). Among Hispanics, CRC
screening use varies depending on multiple factors, which suggest higher risk of
CRC screening underuse among Western US Hispanics that are the focus of Aim
2. In a multivariate analysis of the 2000 NHIS examining two CRC screening
techniques separately (Gorin and Heck 2005), CRC screening use varied across
Hispanic subgroups: Puerto Ricans and Central/South Americans had half the
odds of Mexican Americans (OR: 0.50 (0.28-0.89) and 0.42 (0.21-0.85),
respectively) of having received any endoscopy in the past five years, although
for the second technique considered, no Hispanic subgroups had significantly
different FOBT use within the previous year than Mexican Americans. It may not
have been possible to detect differences between Mexican Americans and each
Cubans and Dominican Americans because of small sample sizes for those
subgroups. In another study examining Hispanic subgroups, which used
combined data from 2001-2005 MEPS and 2000-2004 NHIS (Jerant 2008),
Hispanics of Mexican or Dominican origin had larger disparities in comparison to
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non-Hispanic whites than Hispanics of Cuban or Puerto Rican origin vs. nonHispanic whites. CRC screening use among Hispanics varies across geographic
areas as well. A state-level analysis of the 2002 BRFSS (Pollack 2006) found
that Hispanics in Northeastern states (Massachusetts, New Jersey and New
York) had greater CRC screening use within recommended time intervals than
Hispanics in Western States (Arizona, California, Colorado, and New Mexico).
Explanations for Inequitable CRC screening use Among Hispanics
Evidence indicates many factors contribute to Hispanic CRC screening
disparities. In multiple studies, lower SES among Hispanics than nonHispanics/whites has been attributed as a cause of CRC screening underuse
among Hispanics. SES measures that have been studied include income,
employment, education, and health care access factors. Addressing these
factors, which have been labeled fundamental social causes of disease, has
been theorized to be sine qua non for eliminating health inequities (Link and
Phelan 1995).
In a study assessing CRC screening use among Latino subgroups (Miranda
2012), all subgroups had unadjusted disparities in CRC screening use compared
to non-Hispanic whites when only adjusting for age and sex. In a model that
adjusted for education, income, and insurance, only Mexicans and “Other
Latinos” still had inequitable CRC screening use while Cubans and Puerto
Ricans did not have significantly different CRC screening use from non-Hispanic
whites. In analyses of the 2006 New Mexico BRFSS stratified by sex (Gonzales
2012), New Mexico Hispanic women had inequitable CRC screening use versus
white women (OR: 0.55 (0.44-0.70)) that was not statistically eliminated after
controlling for several blocks of covariates including survey language,
demographics, SES, clinical factors, lifestyle factors, preventive services
utilization factors, or a full model including all the aforementioned covariate
blocks. Controlling for socioeconomic factors (health care coverage, current
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employment status, annual household income and high school-level education)
most noticeably, partially statistically mitigated the disparity for Hispanic women
(OR: 0.73 (0.56-0.97). Gonzales et al. noted that New Mexican Hispanic women
in their sample were less likely to have health care coverage and were more
likely to report being low income (<$25,000), being unemployed or having less
than a high school education. Therefore residual differences remain between
New Mexican Hispanic and non-Hispanic white women that explain the statistical
difference. For New Mexico Hispanic men in contrast, most of the blocks did
statistically eliminate inequitable CRC screening use in comparison to nonHispanic white men except for demographic, clinical and lifestyle factors. In
addition to SES, cultural factors including nation of origin, acculturation factors
and health beliefs/psychosocial factors have also been shown to contribute to
Hispanic CRC screening inequities, which are discussed in a subsequent
sections. While Hispanics have lower CRC incidence and mortality than nonHispanics (Surveillance, Epidemiology, and End Results Program 2013) as was
noted earlier, Hispanics may have excess CRC risk due to lifestyle factors that
increases the need for CRC screening in the Hispanic population including higher
rates of obesity and lower use of other cancer screening tests than nonHispanics whites, although Hispanics have favorably lower rates of smoking and
frequent alcohol consumption (Cokkinides 2012).
Barriers to CRC screening Among Hispanic Men
Although screening rates indicate that CRC screening use has historically been
inequitable among Hispanic women in comparison to men (Gorin and Heck 2005;
Crawley 2008), unique barriers to CRC screening use for Hispanic men have
been noted. In focus group responses of low income/education Hispanics mostly
of Mexican-birth who were living in U.S. cities along the Texas-Mexico border
(Fernandez 2008), the concept of machismo was identified as a barrier to CRC
screening among men, that CRC screening is a violation to manhood. One man
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was even quoted as jokingly saying that men avoid CRC screening because they
think, “I may die, but I’ll die a virgin”. In this study, participants also expressed
the opinion that women visit the doctor more often than men and are inherently
more inclined to accept CRC screening. In an exploratory qualitative study of
attitudes and beliefs about CRC screening among New Mexico Hispanic
subpopulations (Getrich 2012), the importance of machismo notably differed for
two particular subgroups: 1) Hispanos (Hispanics who trace their ancestry from
late-16th century Spanish colonists) concentrated in northern New Mexico and 2)
first-generation Mexicans concentrated in southern New Mexico. For firstgeneration Mexicans, perceptions about receiving colonoscopy included that it
was an affront to heterosexual manhood and/or would negatively affect a man’s
reputation in the community. These privacy and stigma concerns were not held
by Hispanos possibly because of a tighter knit community going back many
generations and the absence of recent immigration enforcement threats, which is
an issue for southern New Mexico first-generation Mexican communities.
Geography
CRCS use varies over geographic regions and depending on population density.
Arkansas had the lowest proportion of its population up-to-date with
recommended CRC screening in 2012, 55.7%, while Massachusetts had the
highest proportion, 76.3% (Klabunde 2013). Among US census regions the
Northeast had higher predicted recommended CRC screening use than the
Midwest and South, but not the West in multivariate analyses of a combined
sample of the 2000, 2003, 2005, and 2008 NHIS (Klabunde 2011). Studies have
consistently found a disparity in CRC screening use for persons living in rural
areas in comparison to their urban counterparts (Shih 2008; Carcaise-Edinboro
and Bradley 2008; Homayoon 2013; Schumacher 2008).
Acculturation
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Some evidence supports an association between CRC screening use and
acculturation (acculturation measures, immigration status, and spoken language)
and cultural factors (factors potentially related to traditional lifestyle for Native
Americans). For measures of Hispanic acculturation evaluated in two studies,
CRC screening use was not significantly predicted by either the Acculturation
Rating Scale for Mexican Americans-II (ARSMA-II) (Yepes-Rios 2006) or the
Marin and Marin Short Acculturation Scale (Shah 2006). Across immigration
status categories, CRC screening use was found to vary. Foreign-born persons
who had been in the US for 15 or more years or for ten or fewer years were less
likely to have ever received CRC screening than US-born non-Hispanic whites,
OR: 0.58 (0.51-0.67) and OR: 0.46 (0.29-0.71), in analyses of the 2000 NHIS
(Shih 2008). No difference was found for foreign-born persons residing in the US
for 10-14 years, OR: 0.85 (CI: 0.49-1.46), although the 10-14 years group had a
small sample. Spoken language has been assessed as a CRC screening
predictor in multiple ways. In two small studies, measures of English speaking
proficiency did not predict CRC screening use (Anderson 2011; Homayoon
2013). In two larger studies, language spoken at home did predict CRC
screening use, among Native Americans (Schumacher 2008) and in a nationally
representative sample comparing English and Spanish speakers in the 2004
MEPS (Carcaise-Edinboro and Bradley 2008). Survey language was found to
significantly predict CRC screening use in one larger study of Latinos and nonLatinos in 23 states offering the 2006 BRFSS in Spanish (Diaz 2008). Factors
potentially related to traditional lifestyle (use of traditional medicines, advice from
traditional healer, identity with tribal tradition, identity with non-Native culture and
participation in traditional events) did not predict CRC screening use, in the large
Education Towards Research and Health (EARTH) Study that surveyed 11,358
Native Americans from Alaska and the Navajo Nation (Schumacher 2008).
Health Beliefs
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Three studies are highlighted that examined health belief/psychosocial factors as
a determinant of CRC screening use. In a survey of 158 European Americans,
African Americans and Mexican Americans recruited in public settings in three
zip codes in San Diego selected based on racial representation and median
income below $50,000 (Cronan 2008), greater perceived efficacy of screening
predicted greater likelihood of being up-to-date with recommended CRC
screening; perceived vulnerability also positively predicted screening, but did not
reach statistical significance; while self-efficacy for screening and perceived
barriers were not significant (Cronan 2008). After having sequentially controlled
other covariates in three earlier models, the addition of psychological factors in
the full, final model statistically eliminated the CRC screening disparity between
European and Mexican Americans.
CRCS psychosocial factors were studied at a community health center in the
University of Kansas Medical center in a sample that was majority aged 40-49
(52.9%), African American (69.3%), low-income (70.6% <$1200/month),
unmarried (85%), and had low health care access (44.4% uninsured) (Greiner
2005). In the subset of the sample aged 50 and older, cancer fatalism
significantly predicted returning the FOBT card that had been provided during
survey administration, and not having any FOBT barriers was positively
predictive and nearly reached statistical significance (particular psychosocial
factors derived for the study from focus group responses), OR: 2.72 (CI:0.957.81). FOBT card return did not depend on CRC screening test preference; trust
in health care providers; or having endoscopy barriers.
Differences between population and provider beliefs about CRC screening in
New Mexico were assessed using a primary survey of PCPs in 2006 and the
2004 New Mexico BRFSS CRC screening module (Hoffman 2011). Population
and provider beliefs were dissonant: physicians attributed patient barriers as
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primarily at fault for CRC screening underuse, while the population attributed not
receiving a physician recommendation as the leading barrier.
Preventive Services Utilization
History of receiving preventive services is a proxy for being health-aware and,
therefore, for being more likely to receive other preventive services. Other
cancer screenings have strongly predicted CRC screening use including recent
receipt of mammography (Gonzalez 2012), recent receipt of pap smears
(Schumacher 2008) and for Hispanics having received other non-CRC cancer
screening tests (Gorin and Heck 2005). A study found that having received an
influenza or pneumonia vaccine predicted being up-to-date with CRC screening
(Klabunde 2007). Whether a person takes preventive medications including a
multivitamin or aspirin did not predict CRC screening in two studies (Anderson
2011; Ioannou 2003).
Patient-Provider Communication
In multiple forms, better patient-provider communication predicts CRC screening
use. Reporting “sometimes”, “usually” , or “always” vs. “never” in response to
questions in the Consumer Assessment of Healthcare Providers and Systems
(CAHPS) survey about how often health care encounters in several ways were
satisfying predicted a higher likelihood of ever having received CRC screening
(Carcaise-Edinboro and Bradley 2008). Provider recommendation has
repeatedly strongly predicted CRC screening use (Yepes-Rios 2006; Jo 2008;
Kelly 2007; Cronan 2008). Perceived medical discrimination strongly negatively
predicted being up-to-date with recommended CRC screening with generally
stronger effects for men than women among African Americans, AIANs, Asians
and Latinos (Crawley 2008).
Health Status
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Evidence is mixed regarding whether worse health predicts CRC screening:
worse health predicted CRC screening for measures of perceived health status
(Cokkinides 2011; Shih 2008; Gorin and Heck 2005; Ioannou 2003) and for
having chronic conditions (Klabunde 2006; Schumacher 2008). Other studies
though did not find that worse perceived health status or having chronic or
comorbid conditions predicted CRC screening (Lian 2008; Anderson 2011;
O'Malley 2005; Hudson 2012; Homayoon 2013; Schumacher 2008; Gonzalez
2012). Worse health status may predict CRC screening use because persons in
poorer health have more health care encounters during which a provider could
prompt them to obtain CRC screening.
Need-Based Factors
Any CRC risk factor is a potential CRC screening predictor because by affecting
a person’s CRC risk, risk factors are need-based factors for CRC screening in
the Behavioral Model of Health Services Use since higher risk implies a stronger
recommendation to receive CRC screening.
Medical History
Family history of CRC or any cancer predicted CRC screening use in two large
studies (Schumacher 2008; Murff 2008). One study has evaluated differences in
CRC screening likelihood between African Americans and whites who had a
family CRC history (Murff 2008). Whites had a higher odds of having received
colonoscopy in the past five or ten years, and comparing high and low family
history risk level, whites had an even greater advantage compared to African
Americans in the high risk subpopulation (having a first degree relative who was
younger than 50 years when diagnosed with CRC or having multiple first degree
relatives) than in the lesser risk subpopulation (having only one first degree
relative diagnosed at age 50 or later). CRC-related symptoms, personal CRC
history or irritable bowel disease, strongly predicted recent endoscopy use
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(Mobley 2010), although such use is presumably for diagnostic rather than
screening purposes, which should exclude those individuals from an evaluation
of CRC screening predictors. Breast cancer survivors had a small increased
probability of recent endoscopy, as well (Mobley 2010).
Lifestyle Factors
Evidence on the association between lifestyle factors and CRC screening use is
generally mixed. There have been equivocal findings regarding whether tobacco
use negatively predicts CRC screening (Hudson 2012; Homayoon 2013), does
not predict CRC screening (Lian 2008; Anderson 2011; Gorin and Heck 2005;
Schumacher 2008), or is a protective factor (Soneji 2012). Multiple studies found
that former smokers are more likely to have received CRC screening than never
smokers (Ioannou 2003; Schumacher 2008; Wong and Coups 2011;
Brennenstuhl 2010); that finding may be explained by successful quitters being
more health-aware otherwise and motivated to obtain recommended CRC
screening to reduce their CRC risk. In one study of individuals visiting primary
care practices in New Jersey, non-smokers had greater odds of receiving a CRC
screening recommendation, OR: 1.876 (1.24-2.84), and even greater odds of
adhering to a recommendation, OR: 2.59 (1.52-4.43) (Hudson 2012). Evidence
is also mixed for alcohol use: one study found heavy drinking (2+ drinks/day for
men; 1+ drinks/day for women) predicted endoscopy use (Lian 2008) and one
study did not find an effect for alcohol consumption (2+ drinks/day) on CRC
screening use for men who had been recently screened for prostate cancer
(Wong and Coups 2011). A low-fat diet to prevent heart disease predicted CRC
screening in one study (Ioannou 2003). Evidence is mixed that greater physical
activity predicts increased CRC screening (Ioannou 2003; Wong and Coups
2011) or did not affect it (Lian 2008). Evidence is mixed that obesity predicts
increased CRC screening use (Lian 2008; Soneji 2012; Hudson 2012),
decreased use (for compliance with a free scheduled colonoscopy in a low25

income underserved population) (Anderson 2011), or does not predict use
(Homayoon 2013; Schumacher 2008).
Enabling Factors
Socioeconomic Status
In the Behavioral Model of Health Services Use, individual and community SES
influence a person’s ability to pay for and access health services. Individual SES
has been theorized to act as a fundamental social cause of disease by
determining access to resources that influence health (Link and Phelan 1995).
Multiple individual measures of SES predict CRC screening. Increasing
household income consistently predicts greater use of CRC screening (Shapiro
2012; Cokkinides 2011; Shih 2008; Lian 2008; Miranda 2012; Shavers 2010;
Soneji 2012; O'Malley 2005; Joseph 2012; Ioannou 2003; Carcaise-Edinboro and
Bradley 2008; Homayoon 2013; Schumacher 2008). Higher educational
attainment is also consistently positively predictive (Shapiro 2012; Cronan 2008;
Shih 2008; Lian 2008; Pollack 2006; Miranda 2012; Soneji 2012; O'Malley 2005;
Joseph 2012; Carcaise-Edinboro and Bradley 2008; Homayoon 2013). A
combined income and education criteria (less than a 12th grade education and/or
annual income of less than $15,000) was used to dichotomize low vs. high SES
in one study, which also predicted CRC screening use (Diaz 2008). Employment
status has mixed evidence from multiple studies (Yepes-Rios 2006; Ioannou
2003; Homayoon 2013) including that unemployment or retirement (multivariate
adjusted including age 65+ vs. 50-64) positively predicts CRC screening in
comparison to being employed (Lian 2008; Ioannou 2003). The employed may
be less likely to receive CRC screening because they are unable to leave work to
obtain CRC screening. Respondent’s ability to pay was measured in one study
as whether they stated that cost had prevented a doctor’s visit in the previous
year, which did not significantly predict CRC screening use (Wong and Coups
2011).
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Contextual-level SES effects may also be relevant CRC screening predictors,
although evidence is limited. Medicare beneficiaries living in communities with
generally poorer elderly were less likely in six states and more likely in two states
to have recently received endoscopy (Mobley 2010). In another assessment of a
community-level SES effect on CRC screening, greater area-level poverty
predicted lower CRC screening use after controlling for six sets of individual-level
covariates, and CRC screening use was found to vary across smaller ZIP5 area
codes, but not ZIP3 areas (Lian 2008).
Health Care Access
Greater health care access strongly predicts CRC screening use. Having a usual
source of care consistently strongly predicts CRC screening use (Shapiro 2012;
Shih 2008; Shih 2008; Pollack 2006; Shavers 2010; Klabunde 2006), as well as
having a usual PCP (Jo 2008; Lian 2008; Wong and Coups 2011), having a
longer history with one’s current PCP (Farraye 2004), and having health
insurance vs. not (Shapiro 2012; Shih 2008; Lian 2008; Pollack 2006; Miranda
2012; Shavers 2010; Soneji 2012; Joseph 2012; Ioannou 2003; CarcaiseEdinboro and Bradley 2008; Fernandez 2008; Gonzalez 2012; Wong and Coups
2011). Insurance further predicts CRC screening depending on source of
coverage: both those under 65 with private insurance and those aged ≥65 with
Medicare plus a private supplemental tended to have higher CRC screening use
than their only publically insured age-specific counterparts, although source of
coverage was not independently significant after adjusting for individual-level
covariates (Shapiro 2012).
At the contextual level, living in a state with a greater privately insured portion of
the 50-64 year old population was positively associated with CRC screening use,
although did not independently predict use in multivariate analyses (Cokkinides
2011). In the same study, states with a mandate requiring comprehensive
private insurance coverage for CRC screening procedures that had been in effect
27

for one or more years predicted endoscopy in the previous year in comparison to
states without a mandate or a mandate for less than one year. Provider density
was found to influence CRC screening use (Soneji 2012): increasing
gastroenterologist density positively predicted greater CRC screening use, while
increasing PCP density negatively predicted CRC screening use, although the
authors commented that positive effects for PCP density might have been
masked by other factors including collinearity with gastroenterologist density. In
a sample of 272,077 Medicare beneficiaries in 11 states covered by the
Surveillance, Epidemiology, and End Results (SEER) Medicare cancer registry
who survived from 2000-2005, effects of each gastroenterologist, oncologist, and
nurse density on endoscopy use were mixed across states (Mobley 2010).
Effects were also mixed for density of endoscopy facilities. More difficult
transportation conditions generally had a negative influence on the probability of
receiving endoscopy in some states including having moved to a different zip
code, experiencing greater commuter intensity, and, to a lesser extent, a
respondent’s distance to an endoscopy provider (Mobley 2010).
Health Care Utilization
Health care utilization is an indication of opportunities to receive a CRC
screening recommendation and of a patient’s willingness to encounter the health
care system. A greater number of recent doctor visits strongly predicted CRC
screening use in two studies (O'Malley 2005; Homayoon 2013). Having a checkup or preventive visit in the last year vs. further in the past also positively
predicted CRC screening use (Lian 2008; Ioannou 2003; Klabunde 2006; Wong
and Coups 2011).
Social Ties
Indicators of greater social ties usually predict CRC screening use include being
married or partnered in comparison to not being married (Cokkinides 2011; Shih
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2008; Gorin and Heck 2005; Shavers 2010; Soneji 2012; Hudson 2012;
Homayoon 2013; Klabunde 2006; Wong and Coups 2011); and having an
available next of kin, which predicted 4-5 times greater odds of underserved
individuals following through with a scheduled free colonoscopy appointment
(Anderson 2011). The authors noted that since colonoscopy has become the
overwhelming screening technique of choice, the large majority of patients have
a logistical need for another person to drive them home from the encounter
because of the sedation.
Summary of Colorectal Cancer Screening Predictors
A large variety of factors predicts CRC screening use encompassing
predisposing, enabling and need factors from the Behavioral Model of Health
Services Use. Overall, CRC screening has increased substantially in the last 15
years from less than half of the US population up-to-date with recommended
CRC screening then to nearly two-thirds up-to-date now. Those gains are due to
increasing colonoscopy use, and despite declining FSIG and FOBT use, that can
be attributed to Medicare colonoscopy reimbursement expansions in 1998 and
2001 that lowered financial barriers for colonoscopy and to a shift in provider
opinions favoring colonoscopy.
Amid substantial overall gains in CRC screening use, gains have occurred
broadly with some inequities closing pertaining to predisposing factors,
particularly racial inequities, such that screening rates among whites, blacks, and
Asians are now similar, although inequities persist for AIANs and Hispanics.
CRC screening use varies according to other demographic factors generally
increasing with age, varying substantially across states, and generally being
lower in rural areas, although men and women are similarly likely to be screened.
For minority groups with large immigrant populations, other predisposing factors
salient to CRC screening use include acculturation, such as lower CRC
screening use found among persons born outside the US and among persons
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less comfortable speaking or using English. Some studies have found that
positive health beliefs and attitudes predict CRC screening use, and that health
beliefs are relevant to disparities including racial and ethnic minorities and for
barriers to screening for women. Additional predisposing factors that influence
CRC screening use include having a history of receiving other preventive
services, such as other cancer screenings and immunizations, and having better
patient-provider communication including whether minorities perceive medical
discrimination. Evidence is mixed that worse health status predicts CRC
screening use.
Need-based factors for CRC screening are indicators of increased CRC risk, i.e.
a person is at higher CRC risk that CRC screening potentially would detect.
Some need-based factors pertain to medical history including hereditary or health
status-related risks. Family history of CRC or having CRC-related symptoms
have each strongly predicted likelihood of CRC screening. Other need-based
factors relate to lifestyle risk factors for CRC. Tobacco use generally predicts
CRC screening underuse, although multiple studies have found that former
smokers are more likely to have received screening than never smokers are.
Evidence is mixed for associations between CRC screening and obesity, physical
activity, alcohol consumption and having a healthy diet.
Important enabling factors for CRC screening include SES, health care access,
health care utilization, and social ties. Higher SES generally predicts higher CRC
screening use, often approximated by single-measure proxies such as household
income or education, although less community-level poverty generally also
predicts CRC screening. An exception to higher SES predicting CRC screening
use is the greater likelihood of having received CRC screening among the
unemployed and retired in comparison to the employed, plausibly because of
having more free time to seek CRC screening. Many facets of greater health
care access predict CRC screening use especially having health insurance,
30

having a usual source of care, having a usual PCP, and having a longer history
with one’s current PCP. Effects were mixed for the impact of greater provider
density in a community including of gastroenterologists, oncologists, and nurses,
as well as for the density of endoscopy facilities. Living somewhere with more
difficult transportation conditions was negatively predictive. A persons’ recent
health care utilization history suggests the amount of opportunity they have had
to receive a CRC screening recommendation and willingness/lack of barriers to
encounter the health care system. Having a greater number of recent doctor
visits or having had a more recent checkup strongly predicts CRC screening.
Last, more close social ties generally increases CRC screening use with benefits
to screening use for being married or partnered vs. otherwise and having an
available next of kin to chaperone the patient from a colonoscopy appointment.

Theoretical Framework

The theoretical framework for this study adapts the framework of Tye et al.’s
evaluation of health plan characteristics as predictors of breast cancer screening
mammography (Tye 2004; Tye 2002). Tye et al. began with the commonly used
Behavioral Model of Health Services Use developed by Andersen, Aday and
colleagues (Andersen 1968; Andersen 1995; Andersen and Davidson 2007;
Andersen 2008; Aday, Andersen, and Fleming 1980). In the Behavioral Model,
an individual’s use of health services is influenced by individual and contextual
characteristics that act as either predisposing, enabling or need factors.
Predisposing factors are innate qualities that influence propensity to obtain a
service; enabling factors influence capability to obtain a service; and need factors
indicate perceived need (by the individual) or technical need (based on expert
judgment of the clinician or from evidence-based guidelines) for a service
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(Andersen 1995). Health services utilization contributes to health outcomes, and
the experience from receiving health services and their outcomes provides
feedback that recursively influences a person’s individual and contextual
characteristics and ultimately future health services use.
Tye et al. conducted a literature review to determine organizational and financial
characteristics of health plans that fit in Anderson’s behavioral model as
individual, enabling factors. Although insurance features could be considered
contextual, health plan characteristics were placed at the individual level because
the dataset for their analyses, MEPS, identifies individuals as having certain
health plan characteristics. Several health plan characteristics were classified as
having either an organizational or a financial effect. Tye et al. chose not to use
general health plan categories and/or dichotomous comparisons, such as
managed care vs. indemnity or managed care typologies (e.g. fee-for-service
(FFS), PPOs, HMOs, and point of service (POS)). The broad nature of plan
typologies complicates assessing their effects: the meaning of effects is
obscured by plans within a category varying in their essential features and plans
in different categories sharing features. In addition, although meaningful
differences in service use may be distinguishable by plan type, the specific
feature responsible may be unclear. Instead of using general categories, Tye et
al. decided to assess a set of health plan characteristics as others had done
previously (Conrad 1998; Gold and Hurley 1997; Weiner and de Lissovoy 1993).
Tye et al.’s set of health plan characteristics consisted of eight features: whether
a plan has a defined network of providers; whether coverage for care is restricted
to a network; whether enrollees are required to have a primary care gatekeeper;
the copayment for a physician visit; the deductible amount; the coinsurance rate;
breadth of benefit coverage (medical, dental, vision, and prescription drugs); and
whether a respondent’s health plan used cost containment strategies (e.g.
utilization management; derived from the 1996 MEPS Health Insurance Plan
Abstraction (HIPA) file).
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Tye et al. proposed hypotheses for effects of the health plan characteristics on
utilization of screening mammography, which was informed by causal pathways
derived from two organizational and economic theories. Information-Processing
Theory (Galbraith 1973) was drawn on to propose that organizational
characteristics affect a health plan’s capacity to coordinate and process
information flows. The theory proposes that increasing information processing
capacity enables a health plan to increase awareness of cancer screening
guidelines among providers and patients, which will increase demand for
screening. Financial characteristics were proposed to influence screening by
affecting the out-of-pocket price of mammography, which relates inversely to
demand for screening according to the law of demand from economics and
empirical evidence (Broyles and Rosko 1988), and has been demonstrated
empirically, most notably, by the RAND Health Insurance Experiment (Manning
1987). Using the 1996 MEPS and the adapted Behavioral Model framework, Tye
et al. devised multivariate logistic regression models with a control variable set of
predisposing and enabling factors. Repeated Regressions were conducted to
evaluate each health plan characteristic separately because multicollinearity
between characteristics and missing data for plan characteristics prohibited
testing all characteristics in one model.
This study followed Tye et al.’s theoretical framework and study design to
evaluate insurance features as predictors of CRC screening. Insurance features
were parameterized as discrete organizational and financial features that act as
individual enabling factors, in contrast to categorizations of health plan labels,
typologies, or dichotomous comparisons. The insurance features and covariates
included in multivariate logistic regression analyses were decided based on
evidence from the literature reviews of insurance and non-insurance CRC
screening predictors and by available data in MEPS. Hypotheses for specific
insurance features are proposed in the methods following Tye et al.’s causal
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pathways. The Aim 2 analysis for Western Hispanic and non-Hispanic whites
was derived from the Aim 1 analyses.

Health Insurance Effects Review

Overview of Health Insurance in the US
Americans obtain health insurance from private and/or public sources, although a
large portion of the population remains uninsured; an estimated 47.3 million,
18%, of the nonelderly population (<65 years) were uninsured in 2012 (Kaiser
Commission on Medicaid and the Uninsured 2013). Nearly all the elderly (65+
years) population receives Medicare as a guaranteed entitlement, although
nearly 640,000 elderly (<2%) remained uninsured in 2012 (Kaiser Commission
on Medicaid and the Uninsured 2013). Including all elderly and nonelderly
recipients, Medicare insured over 50 million Americans in 2012, 8 million (17%)
of whom were nonelderly persons with permanent disabilities (The Henry J.
Kaiser Family Foundation 2012). In the nonelderly population (aged <65), 266.9
million in 2012 (of the total 312 million 2012 population), the majority, 55.7% had
employer-sponsored insurance personally or from a spouse or parent; the
second largest portion of the nonelderly, 20.8%, had Medicaid or other public
insurance including the Children’s Health Insurance Plan (CHIP), Medicare, and
military-related coverage; and a small minority, 5.8% had private, non-group
insurance. Considering the extent that being insured actually makes health care
affordable, 31.7 million insured nonelderly persons qualified as underinsured in
2012 (defined as a “household that spent 10% or more of income on medical
care (excluding premiums) or 5% or more if income under 200% poverty”) and
were at risk for not being able to afford needed health care. In total, at least 79
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million Americans were at risk for not being able to afford needed care in 2012
due to being uninsured or underinsured (Schoen 2014).
Population insurance coverage is undergoing a seismic shift due to the full rollout
of the Patient Protection and Affordable Care Act’s (ACA) major provisions in
2014 with uncertain long-term outcomes. During the period from October 1 2013
to May 1 2014, an estimated 20 million Americans gained coverage or have
enrolled in a new insurance offering (Blumenthal and Collins 2014) including an
estimated 8.0 million who obtained insurance through the ACA’s state-based
individual marketplaces, 6.0 million who enrolled in Medicaid or CHIP, 5.0 million
who obtained insurance directly from an insurer, and 1.0 million young adults
aged 19-26 who gained coverage from their parent’s policy. In the most rigorous
calculation to date, researchers have estimated that 57% of enrollees on the
individual marketplaces were previously uninsured, although other survey
estimates ranged from 24-87% (Kliff 2014), so the precise portion of enrollees
who were previously uninsured is unknown. New coverage due to ACA
provisions though undoubtedly represents a substantial reduction of the
uninsured of at least several millions and possibly more than ten million, which is
likely to increase in coming years (Blumenthal and Collins 2014). As noted, the
ways by which the ACA increases the number of insured persons is by easing
enrollment in extant insurance options, rather than introducing fundamentally
new models or entirely replacing existing options. Within and across those
options, insurance features vary, which constrains the interactions and
responsibilities of and between individual enrollees, providers and payers and
ultimately influences enrollees health services utilization including for preventive
services such as CRC screening. In the three largest sources of health
insurance coverage, employer-sponsored insurance, Medicare and Medicaid,
patterns and trends of enrollment in different types of insurance provide an
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indication of the evolving nature of the insurance constraints influencing
enrollees’ utilization including for CRC screening.
Employer-sponsored insurance
In 2013, nearly half of the US population, 149 million nonelderly people, obtained
coverage from employer-sponsored insurance offerings (The Kaiser Family
Foundation and Health Research & Educational Trust 2013). Enrollment by
types of plans has substantially evolved since the intense public focus and statelevel regulatory backlash against managed care in the 1990s (Kronebusch 2009).
In 2000, the proportion of covered workers with conventional FFS coverage was
8% after a steep decline in the previous decade from 73% in 1988, to 46% in
1993, and 27% in 1996 (The Kaiser Family Foundation and Health Research &
Educational Trust 2013). By 2009, the proportion of persons with employersponsored FFS plans dropped below 1%. The proportion of workers in HMO
plans was 14% in 2013 a decline by half from 29% in 2000 (down from a high of
31% in 1996), and Point-of-Service (POS) plans (a hybrid HMO-FFS plan with a
network of providers with lower cost-sharing like an HMO provider and the option
to see non-network providers with higher cost-sharing (Office of Personnel
Management )) have also considerably diminished from a peak of 24% in 1999 to
9% in 2013. Enrollment has increased for two plan types: PPOs are the majority
plan type of covered workers in 2013 (57%) up from 42% in 2000, although the
peak PPO share was 61% in 2005; and high-deductible health plans with a
savings option (HDHP/SO) have a 20% share that has risen from a 4% share
when they were first included in the report for the year 2006 (in the Kaiser Family
Foundation report, the HDHP/SO category refers to the federal legal designation
of such plans, although all HDHP/SOs have an underlying PPO, HMO, POS, or
conventional FFS plan). The trends suggest that employers wanting to offer the
most comprehensive and unrestrictive coverage or employees desiring such
coverage opt for PPOs that have an option of network providers at somewhat
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lower cost, but are less restrictive about access to non-network providers than
other plan types with a greater emphasis on steering enrollees to network
providers. The remaining, more cost-conscious consumers/employers are nearly
split between the less risk-averse who opt for HDHP/SO plans and those who
accept more restrictive HMO or POS plan types with more generous in-network
coverage.
Medicare Managed Care
In 2013, 14.4 million Medicare beneficiaries, 28% of the total 51.4 million, were
enrolled in Medicare Advantage (MA) plans offered by a private company that
contracts with Medicare to provide all Medicare Part A and B benefits (Gold
2013). Current enrollment is an increase from the enrollment low of 5.3 million
MA plan enrollees and 13% of all Medicare beneficiaries in 2003 and 2004. MA
plan enrollment does include private FFS plans, but they had declined to 3% of
enrollees in 2013 from a high of 21% in 2009, so nearly all MA plan enrollees are
in managed care plans. Enrollment grew by 1 million from 2012 to 2013, a 9.7%
increase and by 30% since 2010. The majority, 65%, of MA plan enrollees in
2013 had an HMO plan, a share of enrollees that has been steady recently as
HMO enrollment increased similarly to total MA plan enrollment. The next largest
share of MA plan enrollees, 29%, had local or regional PPOs in 2013, an
increase from a 6% share in 2007.
Managed Care Medicaid
In 2011, 42.4 million Medicaid recipients, 74.2% of the total 57.1 million covered
by Medicaid, were enrolled in a managed care program, an increase from 57.6%
in 2002 (Swisher 2011). Of the 61.5 million Medicaid managed care policies
(19.1 million had more than one plan type), 28.2 million individuals had a
comprehensive coverage plan from either a commercial or Medicaid-only
Managed Care Organization (MCO); 8.9 million had a primary care case
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management plan; and 22.0 million were covered by a prepaid inpatient or
ambulatory care health plan for specific services (e.g. dental or long-term care)
that is a narrower breadth of services than what is considered comprehensive
coverage.
Current Composition and Trends in Health Plan Enrollment Summary
Collectively these figures suggest approximately two-thirds of Americans, around
200 million people, possess health plans that belong to the general umbrella of
managed care (commercial, Medicare or Medicaid plans labeled HMO, POS,
PPO, or HDHP/SO). Plans vary in the extent of how managed they are. The
large share of the employer-sponsored insurance population with PPO plans,
~85 million people, receive and are reimbursed for health services in much the
same way as traditional FFS plans except for having preferred provider networks.
As discussed before, labels belie a health plan’s underlying makeup, but the
enormous number of Americans identified as belonging to some kind of MCO
indicates that the constituent insurance features that make up health plans
influence all Americans’ health services use, directly as plan holders or indirectly
through spillover effects on the greater health care system.
Summary Measures of Health Plan Performance
A few sources offer summary assessments of performance by types of health
plans. HEDIS reports annual health plan performance covering 136 million
Americans enrolled in HMOs and PPOs in the commercial nonelderly and MA
markets (National Committee for Quality Assurance 2013). HEDIS is used to
inform health plans’ internal efforts to improve quality, to inform NCQA’s
accreditation of health plans, and to rank quality across health plans. Although
summary metrics have been devised to summarize performance across HEDIS
measures (Reid 2010), deriving such metrics is difficult because either all
individual HEDIS measures have to be assumed equally important or justification
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needs to be provided for weighting measures unequally and/or considering only
subgroups of measures. In addition, the composition of HEDIS measures
evolves because NCQA’s review process adds to, drops and modifies measures
annually, which makes assessing HEDIS trends difficult, as well; although NCQA
reports that most measures improve over time (National Committee for Quality
Assurance 2013).
Literature sources that review summary domains of performance (i.e. not
individual process and outcomes measures as HEDIS assesses) for health plans
by type are dated. Miller and Luft published three literature reviews of managed
care performance covering 1980-2001 (Miller and Luft 1997; Miller and Luft 1994;
Miller and Luft 2002). The last review of HMO plan performance from 1997-2001
(Miller and Luft 2002) found that quality of care was similar between HMOs and
non-HMOs; some evidence suggested that HMOs had lower use of expensive
services including hospitals; and that HMO enrollees generally experienced
poorer access to care and had lower satisfaction levels. In their 1997 review of
managed care plan performance (Miller and Luft 1997), Miller and Luft found that
managed care plans generally had reduced use of more expensive services,
increased outpatient services, and had inconsistent effects on hospital care,
access and quality. Miller and Luft warned that the literature had largely varying
technical rigor and generalizability and often was older with limited relevance to
the current makeup of managed care. No similarly comprehensive assessment
of managed care plan performance (or a more comprehensive review
distinguishing health plan types and features) was found since Miller and Luft’s
2002 review.
Managed Care and Preventive Services Use
Miller and Luft (Miller and Luft 2002) detailed general effects of HMO
membership on preventive services use. HMOs in comparison to non-HMOs had
predominantly favorable preventive service use with no unfavorable findings. For
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preventive services that HMOs probably had less cost-sharing for than nonHMOs (cancer screenings and flu shots), 12 of 31 study findings were
predominantly favorable to HMOs with no predominantly unfavorable findings.
For preventive services where HMOs likely provided equivalent financial
coverage as non-HMOs (blood pressure checks, clinical breast exams, digital
rectal exams and smoking advice), two of nine results were predominantly
favorable for HMOs with no predominantly unfavorable results.
Managed Care and Overuse of Health Care Services
Studies comparing FFS and managed care populations were included in a recent
systematic review of overuse of health care services in different health care
systems/coverage models with inconclusive findings (Keyhani 2010). Managed
care and FFS covered populations were compared in four studies and found
similar rates of inappropriate use of cardiology procedures, and mixed findings
regarding inappropriate antibiotics use and inappropriate diagnostic testing for
respiratory conditions. Only one of the studies included in the review was
published since 2000, and the authors concluded that the evidence on overuse in
different systems of care is limited and does not suggest any particular system
that best reduces overuse.
Summary of Overall Health Plan Performance
Evidence is limited for summarizing health plan performance. HEDIS measures
are reported annually for health plans that provide coverage to 44% of
Americans, although NCQA does not report summary metrics of overall
performance (National Committee for Quality Assurance 2013). In the most
recent review of managed care plan performance (Miller and Luft 2002), quality
of care was similar for HMOs and non-HMOs, although the authors cautioned
that the methodological quality of the literature varied, and it is now very dated.
Similar caveats were stated in a more recent systematic review of the overuse of
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health care services in different systems that found similar overuse of services
between managed care and FFS covered population (Keyhani 2010).

Health Plan Colorectal Cancer Screening Performance
In the 2012 HEDIS, the CRC screening measure estimated that 63.3 and 55.8%
of eligible persons in commercial HMOs and PPOs, respectively, and 62.1 and
58.4% of eligible persons in Medicare HMOs and PPOs, respectively, were upto-date with recommended CRC screening defined as colonoscopy in the
previous ten years, FSIG in the previous five years, or FOBT within the last year
(National Committee for Quality Assurance 2013). Over time, there has been a
general trend of better performance on the CRC screening measure for all plan
types since the early 2000s. Two studies have assessed the effects of Medicare
plan types on CRC screening use.
Medicare Plan Types
Using data from 10,173 Medicare beneficiaries in the 2000 Medicare Current
Beneficiary Survey (MCBS) (Schneider 2008b), differences in CRC screening
use across Medicare plan types were compared (FFS with supplemental
insurance; FFS with no supplemental; and Medicare managed care (MMC) for
each having received 1) endoscopy in the past five years, 2) FOBT in the past
two years, or 3) overall being up-to-date with screening by either technique.
Schneider et al. had hypothesized that MMC plans favored a cost-effective
screening strategy emphasizing FOBT and limiting more expensive endoscopy
use while FFS Medicare with supplemental insurance would increase endoscopy
use by reducing coinsurance. In propensity score adjusted analyses, MMC
predicted greater FOBT use and overall screening than FFS without
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supplemental coverage, although endoscopy use alone was similar, consistent
with first hypothesis. FFS with supplemental insurance in comparison to MMC
predicted increased odds of endoscopy and overall CRC screening, although
FOBT use was similar between the two plan types, consistent with the second
hypothesis. Schneider et al. reasoned that the findings accorded with policy
changes around that time following CMS initiating coverage of FOBT, FSIG, and
DCBE for average-risk beneficiaries in 1998, but before expanding coverage to
include colonoscopy in 2001 (Gross 2006). In another study using the 2000
MCBS, but examining beneficiaries who had a usual physician (O'Malley 2005),
HMO beneficiaries had higher odds of overall CRC screening (defined as
endoscopy in the past five years or FOBT in the previous year) than FFS
beneficiaries.
Managed Care Medicare Penetration Spillover Effects
In the 11 state analysis of FFS Medicare beneficiaries included in the SEER
cancer registries from 2000-2005 (Mobley 2010), MMC penetration spillover was
measured as the proportion of Medicare beneficiaries enrolled in MMC
organizations in a Primary Care Service Area (PCSA) (a set of validated
geographic units more numerous than counties developed by Dartmouth
researchers designating natural PCP markets derived from Medicare patients
flows to PCPs (Goodman 2003)). Significant coefficients for this variable were
reported at the α = 0.10 level because of its policy importance. For each
percentage point increasing in MMC penetration, the probability of endoscopy
use decreased in eight states by 0.05-0.6%, while Iowa was the only state to
experience positive effects, 0.25% increase in probability of endoscopy use for
each percentage point increase in MMC penetration. The authors commented
that these effects are consistent with Schneider et al.’s findings that MMC favors
FOBT over endoscopy in comparison to FFS Medicare, and the finding may be
explained by spillover of managed care practices and/or if increased managed
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care penetration limited the supply of endoscopic services by discouraging entry
of providers.
Summary of Health Plan Colorectal Cancer Screening Performance
HEDIS performance for CRC screening is the percentage of the covered eligible
population up-to-date with recommended CRC screening and had a range of
55.8 to 63.3% for commercial and Medicare HMOs and PPOs in 2012 (National
Committee for Quality Assurance 2013). In HEDIS 2012, HMOs outperformed
PPOs in both the commercial and Medicare markets, and commercial HMOs
achieved higher screening rates than Medicare HMOs, while Medicare PPOs
achieved higher rates than commercial PPOs. Studies have assessed CRC
screening use by screening strategy, and findings suggest that MMC plans
favored FOBT over endoscopy before Medicare expanded colonoscopy
reimbursement to all average risk persons. Using 2000 Medicare data,
hypothesized effects of Medicare plan types on the use of endoscopy vs. FOBT
were substantiated (Schneider 2008b): MMC predicted greater low-cost FOBT
use while Medicare FFS with a supplemental predicted greater endoscopy use.
In another study of Medicare FFS beneficiaries from 2000-2005 (Mobley 2010),
increasing MMC penetration, a greater proportion of MMC enrollment in a market
area, was found to generally predict lower endoscopy use in Medicare FFS,
plausibly due to hypothesized managed care spillover effects. No more recent
studies were found addressing variations in use of different CRC screening
strategies for nonelderly/non-Medicare commercial health plan types.
Health Insurance Attributes Literature Review
A formal literature search in PubMed covering the previous ten years was
conducted on 06/08/2013 to obtain evidence regarding insurance features that
might predict CRC screening use. General insurance terms and terms for types
of health insurance were paired with specific phrases that would suggest health
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insurance attributes or would suggest a study used the Behavioral Model of
Health Services Use (Andersen 1995): ("Insurance, Health"[Mesh] OR "fee-forservice" OR "health maintenance organization" OR "preferred provider
organization" OR "point of service" OR "independent practice association" OR
"health insurance" OR "health plan" OR "managed care") AND (typolog* OR
"system factors" OR "system characteristics" OR Andersen[tiab] OR "behavioral
model" OR "predisposing characteristics" OR "enabling characteristics"). The
search was designed to generate a breadth of evidence, although the challenge
of searching this topic without any standardized terminology prohibited
conducting a more sensitive search due to the reduced specificity that would
have been necessary. The findings are supplemented with relevant literature
found elsewhere. The literature search generated 107 results from 2003 to 2013;
14 studies were obtained and reviewed; and six were determined to have studied
insurance features effects on health services use. Four additional articles were
identified from reference lists and the literature search of CRC screening
predictors. The findings pertain to provider factors, cost-sharing, and composite
measures of managed care.
Summary of insurance feature Literature search
The insurance feature literature search findings identified many potential
influences of insurance features relating to provider arrangements, cost-sharing,
and composite measures of managed care (Table 2.1).
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Table 2.1 Features Identified by Insurance Features Literature Review
Perspective

General Factors

Enrollee

Cost-sharing

Consumer Access*

Consumer Protection*

Provider

Contractual
Relationships*

Professional Autonomy*
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Specific Factors
Favored services/tiered
cost-sharing
Deductible Amount
First-dollar coverage for
preventive services
Standing referrals for
chronically ill
Exemptions from prior
authorization
Ombudsperson program
Right to sue health plan
Time limit for approval
decisions/internal
appeals
External review
procedures required
Prompt payment to
providers
Whether there are “Hold
harmless” provisions
Providers can learn
review criteria
Reviewer is professional
peer
Internal appeals are
reviewed by professional
peer
Limit financial incentives
for utilization review
employees
Prohibit discharge of
physicians for
nonmedical reasons
Prohibit “gag clauses”

Whistle-blower
protections
Require that medical
director be licensed in
state
Nature of risk or
rewards to providers

Medical Group

Organization

Basic compensation to
medical group

Withholds for ER use
Bonuses for (relevant)
preventive service use
% of (relevant) MD type
in PCP or specialty
network
Use of nurse/mid-level
provider coordinators
% of providers paid by
FFS
% of providers paid by
salary

*All from Kronebusch et al. 2009

Four studies reported findings pertaining to provider arrangements. First,
physician gatekeeping was associated with delays in melanoma biopsy, but no
change in health outcomes (Swetter 2007). Second, individuals cared for in their
last year of life by physicians compensated on a FFS basis rather than capitation
had more prescription drug fills, prescription drug claims and out-of-pocket
expenditures (Fahlman 2006). Third, a Medicare beneficiary having specialists
available when s/he thought they were needed significantly positively predicted
recent CRC screening (O'Malley 2005). Last, percentage of practice revenue
from managed care did not influence utilization of six common preventive
services by the practice’s Medicare patients including lower endoscopy (Pham
2005).
Three studies reported findings on cost-sharing effects. First, for every 1% point
increase in the proportion of family income spent on all health care out-of-pocket
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payments, child asthma exacerbations increased 14% (Ungar 2011). Second,
first dollar (zero deductible) coverage of preventive services contributed to
increased use of four common preventive services assessed, which included
FOBT, in comparison to a control health plan without first dollar coverage, and
preventive services use gains were greater for a low deductible group within the
first dollar coverage cohort than a high deductible group (Meeker 2011). The
authors proposed that individuals who select high-deductible plans are
predisposed to use fewer health services for fundamental unobserved reasons.
Third, having a higher copayment for brand name prescriptions (>$5 in 1998)
reduced prescription drug switching from initial using lansoprazole, the proton
pump inhibitor (PPI) that did not have direct-to-consumer advertising, to
subsequently using of omeprazole, the PPI with direct-to-consumer advertising
(Hansen 2005), while having a deductible for outpatient services predicted higher
switching.
Three studies reported findings on composite measures of managed care. First,
practicing in a state with high managed care state-level regulations vs. no
regulations generally predicted higher physician-level satisfaction on measures of
clinical practice for physicians with a high portion of practice with managed care
enrollees, but markets with greater managed care activity (measured by the
market HMO penetration rate) in states with high state-level managed care
regulations did not experience satisfaction effects at the market-level
(Kronebusch 2009). Second, in a study assessing the health services utilization
of children with special health care needs (CSHCN), principle component and
factor analyses were used to derive three MCO indices of composite MCO
qualities, and their effects were assessed: 1) the Pediatrician-Focused Index
predicted lower outpatient and inpatient use; 2) the Specialist-Focused Index
predicted increased ER visits; and 3) the FFS MCO Index predicted greater
outpatient use and charges. Third, examining the same sample of CSHCN as in
the previous study, an increased likelihood of CSHCN receiving an outpatient
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specialty care visit was predicted by a higher percentage of pediatricians in a
MCO’s PCP network, a lower percentage of network PCPs paid on a FFS basis
versus capitation, and giving bonuses to PCPs for high quality care were
associated with increased odds of receiving an outpatient specialty care visit,
while visits were not predicted by prior authorization exemptions for CSHCN or
percentage of MCO PCPs who were salaried (Shenkman 2005).
Summary of Health Insurance Effects
Overall, the review of health insurance effects on health services utilization did
not provide substantial evidence that pertains to insurance feature effects on
CRC screening. The present enrollment composition of health plans indicates
that managed care network restrictions and cost controls are ubiquitous today,
although the continued popularity of PPOs with less restrictive network rules and
the rising share of persons covered by HDHP/SO plans indicates that access to
providers and affordability are clearly key concerns for consumers (The Kaiser
Family Foundation and Health Research & Educational Trust 2013). Long-term
trends for annual HEDIS measures show that health plan performance on some
process and outcome measures of quality has been improving across plan types
(National Committee for Quality Assurance 2013). For CRC screening
performance specifically, the HEDIS CRC screening measure indicates that
HMOs achieve higher CRC screening rates than PPOs, and study findings
suggest that consistent with expected organizational incentives, MMC plans have
historically favored lower cost FOBT compared to endoscopy procedures
(Schneider 2008b).
A systematic literature search discovered only three findings that pertained to
CRC screening utilization specifically; first-dollar coverage of preventive services
increased FOBT use in a commercial health plan compared to a control plan
without first-dollar coverage (Meeker 2011); believing that specialists were
available when desired predicted increased CRC screening use (O'Malley 2005);
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and percentage of practice revenue from managed care did not affect use of six
preventive services including lower endoscopy (Pham 2005). Many of the
variables in these studies may be unlikely to affect CRC screening use because
the questions they were originally used to assess are not relevant to whether an
individual receives CRC screening (e.g. coinsurance effects on medication
utilization and MCO characteristics’ effects on CSHCN receiving needed
services). Even if variables are specified in a way that is applicable to CRC
screening, including them in analyses depends on their availability in MEPS,
which may be limited. In addition, even though the insurance feature literature
search was constrained to the previous ten years, the findings mostly pertain to
data from the late 1990s and early 2000s and therefore do not indicate more
recent evolving or emerging influences of insurance features.

Full Literature Review Summary

CRC causes substantial morbidity and mortality. CRC incidence and mortality
increases with age, is greater for men than women, and is particularly high for
African Americans compared to other racial and ethnic groups. Other racial and
ethnic minorities (Asians, Hispanics, and AIANs) generally have CRC incidence
and mortality rates lower than the population average, as well as rates among
whites and non-Hispanics (Surveillance, Epidemiology, and End Results
Program 2013). CRC risk increases due to medical history factors including
family history of CRC and personal history of some gastrointestinal conditions
and due to lifestyle risk factors including obesity and cigarette smoking. Overall
five-year survival is 64.9%, although prognosis varies from >90% survival for
earliest stage cancers to <10% survival for late stage cancers, which provides
the rationale for routine CRC screening by detecting cancers earlier and
removing pre-cancerous polyps.
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Rates of CRC screening use have increased substantially since the 1980s,
driven by increased colonoscopy use after Medicare’s reimbursement
expansions (Gross 2006) and by a shift in provider opinion (Klabunde 2009). A
large number of diverse factors predict CRC screening use, which were reviewed
and organized according to the Behavioral Model of Health Services Use
framework as predisposing, enabling, and need-based factors (Andersen 1995).
Predisposing factors include the categories of demographics, acculturation,
health beliefs, preventive services utilization history, patient-provider
communication, and health status; need-based factors include the categories of
medical history related to CRC risk and risk-modifying lifestyle factors; and
enabling factors include SES, health care access, health services utilization
history, and social ties. The large number of factors influencing CRC screening
implies many potential origins and mechanisms contributing to disparities and
many potential avenues for promoting CRC screening to under screened groups.
To evaluate the influence of insurance features on CRC screening use, this study
adopted Tye et al.’s framework based on the Behavioral Model of Health
Services Use specifying insurance features as individual enabling factors. By
assessing insurance features instead of types of health insurance, the study
attempted to isolate effects of specific insurance features. Testable hypotheses
of insurance feature effects are guided by organizational theory that insurance
features affect CRC screening use among enrollees by influencing a health
insurer’s information-processing capacity that affects how effectively an insurer
communicates appropriate CRC screening to providers and enrollees (Galbraith
1973), and by economic theory, which posits that insurance features can
influence the inverse relationship between out-of-pocket costs and demand for
CRC screening (Manning 1987).
An informal review of general effects of health plan types and a systematic
review of insurance feature effects were conducted to inform the selection of
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insurance features for analysis. The informal review of general effects of health
plans by type provided a small amount of mostly dated evidence. Health plan
performance for a couple big categorizations (HMOs vs. PPOs and Commercial
vs. Medicare markets) is reported annually by NCQA in the HEDIS measures,
which have generally improved over time including CRC screening, although
NCQA does not aggregate HEDIS performance into assessments of general
performance domains for different type of health plans or by insurance features
(National Committee for Quality Assurance 2013). Reviews of studies of health
plan performance by type concords with expected effects: MCOs tend to have
lower use of expensive services and have lower performance on patient access
and satisfaction than FFS plans (Miller and Luft 2002). General effects of health
plans on CRC screening performance include improving HEDIS performance
over time and the consistently higher rates of CRC screening for HMOs
compared to PPOs (National Committee for Quality Assurance 2013).
Additionally, literature evidence suggests that MMC plans in comparison to
Medicare FFS plans prefer low-cost FOBT CRC screening to endoscopic CRC
screening (Schneider 2008b). The systematic literature search of insurance
feature effects yielded a small number of studies. Many insurance features were
suggested in the studies pertaining to provider arrangements, cost-sharing and
composite measures of managed care, although it is unlikely that the influences
of insurance features assessed in the reviewed studies would be helpful for
determining insurance feature effects on CRC screening.
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Chapter 3
Methods

This section details the study design, data sources, eligibility criteria, study
variables, data management and statistical analyses for each specific aim.
Study Design
The study is a cross-sectional analysis of secondary survey data assessing the
association between insurance features and likelihood of being up-to-date with
recommended CRC screening. The dependent variable, insurance features, and
control variables were derived from literature review findings and available
measures in the data. The study sample was all respondents in the survey data
who were eligible for CRC screening. Effects of insurance features on CRC
screening likelihood were estimated in multivariate logistic regression models
with several alternate specifications of covariates decided after preliminary
diagnostic analyses. Each insurance feature was evaluated separately because
of collinearity between features. Analyses were guided by the Behavioral Model
of Health Services Use, and hypotheses for the effects of insurance features
were informed by economic and organizational theory.
Data Sources
The data source for this analysis was the MEPS Household Component (MEPSHC), the primary component of the family of MEPS health and health services
utilization surveys, produced by AHRQ, which has a unique breadth of
information on insurance coverage details, CRC screening use, and
demographic and socioeconomic predictors of CRC screening (Agency for
Healthcare Research and Quality 2010). The MEPS-HC is a nationally
representative sample of the civilian non-institutionalized population and collects
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information pertaining to household and individual-level demographics and SES;
health status, medical conditions and health behaviors; health care encounters,
payments and sources of payment; and health insurance characteristics. MEPSHC data was pooled from the years 2011, 2010 and 2009.
The MEPS-HC uses an overlapping panel design whereby a new respondent
panel is formed each year and surveyed five times over two years by computerassisted personal interviewing (CAPI) (Agency for Healthcare Research and
Quality 2013c). Each new panel is sampled from the previous year’s NHIS,
which is produced by the National Center for Health Statistics (NCHS). The
primary MEPS-HC data file is the full-year consolidated file. The 2011, 2010,
and 2009 MEPS-HC sampled 33,622 persons (13,449 families) from panels 15
and 16; 31,228 persons (12,445 families) from panels 14 and 15; and 34,920
persons (13,875 families) individuals from panels 13 and 14, respectively. The
combined response rates for each of the 2009, 2010 and 2011 full year files were
57.2%, 53.5% and 54.9%, respectively. Individuals who appeared twice in the
pooled 2009-2011 dataset (panels 14 and 15) were included in the analyses
twice, which was recommended by MEPS for this study’s multiyear crosssectional analyses by using appropriate survey analyses (rather than only
including them in only one of their two appearances) (Zibman 2014). In addition
to the full-year consolidated file, the Medical Conditions File, one of the other
MEPS-HC data files, was used to derive a comorbidity index (Agency for
Healthcare Research and Quality 2013a). The study exclusively used deidentified data, so institutional review board approval was not needed.
Eligibility Criteria
MEPS respondents were included in the study if they were aged 50-75, did not
have a prior CRC diagnosis, were insured for any amount of time during the year,
and had been “in scope” for the entire survey year (had responded during all
scheduled interview rounds in the survey year) (2009, 2010 or 2011).
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Study Variables

Dependent Variable
The outcome measure for CRC screening status was a binary variable for
whether a person had received CRC screening by any technique within the
USPSTF recommended time intervals (US Preventive Services Task Force
2008). According to the Grade A recommendation for average risk persons aged
50-75, acceptable screening techniques and intervals are 1) a colonoscopy every
ten years, 2) FSIG every five years with FOBT every three years, or 3) FOBT
annually. The MEPS questionnaire asks when a respondent last received each
test (within the past one, two, three, five, or ten years, more than ten years, or
never), which was used in this study to determine if a respondent was up-to-date
with the recommendations. Persons with missing values for all CRC screening
techniques were conservatively assumed not up-to-date with CRC screening.
The 2008 USPSTF recommendations were used, although other notable
guidelines with minor differences were also released around that time including,
in 2008, the “joint effort of the American Cancer Society, US Multisociety Task
Force on Colorectal Cancer, and American College of Radiology”, (McFarland
2008), and, in 2009, the American College of Gastroenterology (Rex 2009). All
of the guidelines agree that routine screening for average risk persons should
begin at age 50 (the American College of Gastroenterology uniquely
recommends that African Americans should start screening at 45 (Rex 2009)),
and have screening strategy recommendations and time intervals that are very
similar to the USPSTF. The USPSTF uniquely asserts that FSIG within the past
five years should be accompanied by FOBT every three years based on findings
from a meta-analysis and modeling simulation of different screening strategies
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(Whitlock 2008). The USPSTF concluded that the evidence was insufficient to
recommend CT colonography and fecal DNA testing and was sufficient to
recommend against DCBE, although the other guidelines have recommendations
for each of those techniques. While the other guidelines do not declare a stop
age for CRC screening (Rex 2009; McFarland 2008), the USPSTF guidelines
recommend stopping routine CRC screening at age 75. The USPSTF
recommendations have been used to define being up-to-date with CRC
screening in recent benchmark estimates of the percentage of the national
population that was screened using national survey data (Klabunde 2013;
Shapiro 2012; Joseph 2012). By specifying the dependent variable in this study
consistent with the main USPSTF screening recommendation for those aged 5075, this study focused on the segment of the population that is most universally
agreed upon by all guidelines and was consistent with recent benchmark
estimates of national CRC screening use.
Control Variables
Different combinations of CRC screening predictor covariates were controlled for
in several models. Table 3.1 lists the relevant control variables that were
available in MEPS for all three data years. All control variables were derived
from respondent self-report either in the full-year consolidated file or the Medical
Conditions File for self-reported medical conditions, which were used to compute
the updated Charlson comorbidity score (Quan 2011). The available control
variables encompassed all three domains of factors that influence health services
use according to the Behavioral model, which are predisposing factors:
demographics, acculturation, preventive services utilization and health status;
need-based factors: lifestyle factors and personal medical history; and enabling
factors: education/income, health care access, and social ties. Fixed effect
dummy variables for survey year were included in all models.
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Table 3.1 Control Variables
Variable

Levels

Predisposing Factors
Demographics
Age

Continuous

Sex

Male/Female
White, non-Hispanic
White, Hispanic
Black, non-Hispanic
Asian, non-Hispanic
Other
Northeast
Midwest
South
West

Race/Ethnicity

Census region

Metropolitan Statistical Area

Yes/No
Acculturation

Immigration status

US born
Foreign born, lived in US <15 years
Foreign born, lived in US >15 years

Whether comfortable speaking English

Yes/No

Survey Language

English
Spanish/English and Spanish/Other
Preventive Services Utilization
Twice a year or more
Once a year
Less than once a year
Never go to the dentist
Within the last year
Within past two years
More than two years
Never

Dental check-up frequency

Most recent flu vaccine
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Table 3.1 (cont.)
Health Status
Excellent
Very good
Good
Fair/Poor
0
1
2
3 or more comorbidities

Self-reported health status

Comorbidity (Quan et al.’s updated
Charlson’s comorbidity index)

Need-Based Factors
Lifestyle Factors
Current smoker

Yes/No

Body mass index

Underweight
Normal weight
Overweight
Obese
Personal Medical History

Personal cancer diagnosis other than
CRC

Yes/No

Enabling Factors
Education/Income
Less than a HSD
HSD/GED
Bachelor’s degree
Graduate/Doctorate degree
Other degree
<100%
100-200%
200-400%
>400%

Educational attainment

Household income (% of the federal
poverty level)
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Table 3.1 (cont.)
Health Care Access
Having a usual source of care

Yes/No

1-6 months
7-11 months
Continuous coverage
Zero
Number of office-based physician/nurse One
practitioner/physician’s assistant visits
Two
in last year
Three
Four or more
Months of insurance coverage in
survey year

Social Ties
Married
Widowed
Divorced/Separated
Never Married

Marital status

HSD: high school degree; GED: general educational development
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Insurance Features
Insurance features were the primary independent variables of interest, which act
as individual enabling factors. Organizational health plan features and whether a
respondent’s household had a FSA were derived from self-reported health plan
characteristics in the Managed Care (MC) questionnaire section. Self-reported
responses are obtained using computer-assisted personal interview, which
includes questions, instructions, help available with definitions for key terms (e.g.
HMO, primary care doctor, and routine care), and skip patterns depending on the
topic and a respondent’s answers. Cost-sharing percentage was calculated
using payment amount and sources of payments data. Insurance features and
variable levels are listed in Table 3.2.
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Table 3.2 Insurance Features (Enabling Factors)
Variable

Levels

MEPS Criteria for
having feature

Organizational
Whether respondent’s
insurance defined a
provider network (DPN)

Yes/No

Whether respondent’s
insurance restricted
coverage to a DPN

Yes/No

PRVDRL31/42/11 = 1
or PRVHMO31/42/11 = 1
or MCDHMO31/42/11 = 1
PRDRNP31/42/11 = 2
or PHMONP31/42/11 = 2
or PMNCNP31/42/11 = 2
(No if INSURC11 = 4 or 6)

Whether insurance used
gatekeeping

PRVMNC31/42/11 = 1

Yes/No

or MCDMC31/42/11 = 1
or PRVHMO31/42/11 = 1
or MCDHMO31/42/11 = 1
Financial

Cost-sharing categories

 0%
 Top fifth percentile of costsharing distribution
 Internal tertiles of costsharing distribution (other
than 0% and top fifth
percentile)
 Those with no spending in
the survey year

Yes/No
Whether respondent’s
family had a Flexible
Spending Account (FSA)

Cost-sharing computation:
TOTSLF09/10/11 /
TOTEXP09/10/11
Variable categories:







0% cost-sharing
>0% to 35th percentile
35th to 65th percentile
65th to 95th percentile
95th percentile to 100%
TOTEXP11 = 0

FSAGT31 = 1
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Organizational Features
Having a DPN
Respondents were identified as having insurance with a DPN if the respondent
reported being in an HMO from a private source (PRVHMO31/42/11 = 1) or
through Medicaid (MCDHMO31/42/11 = 1), or if they reported having “coverage
by a private insurance source that has a book or list of doctors”
(PRVDRL31/42/11 = 1).
Provider network restrictions
Respondents were defined as having insurance that restricted care to a coverage
network if the respondent reported having insurance that does not pay for visits
to non-plan doctors without a referral (PRDRNP31/42/11 = 2, or
PHMONP31/42/11 = 2 or PMNCNP31/42/11 = 2). The MEPS variables used to
construct this variable only apply to those with any private insurance, i.e., those
who are privately insured under age 65 and MA beneficiaries. Medicare
recipients without any private insurance (i.e. traditional FFS Medicare) were
assumed to not have provider network restrictions (INSURC11 = 4 or 6;
INSURC11 was introduced in MEPS 2011, so was manually derived to use with
MEPS 2009 and 2010). Whether individuals under age 65 with only public
insurance had coverage restricted to a DPN could not be ascertained, so those
respondents were excluded from analyses of this variable.
Gatekeeper requirement
Respondents were defined as having insurance that used gatekeeping if the
respondent reported being in an HMO (PRVHMO31/42/11 = 1
or MCDHMO31/42/11 = 1) or being in a gatekeeper plan from any private
insurance (PRVMNC31/42/11 = 1) or Medicaid (MCDMC31/42/11 = 1) meaning
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the respondent was required to sign up with a gatekeeper for all routine care
(physician, group of doctors or clinic).
Financial Features
Cost-sharing percentage
A respondent’s level of cost-sharing in the survey year was estimated by
computing the proportion of total expenditures that were paid out-of-pocket by
the respondent (TOTSLF09/10/11 / TOTEXP09/10/11), which corresponds to a
percentage from 0% to 100%. Cost-sharing percentage could not be estimated
for those who did not have any spending in the survey year (TOTEXP09/10/11 =
0). The cost-sharing distribution had decreasing density of respondents from to
zero to 100% with a bolus of people at each 0% and 100%. The boluses and
persons with no spending potentially contain unique population segments. At the
low end of the cost-sharing distribution, those with zero cost sharing were
probably more likely to be recipients of public insurance, Medicaid or other
programs with zero cost-sharing, and made up ~6% of each sample. Having
zero cost-sharing because of having public insurance suggests this segment of
the distribution was more likely poorer and disadvantaged in other ways. The
disadvantage in the population segment with 0% cost-sharing was expected
would reduce the likelihood of being up-to-date with recommended CRC
screening independent of the effect of having zero or extremely low cost-sharing.
It is not clear what would be the net effect to screening use for this population
segment when also accounting for the cost-sharing effect.
At the other end of the cost-sharing range, two possible, non-exhaustive
explanations for having 100% or close to 100% cost-sharing were that a
respondent had insurance with a high deductible, which was not exceeded in the
year, or that a respondent was only insured for part of the year and only or
primarily had health care expenses during the time that they were uninsured.
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These two explanations did not suggest a single gestalt for those with 100% or
near 100% cost-sharing, so it is unclear what would be the ultimate effect on
screening use for this population segment.
The ultimate effect of cost-sharing at each end of the cost-sharing distribution is
unclear and may not accord with the expected inverse relationship between costsharing and utilization (Manning 1987). In consideration of this ambiguity, costsharing was specified as a categorical variable cutting the cost-sharing
distribution into five levels. The first level was those with no (0%) cost-sharing
(approximately 6% of the distribution as previously noted) and the fifth level was
the top 5% of the cost sharing distribution (95th percentile to 100% cost-sharing)
for the practical analytic purpose of ensuring that all samples had at least 100
respondents in the highest cost-sharing category. The remaining internal
distribution was split into three groups, so each includes approximately 30% of
the sample (>0% to the 35th percentile, 35th to 65th percentile, and 65th to 95th
percentile). Sample weights were accounted for when splitting the cost-sharing
distribution. Those without any medical spending in the survey year were
included in the cost-sharing variable as a sixth category. Not having any
spending in the survey year suggests a person did not encounter the health care
system in the survey year, which may indicate that the person was fairly healthy
and/or not health aware, although the ultimate implication for CRC screening use
among those without any spending is unclear. The procedure for constructing
the categorical variable was repeated separately for each sample.
Flexible Spending Accounts
A binary variable for whether a respondent’s household had a FSA in the survey
year was included for the first time in the 2011 MEPS. A FSA is an employerestablished savings account that the employee funds with pre-tax dollars and can
use to pay for qualified out-of-pocket medical expense (Internal Revenue Service
2013). FSA funds are “use-it-or-lose-it”: remaining funds in the FSA account are
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forfeit at the end of the plan year, although plans are allowed to permit a grace
period of up to 2.5 months into the following plan year during which the funds
may be used. The literature review findings and causal pathways used from Tye
et al. did not provide immediate guidance for how having a FSA account might
affect CRC screening use. For these analyses, it was assumed that having an
FSA (FSAGT31 = 1) suggests that a person is health aware, so those who have
FSAs were expected to be more likely to be up-to-date with recommended
preventive services including CRC screening. Analyses for the FSA variable are
restricted to the MEPS 2011 sample.
Data Management
The 2009, 2010 and 2011 MEPS Household Components and Medical
Conditions files were freely downloadable on the MEPS website (Agency for
Healthcare Research and Quality 2013). Survey methods were used to account
for MEPS’ complex survey design and correlation between survey years, so that
standard errors were correctly computed. Sampling weights were used
corresponding to the US civilian, non-institutionalized population. Stata version
13.1 was used for all analyses (StataCorp, LP College Station, TX). All
categorical covariates were included with a “missing” category, because STATA
removes observations from analyses “listwise” (if a value for any covariate is
missing, the observation is dropped from the analyses). In addition to preserving
sample size, including the “missing” category accounts for variance in the
outcome explained by missing values.

Statistical Analyses

Aim 1. Evaluate the association between insurance features and likelihood
of being up-to-date with USPSTF-recommended CRC screening.
64

Analytic Plan for Aim 1
The analytic approach for Aim 1 was to perform multivariate logistic regression to
assess insurance feature effects on likelihood of being up-to-date with
recommended CRC screening while accounting for covariates. The following
sections detail descriptive statistics, fitting the multivariate logistic regression
models, and sensitivity analyses.
Descriptive Univariate and Bivariate Statistics
Summary univariate statistics were computed. For age, counts were reported by
five-year increments, although age was included in analyses as a continuous
variable. Any sparse variable levels were combined with other levels of the
variable. Bivariate associations between CRC screening status and independent
variables were assessed by performing Chi-square tests using an F statistic,
which is derived from the Pearson Chi-Square statistic corrected for the survey
design with the second-order correction of Rao and Scott (Rao and Scott 1984).
This statistic, the “Design-based F statistic” is Stata 13.1’s default test of
independence for two-way tables of survey data and is recommended “in all
situations”. The p value is interpreted in the same way as the uncorrected
Pearson Chi-Square test. Covariates that did not have a significant bivariate
association at p<0.1 were not included in subsequent analyses.
Multivariate Logistic Regressions
MVLR was performed to assess insurance feature effects while controlling for
covariates. Logistic regression is the standard method to model binary
outcomes. Logistic regression is a generalized linear model that uses maximum
likelihood estimation with a binomial family and logit link function to predict
probabilities between zero and one. The following procedure was used to select
covariates for models and estimate insurance feature effects.
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Multiple models were run for each insurance feature and for each sample to
reveal variation in insurance effects depending on model specification. First,
covariates were assessed in blocks of substantively related covariates
(demographics; acculturation; education and income; lifestyle factors; health
status; prevention history; and health care access) in multivariate logistic
regressions without including any insurance features. In this step, marital status
was included in the demographics block and personal cancer history was
included in the health status block. Any covariates in each block that did not
remain significant at p<0.05 were not included in subsequent analyses. For the
remaining covariates in each block, whether any covariates were collinear or
collinear with the outcome was assessed using the stata command ––_–rmdcoll–
, which can accommodate categorical variables.
Second, Insurance features were then assessed with each covariate block
separately. In this step, demographics and acculturation factors were collapsed
as one block, and lifestyle and health status/personal cancer history were
collapsed as one block. The effect of the binary insurance features on likelihood
of being up-to-date with recommended CRC screening was estimated in terms of
multivariate adjusted percentage point change (e.g. “having a DPN predicted an
X% point change in likelihood of being up-to-date with recommended CRC
screening”) with 95% confidence interval using the Stata –margins– command
and –dydx()– option and in terms of multivariate-adjusted percentages for the
categories of the cost-sharing percentage variable using the main option in the –
margins– command. The reported multivariate adjusted percentages are the
percentages of respondents predicted to be up-to-date with recommended CRC
screening at each level of an independent variable level when the independent
variable is alternately artificially fixed at each of its levels while all other
covariates remain varied at their observed levels. Multivariate-adjusted
percentages are known by other names including “predictive margins” (Graubard
and Korn 1999) and “recycled predictions” (Basu and Rathouz 2005).
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Multivariate-adjusted percentages are easy to interpret and avoid the problem of
adjusted odds ratios diverging from relative risk ratios when the outcome variable
is common, especially >50%, as is the case for CRC screening status.
Third, Insurance feature effects were then assessed in two multi-block models
including multiple covariate blocks. A full model was assessed including all
blocks, and a reduced full model was run including all covariate blocks except for
the preventive services utilization and health care access blocks, which may bias
insurance feature effects toward a null effect if factors in those blocks (or
unobserved factors associated with those factors) are intermediate factors on the
causal pathway from insurance features to obtaining CRC screening.
Logistic Equation formula and notation
The general logistic equation for the analyses is
Yi = log (pi/(1-pi)) = β0 + β1 (insurance feature) + Σβ(covariates) + μ
Where
Yi = logit of the probability, pi, that a person was up-to-date with recommend
CRC screening
β0 = intercept
μ = error term

Hypotheses

Hypotheses for the insurance features that were actually analyzed were specified
based on the criteria in the overarching Aim 1 hypothesis in Chapter 1. Study
hypotheses were derived from the causal pathways noted by Tye et al., which
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proposed that organizational factors would influence CRC screening use
according to the information-processing theory, and financial characteristics
influence out-of-pocket costs thereby altering demand for CRC screening
procedures. This study’s three organizational insurance features were the same
as those used by Tye et al. and have equivalent hypotheses. This study’s two
financial insurance features were newly examined. As previously discussed, an
effect for the FSA variables was not suggested by the extant literature and the
causal pathways, so a basis for a hypothesis for that variable has been
proposed. The hypotheses are tested by assessing whether multivariate logistic
regression coefficient estimates for the insurance features are different from
zero.
Organizational Hypotheses
DPN
Having insurance that defined a provider network was hypothesized would
increase likelihood of being up-to-date with recommended CRC screening in
comparison to individuals with insurance without a DPN.
Coverage Restricted to a DPN
Having insurance that restricted care to a DPN was hypothesized would increase
likelihood of being up-to-date with recommended CRC screening in comparison
to not having insurance that restricted care to a DPN
Physician Gatekeeper Requirement
Having insurance that used gatekeeping was predicted would increase likelihood
of being up-to-date with CRC screening in comparison to not having gatekeeping
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Rationale for Organizational insurance feature Hypotheses
Following Tye et al.’s rationale, structures that enable insurers to improve
information flows from administration to clinicians and enrollees will be more
likely to achieve organizational goals (Galbraith 1973) such as increasing CRC
screening. Having a DPN, having care restricted to a DPN, and using
gatekeeping were expected to increase the insurer’s ability to communicate and
motivate appropriate CRC screening to providers and enrollees.
Financial Hypotheses
Cost-Sharing
Overall, greater cost-sharing, i.e. a higher percentage of total payments paid outof-pocket in the survey year, was hypothesized would predict decreased
likelihood of being up-to-date with recommended CRC screening. An exception
to that relationship occurred: having 0% cost-sharing predicted a negative effect
on likelihood of being up-to-date with recommended CRC screening, although it
is unclear what effect 0% cost-sharing would have relative to other cost-sharing
percentages. Having no spending in a year was hypothesized would have a
negative effect on likelihood of being up-to-date with recommended CRC
screening, although it is unclear what effect having no spending would have
relative to the cost-sharing percentages.
Flexible Spending Account
Having a FSA was hypothesized would increase likelihood of being up-to-date
with CRC screening in comparison not having a FSA.
Rationale for Financial insurance feature Hypotheses
Having greater cost-sharing during the survey year was expected would be
correlated with higher out-of-pocket costs or otherwise greater financial barriers
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to obtaining needed services (and/or possibly is associated with other nonfinancial barriers). The disadvantage suggested by greater cost-sharing during
the survey year was therefore expected would predict decreased likelihood of
being up-to-date with recommended CRC screening. Those with 0% costsharing were probably more likely to be recipients of public insurance, Medicaid
or other programs with 0% cost-sharing in the survey year. Disadvantage that is
associated with being a recipient of those programs was expected to have a
negative effect on CRC screening likelihood. Individuals who had no medical
spending during the survey year probably had not encountered the health care
system during the survey year, which may indicate that the person was fairly
healthy; averse to encountering the health care system because of financial
barriers, personal preferences, or other reasons; and/or was not health aware.
Intentional or unintentional avoidance of the healthcare system would reduce the
probability of receiving a recommendation to obtain CRC screening. In total, not
having any spending was expected to predict reduced CRC screening likelihood.
Evidence of financial planning for medical expenses may be associated with
generally being more health aware. Having a FSA may indicate that an
individual or family was planning for medical expenses.
Aim 2. Evaluate the association between insurance features and likelihood
of being up-to-date with USPSTF-recommended CRC screening among
Western US Hispanic and non-Hispanic whites.
Hypothesis: Aim 1’s hypothesized benefits of increased CRC screening use due
to insurance features will be greater for Western non-Hispanic whites than
Hispanic whites.
Rationale for Hypothesis for Aim 2:
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Greater socioeconomic disadvantage among Western Hispanic whites in
comparison to non-Hispanic whites is expected to limit the ability of Hispanic
whites to benefit from having insurance features that foster CRC screening use.
Analytic Plan for Aim 2
The sample for the Aim 2 sub-analysis of Western Hispanic and non-Hispanic
whites was generated using the sample from Aim 1 analyses and further limiting
eligibility to Hispanics and non-Hispanic whites in the Western US census region.
Model selection for Aim 2 followed the same procedure as for Aim 1 with two
modifications. In the multivariate logistic regressions, Hispanic vs. non-Hispanic
white ethnicity was included in the models without insurance features and the
models with insurance features and separate covariate blocks. In the models
with covariate blocks and insurance features, an interaction term for insurance
features and Hispanic ethnicity was included to assess if ethnicity mediated
insurance feature effects.
In all Aim 2 analyses that estimated main effects, the Bonferroni correction was
applied for calculating 95% confidence intervals to account for multiple
comparisons within the interaction term (insurance feature*Hispanic ethnicity).
The Bonferroni correction protects against inflating the experimentwise error rate
(the probability of a Type I error) by dividing the experimentwise error rate by the
number of comparisons performed to calculate the comparisonwise error rate.
Contrast tests were performed to test specific effects in the findings. For the
binary insurance features, five contrast test were performed: the difference
between predicted screening likelihood for Hispanics vs. non-Hispanics, 1)
without the insurance feature, and 2) with the insurance feature; the difference
between predicted screening likelihood with the feature vs. without the feature, 3)
for non-Hispanic whites, and 4) for Hispanics whites; and 5) the net effect for
Hispanics vs. non-Hispanics of contrast test 4) minus contrast test 3). For the
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cost-sharing variable, five contrast tests were performed for Hispanics vs. nonHispanics whites within each of the cost-sharing variable levels.

Sensitivity Analyses

Potential Incorrect Temporal Ordering of Insurance Features and Being UpTo-Date with Recommended CRC screening
A sensitivity analysis was performed to account for potential bias due to incorrect
temporal ordering, that a person could have gained their current insurance
features after their last screening. Respondents’ insurance features pertained to
the MEPS survey year although a respondent could have been up-to-date with
recommended CRC screening due to having received screening prior to the
survey year (as much as 10 years before for colonoscopy). Because people
change insurance when they gain employment, change employment, enroll in
Medicare or for other reasons, it is likely that some respondents had different
insurance when they were last screened than reported in MEPS, and the
likelihood of having different insurance is expected to increase for individuals
who had their last CRC screening further in the past. In order to assess this
temporal ordering concern, sensitivity analyses of Aims 1 and 2 were conducted
with a second dependent variable: any colonoscopy, FSIG or FOBT within the
last year. If insurance features more strongly influenced more recent CRC
screening use, insurance features would be expected to have a greater impact
on CRC screening use in the previous year than on being up-to-date with
USPSTF-recommended CRC screening. For the sensitivity analyses, the
samples were restricted to those who had been screened in the past year and
those who were not up-to-date with recommended CRC screening. Those who
were up-to-date with screening but not in the past year were excluded from the
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sample because it would not have been appropriate to combine them with those
who were not up-to-date with screening. The procedure used to fit models for
Aims 1 and 2 was repeated to perform the sensitivity analysis.
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Chapter 4
Results

This chapter presents analytic findings that address the main and sensitivity
analyses for Aims 1 and 2. The reported analyses include univariate sample
characteristics; unadjusted bivariate associations of the CRC screening
outcomes and the levels of the covariates and of the insurance features; and
multivariate adjusted estimates of the main effects for each insurance feature.
Results are presented for the binary insurance features first for each Aim and
then for the cost-sharing variable for each Aim.

Sample Characteristics

Aim 1 Sample Characteristics
Table 4.1a presents the characteristics of the full Aim 1 sample, which included
all MEPS respondents who were eligible for CRC screening. The sample
included persons aged 50-75, with insurance for any part of the survey year and
without a prior colon or rectal cancer diagnosis, which includes 21,085
respondents from 2009-2011 MEPS representing an annualized populationweighted 74,526,972 Americans. The MEPS years 2009, 2010, and 2011 made
contributions of 31.8%, 33.2%, and 35.0% of the weighted sample, respectively.
The sample mostly represented insured Baby Boomers, so the sample was more
white, non-Hispanic, and female than the full American population, which also
includes those under age 50, greater than age 75, and the uninsured. The
sample’s mean and median ages were 60.5 and 60, and each subsequent fiveyear band had fewer respondents with 5,440 (26.3%) respondents aged 50-54
years and 3,008 (14.3%) respondents aged 70-75 years. The sample was
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52.3% female and 76.8% non-Hispanic white with small minorities each of
Hispanic whites, 7.3%; non-Hispanic blacks, 9.9%; non-Hispanic Asians, 3.9%;
and other race/ethnicities, 2.1%. The contributions of the categories of
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Table 4.1 Univariate Summary Statistics
4.1a, Aim 1 Full Sample

Total

Weightedsample
annualized
population
size

Unweighted
sample size

74,526,972

21,085

4.1b, Aim 2 Full Sample

Weighted
% of
sample

Weightedsample
annualized
population
size

Unweighted
sample size

Weighted
% of
sample

100.0

13,853,125

3,751

100.0

Covariates
Age groups
50-54
55-59
60-64
65-69
70-75

19,616,829
17,113,336
14,799,696
12,344,575
10,652,535

5,440
4,955
4,006
3,676
3,008

26.3
23.0
19.9
16.6
14.3

3,732,117
3,093,918
2,755,905
2,310,724
1,960,462

976
848
728
675
524

26.9
22.3
19.9
16.7
14.2

Sex
Male
Female

35,522,688
39,004,283

9,659
11,426

47.7
52.3

6,689,884
7,163,240

1,775
1,976

48.3
51.7

Race/Ethnicity
non-Hispanic white
Hispanic white
non-Hispanic black
non-Hispanic Asian
Other

57,230,823
5,435,947
7,402,528
2,893,011
1,564,664

12,086
2,933
4,062
1,429
575

76.8
7.3
9.9
3.9
2.1
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Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

White/Ethnicity
non-Hispanic white
Hispanic white

11,647,438
2,205,687

2,584
1,167

84.1
15.9

9,287,045
883,773
2,699,080
983,226

2,463
276
741
271

67.0
6.4
19.5
7.1

Marital status
Married
Widowed
Divorced/Separated
Never married

49,932,668
5,579,601
13,698,075
5,316,628

13,180
1,880
4,289
1,736

67.0
7.5
18.4
7.1

Census region
Northeast
Midwest
South
West

14,602,864
16,826,354
26,798,988
16,298,767

3,639
4,432
7,935
5,079

19.6
22.6
36.0
21.9

Metropolitan Statistical Area Status
Urban
Rural

61,445,605
13,081,367

17,598
3,487

82.4
17.6

12,163,438
1,689,686

3,412
339

87.8
12.2

Immigration status
US born
Foreign born, lived in US <15 years
Foreign born, lived in US > 15 years
missing

65,621,990
1,175,053
7,546,034
183,895

16,955
574
3,388
168

88.1
1.6
10.1
0.2

11,861,037
169,394
1,770,013
52,681

2,843
66
812
30

85.6
1.2
12.8
0.4
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Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

Whether comfortable speaking English
Comfortable
Not comfortable
missing

71,561,893
2,297,908
667,170

19,307
1,358
420

96.0
3.1
0.9

13,129,265
573,108
150,751

3,277
374
100

94.8
4.1
1.1

Interview language
English
Spanish, Spanish and English, or other

71,683,863
2,843,108

19,379
1,706

96.2
3.8

13,021,417
831,708

3,220
531

94.0
6.0

Dental checkup frequency
Twice a year or more
Once a year
Less than once a year
Never go to dentist
missing

35,880,939
14,571,697
12,437,074
10,949,689
687,572

8,550
4,434
4,003
3,754
344

48.1
19.6
16.7
14.7
0.9

7,300,778
2,830,157
2,245,895
1,345,834
130,461

1,703
837
702
453
56

52.7
20.4
16.2
9.7
0.9

Most recent flu shot
Within past year
Within past two years
More than two years
Never received flu shot
missing

39,279,276
6,072,806
6,691,000
20,816,672
1,667,217

10,632
1,752
1,859
6,177
665

52.7
8.1
9.0
27.9
2.2

7,071,013
1,342,285
1,436,096
3,684,262
319,469

1,892
348
354
1,046
111

51.0
9.7
10.4
26.6
2.3
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Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

Perceived health status
Excellent
Very good
Good
Fair/Poor
missing

14,710,229
24,730,156
22,582,379
12,431,749
72,459

3,660
6,461
6,692
4,219
53

19.7
33.2
30.3
16.7
0.1

3,097,957
4,740,141
3,729,675
2,268,360
16,992

736
1,230
1,064
713
8

22.4
34.2
26.9
16.4
0.1

Have any personal non-CRC cancer
history
No
Yes
missing

61,732,591
12,768,428
25,953

17,944
3,114
27

82.8
17.1
0.0

11,294,213
2,558,130
782

3,139
611
1

81.5
18.5
0.0

Quan et al.’s updated Charlson
comorbidity index
0
1
2
3+

47,693,178
13,852,869
7,772,125
5,208,799

13,186
4,287
2,111
1,501

64.0
18.6
10.4
7.0

9,118,062
2,316,786
1,546,859
871,417

2,419
709
391
232

65.8
16.7
11.2
6.3

Smoking status
Non-smoker
Current Smoker
missing

58,449,915
10,969,071
5,107,986

15,887
3,189
2,009

78.4
14.7
6.9

11,448,867
1,419,922
984,336

3,019
394
338

82.6
10.2
7.1
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Table 4.1 (cont.)
BMI categories
Underweight
Normal weight
Overweight
Obese
missing

Aim 1 Full Sample

Aim 2 Full Sample

676,202
19,842,682
27,122,296
25,133,732
1,752,059

201
5,489
7,577
7,243
575

0.9
26.6
36.4
33.7
2.4

103,927
3,966,023
5,159,187
4,300,219
323,768

29
1,025
1,419
1,184
94

0.8
28.6
37.2
31.0
2.3

Household income as a percentage of the federal poverty
level
Poor/Negative (<100%)
5,931,779
Near poor/Low income (100-200%)
10,094,014
Middle Income (200-400%)
20,011,870
High Income (>400%)
38,489,309

2,580
3,598
6,226
8,681

8.0
13.5
26.9
51.6

950,485
1,738,222
3,623,543
7,540,875

353
606
1,107
1,685

6.9
12.5
26.2
54.4

Educational attainment
Less than a HSD
HSD/GED
Bachelor's
Graduate/Doctorate Degree
Other Degree
missing

7,820,961
35,097,336
14,292,606
9,722,163
7,176,365
417,540

3,597
9,935
3,410
2,168
1,730
245

10.5
47.1
19.2
13.0
9.6
0.6

1,392,248
6,016,338
2,900,712
1,973,788
1,457,629
112,410

714
1,581
638
432
338
48

10.1
43.4
20.9
14.2
10.5
0.8

Number of months insured in survey year
1-6
7-11
12

2,277,851
2,988,984
69,260,137

902
1,019
19,164

3.1
4.0
92.9

478,550
623,928
12,750,646

161
206
3,384

3.5
4.5
92.0
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Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

Number of outpatient provider visits in
year including physicians PAs and NPs
0
1
2
3
4
5+

11,980,980
10,245,516
9,597,893
7,695,299
6,170,006
28,837,278

4,129
3,026
2,744
2,135
1,659
7,392

16.1
13.7
12.9
10.3
8.3
38.7

2,541,009
1,947,692
1,774,052
1,395,529
1,032,987
5,161,856

827
526
486
361
271
1,280

18.3
14.1
12.8
10.1
7.5
37.3

Had a usual source of care
No
Yes
missing

7,283,012
66,335,649
908,310

2,345
18,239
501

9.8
89.0
1.2

1,341,419
12,397,949
113,756

415
3,270
66

9.7
89.5
0.8

7,153
6,662
7,270

31.8
33.2
35.0

1,283
1,196
1,272

31.7
34.3
34.1

10,095
10,085
905

47.7
49.1
3.2

1,596
2,048
107

43.4
54.4
2.2

Year
2009
2010
2011

Insurance Features
Insurance had a DPN
No
Yes
missing

35,547,734
36,606,857
2,372,381
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6,017,505
7,536,354
299,265

Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

Coverage was restricted to a DPN
No
Yes
missing

56,370,038
12,317,995
5,838,938

15,068
3,588
2,429

75.6
16.5
7.8

9,709,907
3,194,268
948,950

2,469
903
379

70.1
23.1
6.9

Insurance used gatekeeping
No
Yes
missing

45,724,432
26,577,943
2,224,596

12,314
7,941
830

61.4
35.7
3.0

7,798,892
5,768,384
285,849

1,989
1,667
95

56.3
41.6
2.1

Household had a FSA
No
Yes
missing

22,746,654
2,713,425
631,509

6,440
579
251

87.2
10.4
2.4

4,121,188
493,562
107,077

1,130
101
41

87.3
10.5
2.3

Cost-sharing categories for Aim 1 Sample
0%
0.1 to 13.0%
13.1 to 29.8%
29.8 to 85.8%
85.8 to 100%
No spending in year

3,675,780
21,048,250
21,017,985
21,110,164
3,498,345
4,176,448

1,392
6,211
5,415
5,373
980
1,714

4.9
28.2
28.2
28.3
4.7
5.6
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Table 4.1 (cont.)

Aim 1 Full Sample

Aim 2 Full Sample

Cost-sharing categories for Aim 2 Sample
0%
0.1 to 13.9%
14.0 to 32.3%
32.3 to 88.4%
88.4 to 100%
No spending in year

659,872
3,961,279
3,945,991
3,940,298
655,187
690,499

216
1,127
972
974
172
290

4.8
28.6
28.5
28.4
4.7
5.0

Prevalence of Being Up-to-Date with USPSTF-Recommended CRC Screening Strategies
Received colonoscopy in past ten years
No
30,691,116
Yes
43,835,855

41.2
58.8

6,063,081
7,790,043

1,806
1,945

43.8
56.2

Received flexible sigmoidoscopy in past five years with FOBT in past three years
No
72,487,484
20,461
97.3
Yes
2,039,488
624
2.7

13,142,436
710,689

3,542
209

94.9
5.1

87.8
12.2

11,546,560
2,306,565

3,123
628

83.3
16.7

37.5
62.5

5,082,242
8,770,883

1,519
2,232

36.7
63.3

Received FOBT in past year
No
Yes

65,427,664
9,099,307

9,621
11,464

18,430
2,655

Up-to-Date with USPSTF recommended CRC screening by any strategy
No
27,913,067
8,739
Yes
46,613,905
12,346
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race/ethnicity corresponded to weighted, annualized populations of 57.2 million
white non-Hispanics, 5.4 million Hispanic whites, 7.4 million non-Hispanic blacks,
2.9 million non-Hispanic Asians, and 1.6 million persons of other race/ethnicity.
Over one-third of respondents, 36.0%, resided in the Southern census region,
while approximately one-fifth resided in the Northeast (19.6%), Midwest (22.6%),
and Western (21.9%) regions. Large majorities of the respondents resided within
a MSA, 82.4%; were born in the US, 88.1%; were comfortable speaking English,
96.0%; and had completed the MEPS-HC in English only, 96.2%. As a portion of
the full sample, most foreign-born persons had resided in the US 15 or more
years, 10.1% of the full sample, while foreign-born persons who had resided in
the US less than 15 years comprised only 1.6% of the sample.
Majorities or near majorities reported being up-to-date with recommended
preventive care and being in good health without serious illness. Nearly half
reported receiving dental checkups twice a year or more often (48.1%), while
progressively smaller minorities reported less frequent checkups. Most reported
receiving a flu shot within the past year, 52.7% although the largest minority
reported never having received a flu shot, 27.9%. For lifestyle-related needbased factors, respondents reported low smoking rates, 14.7%, and the mean
and median BMI (to the tenth of a BMI point) were 28.6 and 27.5, respectively,
with high rates of obesity, 33.7%, and overweight BMI, 36.4%, while only 0.9%
were underweight. Most people reported very good, 33.2%, or good, 30.3%,
health status, while small proportions perceived their health status to be at the
extremes: excellent, 19.7%, and fair/poor, 16.7%. The mean score on Quan et
al.’s updated Charlson Comorbidity index was 0.67, and the distribution was
positively skewed with nearly two-thirds of the sample, 64.0%, having a score of
zero (i.e. no conditions that accrued points on the index) and the largest minority,
18.6%, had an index score of one. 17.1% of the sample reported a prior cancer
diagnosis other than CRC.
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For enabling factors, the largest proportions had a household income that was
considered high (>400% of the FPL), 51.6%; had only completed high school,
47.1%; were insured for all of the survey year, 92.9%; had visited outpatient
providers five or more times in the survey year, 38.7%; had a usual source of
care, 89.0%; and were married, 67.0%. The mean and median household
incomes as a percentage of the federal poverty level were 499.4% and 413.7%,
and the distribution of household income was negatively skewed. The mean and
median numbers of outpatient provider visits were 5.6 and three, and the
distribution was positively skewed with the largest minority having no visits,
16.1%.
Prevalence of the insurance features indicates the nature of some of the variation
in national health insurance coverage. Nearly half of the sample, 49.1%, had
insurance with a DPN, while only 16.5% had coverage that was restricted to their
provider network. Just over one-third of the sample, 35.7%, had insurance that
used gatekeeping. The mean and median cost-sharing percentages, were
27.6% and 20.7%, respectively while 5.6% had no spending (the cost-sharing
percentage estimate for the entire 2009-2011 MEPS sample was consistent with
recent national estimates of the percentage of national health expenditures paid
by households (Martin 2014)). In 2011, only 10.4% of the respondents’
households had a FSA.
CRCS use was consistent with other recent estimates of screening rates. In the
sample, 62.5% were up-to-date with USPSTF-recommended CRC screening,
which mostly reflected the 58.8% of the sample who had received colonoscopy
within the previous ten years. In the sample, 12.2% had received FOBT in the
previous year and 2.7% had received FSIG within the previous five years with
FOBT within the previous three years. Over the included survey years, 60.4%,
63.4% and 63.6% of respondents were up-to-date with recommended CRC
screening in 2009, 2010, and 2011, respectively.
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Aim 2 Sample Characteristics
The Aim 2 sample of Western US Hispanic and non-Hispanic whites (Table 4.1b)
was generally similar to the Aim 1 full US sample although had some notable
differences. Patterns of key sociodemographic factors were generally similar
between the samples including age, sex and marital status, although less of the
Aim 2 sample resided in a rural area than the Aim 1 sample, 12.2 vs. 17.6%.
The Aim 2 sample was less acculturated than the Aim 1 sample. In comparison
to the Aim 1 sample, the Aim 2 sample had a greater proportion of foreign-born
respondents, 14.4 vs. 11.9%; a greater proportion of respondents who were not
comfortable speaking English, 4.1 vs. 3.1%; and a greater proportion of
respondents who completed MEPS in Spanish, Spanish and English or another
language, 6.0 vs. 3.8%.
Health-related covariates were generally similar between the samples. Receipt
of preventive services was similar between Aim 1 and Aim 2’s samples, and the
health measures suggested similar overall health. Lifestyle factors were slightly
favorable for the Aim 2 sample, which had a lower proportion of smokers 10.2 vs.
14.7%, a higher proportion of normal weight, 28.6 vs. 26.6%, and a lower
proportion of obese, 31.0 vs. 33.7%.
Enabling factors were generally similar between the samples. The Aim 2 sample
had a slightly more favorable profile for education and income measures, proxies
for SES, with slightly greater proportions in higher income and education
categories and smaller proportions in lower income and education categories
than the Aim 1 sample. Health care access patterns did not consistently differ in
a substantive way between the two aims’ samples.
For the insurance features, the Aim 2 sample was more likely to have an
organizational insurance feature indicating the insurer had greater administrative
control. The Aim 2 sample, in comparison to the Aim 1 sample, had a larger
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proportion of respondents with insurance that defined a provider network, 54.4
vs. 47.7%; a larger proportion with coverage restricted to a DPN, 23.1 vs. 16.5%;
and a larger proportion of respondents with insurance that used gatekeeping,
41.6 vs. 35.7%. For the financial insurance features, the Aim 2 sample had an
equal proportion of respondents who had a FSA as the Aim 1 sample, and the
Aim 2 sample had a slightly greater cost-sharing mean, 29.4 vs. 27.6%, and
median, 22.0 vs. 20.7%, than the Aim 1 sample.
A slightly greater proportion of the Aim 2 sample was up-to-date with
recommended CRC screening by any technique, 63.3 vs. 62.5%, although the
Aim 2 sample more often was up-to-date with screening by having received
screening other than colonoscopy. Aim 2 had slightly lower colonoscopy use in
the previous ten years, 56.2 vs. 58.8%; greater guideline-consistent FSIG use,
5.1 vs. 2.7%; and greater FOBT use in the previous year, 16.7 vs. 12.2%.

Bivariate Analyses

Aim 1 Analyses
In the Aim 1 samples, likelihood of being up-to-date with recommended CRC
screening significantly varied across levels of most variables, which included the
full Aim 1 sample (Table 4.2a, unadjusted n=21,085), the reduced sample
excluding those under age 65 with only public insurance (Table 4.2b, unadjusted
n=18,686) and the reduced sample with only MEPS 2011 (Table 4.2c,
unadjusted n=7,270). The associations generally agreed with patterns in the
literature. In this section, “significant” findings refer to all three samples unless
noted otherwise. Reported percentages of screening likelihood apply only to the
full sample unless noted otherwise.

87

CRCS likelihood varied significantly for some innate sociodemographic
characteristics. As age increased screening likelihood generally increased,
although did not significantly differ between the 60-64, 65-69, and 70-75 groups
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Table 4.2 Aim 1 Bivariate Associations with Likelihood of Being Up-to-Date with Recommended CRC Screening
for Main Analysis Samples

4.2 a, Full MEPS 2009-2011 sample

Total (n=21,085)

%

95% CI

62.5

[61.3,63.8]

Table 4.2b, Reduced MEPS 2009-2011
sample excluding those age 50-64 with
only public insurance

Total (n=18,686)

%

95% CI

63.7

[62.4,65.0]

[45.5,50.1]
[60.6,65.2]
[68.9,73.1]
[70.1,74.6]
[69.3,74.4]

Table 4.2c, Reduced sample of only
MEPS 2011
%

95% CI

Total (n=7,270)

63.6

[61.8,65.4]

Age groups
50-54 (n=1,825)
55-59 (n=1,675)
60-64 (n=1,396)
65-69 (n=1,298)
70-75 (n=1,076)

47.8
62.4
70.5
74.1
72.3

[44.4,51.1]
[59.0,65.6]
[67.9,72.9]
[70.8,77.2]
[68.3,76.0]

Covariates
Age groups
50-54 (n=5,440)
55-59 (n=4,955)
60-64 (n=4,006)
65-69 (n=3,676)
70-75 (n=3,008)

47.1
61.3
69.5
72.4
71.9

[45.0,49.2]
[59.1,63.5]
[67.6,71.3]
[70.1,74.6]
[69.3,74.4]

Design-based F(3.91, 809.91) = 111.4834 Pr
= 0.000
Sex
Male (n=9,659)
Female (n=11,426)

63.0
62.2

[61.3,64.6]
[60.6,63.7]

Design-based F(1.00, 207.00) = 0.6461 Pr =
0.422

Age groups
50-54 (n=4,551)
55-59 (n=4,153)
60-64 (n=3,298)
65-69 (n=3,676)
70-75 (n=3,008)

47.8
62.9
71.1
72.4
71.9

Design-based F(3.94, 816.11) = 96.9452 Pr
= 0.000
Sex
Male (n=8,722)
Female (n=9,964)

64.3
63.1

[62.7,66.0]
[61.5,64.7]

Design-based F(1.00, 207.00) = 1.3966 Pr =
0.239
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Design-based F(3.68, 761.51) = 52.1362 Pr
= 0.000
Sex
Male (n=3,339)
Female (n=3,931)

64.9
62.5

[62.6,67.1]
[60.3,64.7]

Design-based F(1.00, 207.00) = 3.2829 Pr =
0.071

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Race/Ethnicity
non-Hispanic white
(n=12,086)
Hispanic white (n=2,933)
non-Hispanic black
(n=4,062)
non-Hispanic Asian
(n=1,429)
Other (n=575)

Race/Ethnicity
non-Hispanic white
(n=11,213)
Hispanic white (n=2,380)
non-Hispanic black
(n=3,315)
non-Hispanic Asian
(n=1,312)
Other (n=466)

Race/Ethnicity
non-Hispanic white
(n=4,164)
Hispanic white (n=991)
non-Hispanic black
(n=1,415)
non-Hispanic Asian
(n=499)
Other (n=201)

64.6
53.1

[63.2,66.1]
[50.2,56.1]

61.3

[58.9,63.5]

46.2
54.7

[42.6,49.8]
[49.1,60.1]

Design-based F(3.86, 799.27) = 34.6689 Pr
= 0.000
Marital status
Married (n=13,180)
Widowed (n=1,880)
Divorced/Separated
(n=4,289)
Never married (n=1,736)

64.4
67.3

[62.8,66.0]
[64.1,70.4]

57.9
52.2

[55.8,60.0]
[48.8,55.5]

Design-based F(2.92, 603.45) = 24.1075 Pr
= 0.000

65.5
54.6

[63.9,67.0]
[51.4,57.7]

63.9

[61.3,66.4]

47.0
56.1

[43.2,50.8]
[50.0,62.0]

Design-based F(3.90, 807.79) = 30.2854 Pr
= 0.000
Marital status
Married (n=12,406)
Widowed (n=1,669)
Divorced/Separated
(n=3,349)
Never married (n=1,262)

65.0
68.4

[63.4,66.6]
[65.1,71.5]

59.4
54.7

[57.1,61.7]
[50.9,58.5]

Design-based F(2.93, 607.20) = 15.5427 Pr
= 0.000
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65.5
56.0

[63.3,67.6]
[51.9,60.0]

63.8

[60.6,66.9]

44.4
61.3

[38.7,50.2]
[53.0,69.1]

Design-based F(3.89, 806.05) = 16.4120 Pr
= 0.000
Marital status
Married (n=4,490)
Widowed (n=635)
Divorced/Separated
(n=1,501)
Never married (n=644)

65.6
67.2

[63.4,67.8]
[62.0,71.9]

59.3
53.7

[55.9,62.6]
[48.8,58.6]

Design-based F(2.92, 603.47) = 10.1448 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample
Census Regions
Northeast (n=3,639)
Midwest (n=4,432)
South (n=7,935)
West (n=5,079)

64.4
61.4
62.7
61.8

[61.8,66.9]
[58.7,64.0]
[60.4,64.9]
[59.3,64.3]

Design-based F(2.96, 613.61) = 0.9510 Pr =
0.415
Metropolitan Statistical Area
Status
Urban (n=17,598)
63.2
Rural (n=3,487)
59.3

[61.8,64.7]
[56.5,62.1]

Design-based F(1.00, 207.00) = 5.9579 Pr =
0.015
Immigration status
US born (n=16,955)
Foreign born, lived in US
<15 years (n=574)
Foreign born, lived in US
> 15 years (n=3,388)
missing (n=168)

64.0

[62.6,65.3]

33.7

[26.6,41.6]

55.3
41.3

[52.6,58.0]
[28.6,55.3]

Design-based F(2.63, 545.41) = 38.1498 Pr
= 0.000

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Census Regions
Northeast (n=3,104)
Midwest (n=4,018)
South (n=7,021)
West (n=4,543)

Census Regions
Northeast (n=1,277)
Midwest (n=1,589)
South (n=2,687)
West (n=1,717)

65.7
62.2
63.7
63.5

[62.9,68.4]
[59.5,64.8]
[61.4,65.9]
[60.9,66.1]

Design-based F(2.98, 617.17) = 1.0715 Pr =
0.360
Metropolitan Statistical Area
Status
Urban (n=15,650)
64.4
Rural (n=3,036)
60.3

[62.9,65.8]
[57.4,63.3]

Design-based F(1.00, 207.00) = 5.7149 Pr =
0.018
Immigration status
US born (n=15,193)
Foreign born, lived in US
<15 years (n=468)
Foreign born, lived in US
> 15 years (n=2,882)
missing (n=143)

65.0

[63.6,66.4]

34.2

[26.4,42.9]

56.6
41.0

[53.6,59.6]
[26.9,56.7]

Design-based F(2.67, 551.97) = 31.8609 Pr
= 0.000
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64.4
62.9
64.9
61.6

[60.6,68.0]
[59.9,65.7]
[61.3,68.3]
[57.4,65.7]

Design-based F(2.84, 588.61) = 0.6872 Pr =
0.553
Metropolitan Statistical Area
Status
Urban (n=6,097)
64.3
Rural (n=1,173)
60.8

[62.2,66.3]
[56.9,64.6]

Design-based F(1.00, 207.00) = 2.3982 Pr =
0.123
Immigration status
US born (n=5,851)
Foreign born, lived in US
<15 years (n=203)
Foreign born, lived in US
> 15 years (n=1,139)
missing (n=77)

65.4

[63.4,67.4]

36.0

[28.0,44.8]

53.7
54.0

[49.4,58.0]
[34.9,72.0]

Design-based F(2.59, 535.45) = 23.5010 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Whether comfortable
speaking English
Comfortable (n=19,307)
Not comfortable
(n=1,358)
missing (n=420)

64.3

[63.0,65.6]

Whether comfortable
speaking English
Comfortable (n=6,646)

64.3

[62.4,66.1]

43.8
50.3

[38.6,49.2]
[42.2,58.3]

Not comfortable (n=475)
missing (n=149)

47.2
59.1

[40.7,53.7]
[47.0,70.3]

63.3

[62.0,64.5]

Whether comfortable
speaking English
Comfortable (n=17,337)

44.2
48.6

[39.9,48.6]
[41.4,55.8]

Not comfortable (n=992)
missing (n=357)

Design-based F(1.65, 341.03) = 48.8486 Pr
= 0.000
Interview Language
English (n=19,379)
Spanish, Spanish and
English, or other
(n=1,706)

63.1

[61.9,64.4]

47.6

[43.3,52.1]

Design-based F(1.00, 207.00) = 49.7657 Pr
= 0.000

Design-based F(1.61, 333.85) = 38.6057 Pr
= 0.000
Interview Language
English (n=17,396)
Spanish, Spanish and
English, or other
(n=1,290)

64.2

[62.9,65.5]

Interview Language
English (n=6,666)

64.1

[62.3,66.0]

47.8

[42.9,52.7]

Spanish, Spanish and
English, or other (n=604)

52.7

[46.1,59.1]

Design-based F(1.00, 207.00) = 45.2884 Pr
= 0.000
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Design-based F(1.85, 383.18) = 15.1457 Pr
= 0.000

Design-based F(1.00, 207.00) = 12.1468 Pr
= 0.001

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Dental checkup
frequency
Twice a year or more
(n=8,550)
Once a year (n=4,434)
Less than once a year
(n=4,003)
Never go to dentist
(n=3,754)
missing (n=344)

Dental checkup
frequency
Twice a year or more
(n=8,207)
Once a year (n=3,947)
Less than once a year
(n=3,298)
Never go to dentist
(n=2,918)
missing (n=316)

Dental checkup
frequency
Twice a year or more
(n=2,981)
Once a year (n=1,516)
Less than once a year
(n=1,404)
Never go to dentist
(n=1,234)
missing (n=135)

72.4
59.8

[70.8,74.0]
[57.4,62.1]

53.0

[50.7,55.4]

48.1
7.2

[45.8,50.4]
[4.2,12.1]

72.8
60.2

[71.1,74.4]
[57.6,62.7]

53.5

[50.9,56.1]

49.8
6.7

[47.1,52.5]
[3.8,11.7]

Design-based F(3.38, 699.65) = 151.3427 Pr
= 0.000

Design-based F(3.42, 707.65) = 124.7639 Pr
= 0.000

Most recent flu shot
Within past year
(n=10,632)
Within past two years
(n=1,752)
More than two years
(n=1,859)
Never received flu shot
(n=6,177)
missing (n=665)

Most recent flu shot
Within past year
(n=9,515)
Within past two years
(n=1,521)
More than two years
(n=1,624)
Never received flu shot
(n=5,441)
missing (n=585)

72.7

[71.3,74.0]

60.8

[57.6,64.0]

55.4

[52.2,58.5]

49.2
25.4

[47.2,51.1]
[20.4,31.1]

Design-based F(3.88, 803.84) = 179.1230 Pr
= 0.000

73.7

[72.4,75.0]

62.3

[59.0,65.5]

56.1

[52.8,59.5]

50.5
25.5

[48.4,52.5]
[20.1,31.7]

Design-based F(3.86, 799.26) = 162.9618 Pr
= 0.000
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74.3
60.5

[72.1,76.4]
[56.6,64.3]

53.5

[50.4,56.5]

47.8
5.0

[43.3,52.2]
[1.5,14.9]

Design-based F(3.86, 799.26) = 68.0761 Pr
= 0.000

Most recent flu shot
Within past year
(n=3,693)
Within past two years
(n=633)
More than two years
(n=626)
Never received flu shot
(n=2,066)
missing (n=252)

74.6

[72.7,76.5]

62.0

[56.8,66.9]

55.9

[50.7,61.1]

48.5
24.0

[45.1,51.8]
[16.6,33.5]

Design-based F(3.91, 809.16) = 78.7728 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample
Perceived health status
Excellent (n=3,660)
Very good (n=6,461)
Good (n=6,692)
Fair/Poor (n=4,219)
missing (n=53)

62.1
64.4
62.2
60.3
4.8

[60.1,64.2]
[62.5,66.3]
[60.4,63.8]
[58.2,62.4]
[1.0,19.8]

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Perceived health status
Excellent (n=3,539)
Very good (n=6,177)
Good (n=5,932)
Fair/Poor (n=2,990)
missing (n=48)

Perceived health status
Excellent (n=1,305)
Very good (n=2,224)
Good (n=2,296)
Fair/Poor (n=1,428)
missing (n=17)

62.5
65.1
63.5
62.8
5.1

[60.4,64.6]
[63.1,67.0]
[61.8,65.3]
[60.3,65.2]
[1.1,20.8]

62.4
65.5
62.7
63.5
13.8

[59.3,65.4]
[62.4,68.4]
[60.0,65.4]
[60.4,66.5]
[2.0,55.1]

Design-based F(3.45, 714.99) = 8.6670 Pr =
0.000

Design-based F(3.46, 715.46) = 6.6498 Pr =
0.000*

Design-based F(3.70, 766.37) = 2.4395 Pr =
0.050*

Have any personal non-CRC cancer
history
No (n=17,944)
60.1 [58.8,61.4]
Yes (n=3,114)
74.4 [71.8,76.8]
missing (n=27)
36.1
[9.6,75.0]

Have any personal non-CRC cancer
history
No (n=15,851)
61.2 [59.9,62.5]
Yes (n=2,809)
75.5 [72.8,78.0]
missing (n=26)
36.1
[9.6,75.0]

Have any personal non-CRC cancer
history
No (n=6,172)
60.9 [58.9,62.8]
Yes (n=1,086)
76.9 [73.2,80.1]
missing (n=12)
27.2
[3.2,81.0]

Design-based F(1.78, 367.80) = 69.7013 Pr
= 0.000

Design-based F(1.75, 362.37) = 64.5696 Pr
= 0.000

Design-based F(1.82, 376.10) = 37.9292 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=13,186)
58.9
1 (n=4,287)
65.6
2 (n=2,111)
72.8
3+ (n=1,501)
72.0

[57.6,60.3]
[63.2,68.0]
[70.1,75.4]
[68.8,75.0]

Design-based F(2.93, 607.16) = 46.0909 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=12,180)
60.0
1 (n=3,582)
67.4
2 (n=1,786)
75.4
3+ (n=1,138)
73.9

[58.6,61.3]
[64.7,69.9]
[72.4,78.1]
[70.5,77.0]

Design-based F(2.92, 604.14) = 47.8177 Pr
= 0.000
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Quan et al.'s updated Charlson
comorbidity index
0 (n=4,503)
59.7
1 (n=1,549)
67.7
2 (n=702)
72.6
3+ (n=516)
75.1

[57.8,61.6]
[64.0,71.1]
[67.8,76.9]
[70.7,78.9]

Design-based F(2.94, 608.39) = 21.8104 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Smoking status
Non-smoker (n=15,887)
Current Smoker
(n=3,189)
missing (n=2,009)

Smoking status
Non-smoker (n=14,396)
Current Smoker
(n=2,510)
missing (n=1,780)

Smoking status
Non-smoker (n=5,505)
Current Smoker
(n=1,083)
missing (n=682)

65.6

[64.2,66.9]

51.1
52.4

[48.6,53.5]
[48.8,56.0]

Design-based F(1.97, 407.39) = 86.1723 Pr
= 0.000

BMI categories
Underweight (n=201)
Normal weight (n=5,489)
Overweight (n=7,577)
Obese (n=7,243)
missing (n=575)

57.0
59.8
63.5
65.1
43.3

[47.2,66.2]
[57.9,61.7]
[61.8,65.2]
[63.4,66.8]
[37.7,49.0]

Design-based F(3.93, 814.16) = 17.6989 Pr
= 0.000

66.5

[65.1,67.9]

52.6
52.8

[50.0,55.2]
[49.0,56.6]

Design-based F(1.97, 407.35) = 73.6614 Pr
= 0.000

BMI categories
Underweight (n=154)
Normal weight (n=4,991)
Overweight (n=6,849)
Obese (n=6,176)
missing (n=516)

59.1
60.9
64.6
66.6
43.8

[48.1,69.2]
[58.9,62.8]
[62.9,66.3]
[64.8,68.3]
[37.9,49.8]

Design-based F(3.91, 809.78) = 17.6372 Pr
= 0.000
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66.2

[64.2,68.2]

53.6
53.6

[49.7,57.4]
[47.9,59.1]

Design-based F(1.97, 407.65) = 26.3518 Pr
= 0.000

BMI categories
Underweight (n=76)
Normal weight (n=1,909)
Overweight (n=2,538)
Obese (n=2,534)
missing (n=213)

49.8
60.9
64.4
67.0
42.3

[32.9,66.6]
[58.0,63.8]
[61.6,67.2]
[64.6,69.4]
[34.1,50.9]

Design-based F(3.75, 775.36) = 8.9901 Pr =
0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=2,580)
55.1 [52.2,58.0]
Near poor/Low income
(100-200%) (n=3,598)
54.0 [51.6,56.4]
Middle Income (200400%) (n=6,226)
58.6 [56.6,60.5]
High Income (>400%)
(n=8,681)
68.0 [66.4,69.6]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=1,464)
60.6 [56.9,64.1]
Near poor/Low income
(100-200%) (n=2,838)
55.8 [53.3,58.4]
Middle Income (200400%) (n=5,806)
59.0 [57.0,61.0]
High Income (>400%)
(n=8,578)
68.0 [66.4,69.7]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=940)
59.3 [55.1,63.5]
Near poor/Low income
(100-200%) (n=1,338)
55.7 [52.3,59.1]
Middle Income (200400%) (n=2,092)
59.5 [56.6,62.4]
High Income (>400%)
(n=2,900)
68.6 [66.2,70.9]

Design-based F(2.68, 555.57) = 56.4553 Pr
= 0.000

Design-based F(2.67, 551.82) = 39.8194 Pr
= 0.000

Design-based F(2.91, 602.19) = 21.2537 Pr
= 0.000

Educational attainment
Less than a HSD
(n=3,597)
HSD/GED (n=9,935)
Bachelor's (n=3,410)
Graduate/Doctorate
Degree (n=2,168)
Other Degree (n=1,730)
missing (n=245)

50.2
60.3
67.5

[47.2,53.1]
[58.7,61.8]
[65.2,69.7]

72.3
65.2
42.6

[69.4,75.1]
[62.1,68.2]
[30.9,55.1]

Design-based F(4.76, 985.11) = 32.5034 Pr
= 0.000

Educational attainment
Less than a HSD
(n=2,654)
HSD/GED (n=8,844)
Bachelor's (n=3,258)
Graduate/Doctorate
Degree (n=2,121)
Other Degree (n=1,603)
missing (n=206)

51.7
61.3
68.0

[48.5,54.8]
[59.6,62.9]
[65.6,70.3]

72.5
65.6
45.1

[69.6,75.3]
[62.4,68.8]
[31.8,59.1]

Design-based F(4.72, 977.23) = 24.9177 Pr
= 0.000
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Educational attainment
Less than a HSD
(n=1,188)
HSD/GED (n=3,446)
Bachelor's (n=1,163)
Graduate/Doctorate
Degree (n=776)
Other Degree (n=589)
missing (n=108)

52.6
62.6
65.7

[48.7,56.6]
[60.3,64.8]
[62.0,69.3]

72.7
64.2
49.5

[68.4,76.6]
[59.2,68.9]
[35.3,63.8]

Design-based F(4.32, 894.51) = 10.5883 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Number of months insured in survey year
1-6 (n=902)
43.5 [38.7,48.4]
7-11 (n=1,019)
47.1 [42.8,51.4]
12 (n=19,164)
63.8 [62.5,65.1]

Number of months insured in survey year
1-6 (n=666)
45.0 [39.8,50.4]
7-11 (n=787)
48.6 [43.7,53.5]
12 (n=17,233)
64.8 [63.5,66.1]

Number of months insured in survey year
1-6 (n=325)
41.1 [33.2,49.5]
7-11 (n=380)
54.8 [48.1,61.3]
12 (n=6,565)
64.8 [63.0,66.6]

Design-based F(2.00, 413.72) = 61.0515 Pr
= 0.000

Design-based F(1.99, 412.91) = 47.4388 Pr
= 0.000

Design-based F(1.99, 411.30) = 21.1575 Pr
= 0.000

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=4,129)
35.4 [33.2,37.6]
1 (n=3,026)
53.3 [51.0,55.6]
2 (n=2,744)
61.5 [59.1,63.8]
3 (n=2,135)
64.1 [61.3,66.8]
4 (n=1,659)
68.3 [65.3,71.3]
5+ (n=7,392)
75.8 [74.2,77.4]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=3,745)
36.4 [34.2,38.8]
1 (n=2,801)
54.3 [51.9,56.6]
2 (n=2,477)
62.5 [60.0,65.0]
3 (n=1,918)
65.9 [62.9,68.7]
4 (n=1,503)
69.7 [66.6,72.6]
5+ (n=6,242)
77.7 [76.0,79.3]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=1,500)
37.3 [33.8,41.0]
1 (n=1,037)
56.1 [52.1,59.9]
2 (n=934)
59.9 [55.3,64.2]
3 (n=724)
65.3 [61.0,69.3]
4 (n=575)
68.6 [63.2,73.5]
5+ (n=2,500)
76.9 [74.6,79.0]

Design-based F(4.77, 987.34) = 222.3643 Pr
= 0.000

Design-based F(4.79, 991.82) = 212.1011 Pr
= 0.000

Design-based F(4.68, 969.59) = 79.9336 Pr
= 0.000

Had a usual source of
care
No (n=2,345)
Yes (n=18,239)
missing (n=501)

Had a usual source of
care
No (n=2,048)
Yes (n=16,184)
missing (n=454)

34.6
66.0
34.2

[31.7,37.6]
[64.7,67.2]
[27.5,41.6]

Design-based F(1.94, 400.74) = 257.2895 Pr
= 0.000

35.6
67.2
33.6

[32.7,38.7]
[65.9,68.5]
[26.7,41.2]

Design-based F(1.94, 402.21) = 243.7756 Pr
= 0.000
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Had a usual source of
care
No (n=795)
Yes (n=6,264)
missing (n=211)

32.7
67.2
36.2

[27.9,37.9]
[65.4,69.0]
[24.1,50.3]

Design-based F(1.98, 410.31) = 88.6458 Pr
= 0.000

Table 4.2 (cont.)
Full MEPS 2009-2011 sample
Year
2009 (n=7,153)
2010 (n=6,662)
2011 (n=7,270)

60.4
63.4
63.6

[58.8,62.0]
[61.8,65.0]
[61.8,65.4]

Design-based F(1.77, 365.88) = 6.8504 Pr =
0.002

Reduced MEPS 2009-2011 sample

Reduced MEPS 2011 sample

Year
2009 (n=6,366)
2010 (n=5,910)
2011 (n=6,410)

Year
2009 (n=0)
2010 (n=0)
2011 (n=7,270)

0.0
0.0
63.6

[61.8,65.4]

Household had a FSA
No (n=6,440)
Yes (n=579)
missing (n=251)

63.2
69.9
53.7

[61.2,65.1]
[64.8,74.6]
[42.7,64.4]

61.5
64.6
64.8

[59.9,63.1]
[62.9,66.2]
[63.0,66.7]

Design-based F(1.78, 369.39) = 6.7254 Pr =
0.002

Insurance Features
Insurance had a DPN
No (n=10,095)
Yes (n=10,085)
missing (n=905)

[61.8,65.2]
[60.6,63.6]
[49.7,58.8]

Coverage was restricted to a DPN
No (n=15,068)
64.0 [62.6,65.4]
Yes (n=3,588)
62.2 [59.6,64.7]
missing (n=30)
67.0 [43.5,84.3]

Design-based F(1.89, 391.33) = 6.6330 Pr =
0.002*

Design-based F(1.94, 401.00) = 1.0863 Pr =
0.337

Insurance used
gatekeeping
No (n=12,314)
Yes (n=7,941)
missing (n=830)

63.5
62.1
54.3

63.8
61.0
54.7

[62.2,65.4]
[59.2,62.7]
[50.0,59.4]

Design-based F(1.85, 381.98) = 8.3021 Pr =
0.000
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Design-based F(1.95, 403.74) = 4.8483 Pr =
0.009

Table 4.2 (cont.)
Full MEPS 2009-2011 sample
Cost-sharing categories for Aim 1 full
Sample
0.0% (n=1,392)
51.7 [48.3,55.1]
0.1 to 13.0% (n=6,211)
67.4 [65.6,69.1]
13.1 to 29.8% (n=5,415)
69.4 [67.5,71.2]
29.8 to 85.8% (n=5,373)
63.9 [61.9,65.9]
85.8 to 100% (n=980)
44.1 [39.9,48.4]
No spending in year
(n=1,714)
21.5 [18.9,24.4]
Design-based F(4.77, 988.09) = 151.8004 Pr
= 0.000
* there was not an overall significant difference (p<0.1) for the variable after excluding the missing category
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and non-significantly declined in the 70-75 group compared to the 65-69 group.
For race/ethnicity categories, screening likelihood was higher among nonHispanic whites and non-Hispanic blacks than Hispanic whites and non-Hispanic
Asians. For marital status, married and widowed persons had greater screening
likelihood than divorced/separated or never married persons did. For the
respondent’s MSA designation, urban vs. rural had 4% points greater screening
likelihood, 63.2 vs. 59.3%, which was significant in the full sample and the
reduced 2009-2011 sample although the difference did not reach significance in
the reduced MEPS 2011 sample, 64.3 vs. 60.8% (p=0.123). The
sociodemographics with non-significant variation in screening likelihood were sex
and census region, although the difference in the reduced 2011 MEPS sample
almost reached significance for men having greater screening likelihood than
women, 64.9 vs. 62.5% (p =0.071).
For other predisposing and enabling factors related to social status or SES,
greater social status or SES generally predicted significantly higher screening
likelihood including greater acculturation and higher income and educational
attainment. Each greater income category did not though consistently increase
screening likelihood. The lowest income category (household income <100%
FPL) had non-significantly greater screening likelihood than the second lowest
category (100-200% FPL) in the full sample and both reduced samples. The
lowest sample income category also had similar screening likelihood as the
middle-income category (200-400% FPL) in both reduced samples. Over the
survey years, screening likelihood was equivalent in 2010, 63.4%, and 2011,
63.6%, which was an increase from 2009, 60.4%.
Considering the lifestyle and health-related predisposing and need factors, level
of health and screening likelihood had inconsistent associations. For some
variables, better health predicted greater screening likelihood including
consistent and large increases for more frequent or recent use of other
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preventive services (dental checkups and flu shots) and a large difference for
being a non-smoker vs. smoker, 65.6 vs. 51.1%. For other variables, worse
health predicted greater screening likelihood including having any non-CRC
cancer diagnosis, 74.4 vs. 60.1%; being obese or overweight compared to
normal weight; or having a Charlson Comorbidity Index score of two or greater in
comparison to a score of one or having a score of one compared to zero.
Perceived health status was a weaker predictor of screening likelihood and did
not remain significant in either of the two reduced sample models for Aim 1.
Greater health care access consistently predicted substantial significant
increases in screening likelihood including being insured for all vs. part of the
survey year, having a greater number of outpatient provider visits in the survey
year, and having a usual source of care vs. not, 66.0 vs. 34.6%.
Insurance features were sometimes associated with significant variation in
screening likelihood. Screening likelihood was significantly higher for
respondents who had insurance that did not use gatekeeping, 63.8 vs. 61.0%; for
respondents whose household had an FSA, 69.9 vs. 63.2% (Table 4.2b); and for
respondents whose cost-sharing was in any of the internal tertiles of the costsharing distribution (greater than 0% and below the 95th percentile of costsharing) in comparison to respondents with 0% cost-sharing, cost-sharing in the
top 5th percentile (85.8-100% of spending in the survey year paid out-of-pocket
for the Aim 1 main analysis), or had no spending in the survey year. Screening
likelihood did not significantly vary depending on having insurance with a DPN or
having insurance that restricted coverage to a DPN (Table 4.2c).
Bivariate associations for the Aim 1 sensitivity analysis (Table 4.3) for the binary
outcome of having received any CRC screening in the previous year vs. being
not up-to-date with recommended screening were generally consistent with the
main analysis findings.
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Table 4.3 Aim 1 Bivariate Associations with Likelihood of Having Received CRC Screening in the Past Year
for Sensitivity Analysis Samples
Full MEPS 2009-2011 sample of those
screened in previous year and those
not up-to-date with recommended CRC
screening

Total (n=13,929)

%

95% CI

40.3

[39.0,41.7]

Reduced MEPS 2009-2011 sample
excluding those age 50-64 with only
public insurance

Total (n=12,103)

%

95% CI

41.2

[39.7,42.8]

[25.8,30.3]
[34.8,40.3]
[47.2,53.2]
[47.9,54.0]
[48.4,56.0]

Reduced sample of only MEPS 2011
%

95% CI

Total (n=4,574)

38.1

[36.2,40.1]

Age groups
50-54 (n=1,366)
55-59 (n=1,050)
60-64 (n=807)
65-69 (n=728)
70-75 (n=623)

27.1
34.8
43.8
49.5
49.5

[24.2,30.2]
[30.9,38.8]
[39.8,48.0]
[45.0,54.1]
[43.9,55.0]

Covariates
Age groups
50-54 (n=4,150)
55-59 (n=3,219)
60-64 (n=2,486)
65-69 (n=2,237)
70-75 (n=1,837)

27.9
36.6
48.4
51.0
52.2

[25.9,30.0]
[34.3,39.1]
[45.8,51.0]
[47.9,54.0]
[48.4,56.0]

Design-based F(3.84, 794.38) = 68.0447 Pr
= 0.000
Sex
Male (n=6,371)
Female (n=7,558)

40.9
39.8

[39.2,42.7]
[38.1,41.5]

Design-based F(1.00, 207.00) = 1.0386 Pr =
0.309

Age groups
50-54 (n=3,420)
55-59 (n=2,630)
60-64 (n=1,979)
65-69 (n=2,237)
70-75 (n=1,837)

28.0
37.5
50.2
51.0
52.2

Design-based F(3.86, 799.60) = 61.6643 Pr
= 0.000
Sex
Male (n=5,631)
Female (n=6,472)

42.0
40.6

[40.1,43.9]
[38.7,42.5]

Design-based F(1.00, 207.00) = 1.3598 Pr =
0.245
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Design-based F(3.86, 798.02) = 25.2433 Pr
= 0.000
Sex
Male (n=2,105)
Female (n=2,469)

39.8
36.7

[37.1,42.6]
[34.1,39.3]

Design-based F(1.00, 207.00) = 2.9176 Pr =
0.089

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Race/Ethnicity
non-Hispanic white
(n=7,357)
Hispanic white (n=2,267)
non-Hispanic black
(n=2,807)
non-Hispanic Asian
(n=1,096)
Other (n=402)

Race/Ethnicity
non-Hispanic white
(n=6,736)
Hispanic white (n=1,810)
non-Hispanic black
(n=2,237)
non-Hispanic Asian
(n=1,002)
Other (n=318)

Race/Ethnicity
non-Hispanic white
(n=2,413)
Hispanic white (n=716)
non-Hispanic black
(n=926)
non-Hispanic Asian
(n=381)
Other (n=138)

41.3
37.1

[39.7,43.0]
[34.0,40.3]

43.0

[40.2,45.9]

28.3
31.8

[24.7,32.1]
[27.0,37.0]

Design-based F(3.85, 797.52) = 12.9225 Pr
= 0.000
Marital status
Married (n=8,474)
Widowed (n=1,221)
Divorced/Separated
(n=2,949)
Never married (n=1,285)

41.7
46.8

[40.0,43.5]
[42.7,50.9]

36.2
33.0

[33.9,38.6]
[29.5,36.8]

Design-based F(2.93, 607.09) = 12.8878 Pr
= 0.000

42.1
37.6

[40.3,43.9]
[34.2,41.0]

45.5

[42.2,48.8]

29.1
31.7

[25.2,33.2]
[26.8,37.2]

Design-based F(3.80, 786.88) = 13.1340 Pr
= 0.000
Marital status
Married (n=7,873)
Widowed (n=1,072)
Divorced/Separated
(n=2,252)
Never married (n=906)

42.3
47.9

[40.5,44.2]
[43.6,52.2]

36.7
34.8

[34.0,39.5]
[30.7,39.2]

Design-based F(2.96, 612.15) = 9.9234 Pr =
0.000
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38.6
35.8

[36.0,41.1]
[31.3,40.6]

43.3

[39.2,47.5]

24.4
39.8

[19.4,30.2]
[31.2,49.1]

Design-based F(3.68, 762.12) = 6.0854 Pr =
0.000
Marital status
Married (n=2,734)
Widowed (n=387)
Divorced/Separated
(n=993)
Never married (n=460)

39.4
41.8

[36.8,42.0]
[35.8,48.0]

35.3
32.6

[31.5,39.3]
[27.5,38.2]

Design-based F(2.92, 604.56) = 2.7914 Pr =
0.041

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Census region
Northeast (n=2,279)
Midwest (n=2,834)
South (n=5,202)
West (n=3,614)

Census region
Northeast (n=1,872)
Midwest (n=2,552)
South (n=4,516)
West (n=3,163)

Census region
Northeast (n=780)
Midwest (n=968)
South (n=1,645)
West (n=1,181)

39.3
38.0
39.7
44.3

[36.4,42.3]
[35.5,40.6]
[37.1,42.4]
[41.8,46.8]

Design-based F(2.90, 600.73) = 3.9458 Pr =
0.009
Metropolitan Statistical Area
Status
Urban (n=11,642)
41.4
Rural (n=2,287)
35.6

[39.8,42.9]
[32.5,38.8]

Design-based F(1.00, 207.00) = 9.9994 Pr =
0.002
Immigration status
US born (n=10,763)
Foreign born, lived in US
<15 years (n=475)
Foreign born, lived in US
> 15 years (n=2,558)
missing (n=133)

41.2

[39.7,42.8]

17.1

[12.3,23.3]

38.1
27.6

[35.3,41.0]
[16.9,41.8]

Design-based F(2.80, 580.08) = 18.6144 Pr
= 0.000

39.8
39.0
40.3
45.9

[36.5,43.1]
[36.3,41.8]
[37.6,43.2]
[43.0,48.8]

Design-based F(2.93, 606.01) = 4.2629 Pr =
0.006
Metropolitan Statistical Area
Status
Urban (n=10,142)
42.2
Rural (n=1,961)
36.6

[40.5,43.9]
[33.2,40.2]

Design-based F(1.00, 207.00) = 7.6966 Pr =
0.006
Immigration status
US born (n=9,468)
Foreign born, lived in US
<15 years (n=384)
Foreign born, lived in US
> 15 years (n=2,134)
missing (n=117)

42.2

[40.5,43.8]

17.0

[11.9,23.8]

38.6
28.4

[35.3,41.9]
[16.9,43.6]

Design-based F(2.75, 568.93) = 16.7170 Pr
= 0.000
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36.8
36.1
37.8
41.6

[32.4,41.4]
[33.0,39.2]
[33.9,41.8]
[37.4,46.0]

Design-based F(2.84, 587.08) = 1.3982 Pr =
0.244
Metropolitan Statistical Area
Status
Urban (n=3,852)
39.2
Rural (n=722)
33.1

[37.1,41.4]
[28.2,38.4]

Design-based F(1.00, 207.00) = 4.3751 Pr =
0.038
Immigration status
US born (n=3,527)
Foreign born, lived in US
<15 years (n=166)
Foreign born, lived in US
> 15 years (n=823)
missing (n=58)

39.5

[37.3,41.8]

18.0

[12.1,25.9]

32.4
27.3

[28.2,37.0]
[14.1,46.3]

Design-based F(2.46, 509.16) = 10.4290 Pr
= 0.000

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Whether comfortable
speaking English
Comfortable (n=12,497)
Not comfortable
(n=1,102)
missing (n=330)

41.8

[40.2,43.4]

Whether comfortable
speaking English
Comfortable (n=4,096)

38.5

[36.5,40.5]

28.1
31.2

[24.0,32.5]
[23.2,40.5]

Not comfortable (n=369)
missing (n=109)

29.8
39.7

[24.2,36.2]
[25.1,56.4]

40.9

[39.5,42.3]

Whether comfortable
speaking English
Comfortable (n=11,022)

29.5
30.1

[26.0,33.1]
[23.0,38.3]

Not comfortable (n=802)
missing (n=279)

Design-based F(1.88, 389.41) = 17.2263 Pr
= 0.000
Interview Language
English (n=12,554)
Spanish, Spanish and
English, or other
(n=1,375)

40.7

[39.3,42.1]

34.0

[30.2,38.0]

Design-based F(1.00, 207.00) = 10.0181 Pr
= 0.002

Design-based F(1.84, 379.93) = 16.7633 Pr
= 0.000
Interview Language
English (n=11,067)
Spanish, Spanish and
English, or other
(n=1,036)

41.6

[40.1,43.1]

Interview Language
English (n=4,122)

38.3

[36.3,40.3]

33.4

[29.1,38.0]

Spanish, Spanish and
English, or other (n=452)

35.2

[28.8,42.2]

Design-based F(1.00, 207.00) = 11.7045 Pr
= 0.001
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Design-based F(1.88, 389.84) = 2.7503 Pr =
0.068**

Design-based F(1.00, 207.00) = 0.7549 Pr =
0.386

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Dental checkup
frequency
Twice a year or more
(n=5,020)
Once a year (n=3,040)
Less than once a year
(n=2,769)
Never go to dentist
(n=2,766)
missing (n=334)

Dental checkup
frequency
Twice a year or more
(n=4,775)
Once a year (n=2,659)
Less than once a year
(n=2,242)
Never go to dentist
(n=2,120)
missing (n=307)

Dental checkup
frequency
Twice a year or more
(n=1,638)
Once a year (n=985)
Less than once a year
(n=916)
Never go to dentist
(n=902)
missing (n=133)

51.6
37.9

[49.4,53.9]
[35.1,40.7]

29.8

[27.4,32.2]

28.5
3.2

[26.3,30.6]
[1.5,6.5]

Design-based F(3.28, 679.69) = 101.5055 Pr
= 0.000

Most recent flu shot
Within past year
(n=6,484)
Within past two years
(n=1,138)
More than two years
(n=1,260)
Never received flu shot
(n=4,465)
missing (n=582)

53.0

[51.0,54.9]

38.8

[35.3,42.5]

32.4

[28.8,36.3]

26.2
9.5

[24.4,28.1]
[6.4,14.0]

Design-based F(3.87, 801.17) = 134.8566 Pr
= 0.000

52.0
37.7

[49.7,54.4]
[34.7,40.9]

29.1

[26.4,31.9]

29.8
2.9

[27.2,32.6]
[1.3,6.3]

Design-based F(3.32, 687.54) = 85.3917 Pr
= 0.000

Most recent flu shot
Within past year
(n=5,689)
Within past two years
(n=960)
More than two years
(n=1,079)
Never received flu shot
(n=3,863)
missing (n=512)

53.9

[51.9,55.9]

39.9

[36.1,43.9]

33.0

[29.0,37.3]

27.0
9.6

[25.0,29.1]
[6.2,14.5]

Design-based F(3.84, 795.10) = 120.8314 Pr
= 0.000
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50.6
34.8

[47.4,53.9]
[30.5,39.4]

26.6

[23.2,30.4]

26.2
1.9

[22.5,30.2]
[0.4,9.0]

Design-based F(3.69, 764.61) = 42.8782 Pr
= 0.000

Most recent flu shot
Within past year
(n=2,108)
Within past two years
(n=385)
More than two years
(n=408)
Never received flu shot
(n=1,451)
missing (n=222)

52.2

[49.5,54.9]

36.0

[29.9,42.5]

31.3

[25.3,37.9]

22.0
6.7

[19.1,25.2]
[3.1,14.1]

Design-based F(3.93, 813.45) = 57.0418 Pr
= 0.000

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Perceived health
status
Excellent (n=2,340)
Very good (n=4,147)
Good (n=4,488)
Fair/Poor (n=2,901)
missing (n=53)

Perceived health
status
Excellent (n=2,248)
Very good (n=3,921)
Good (n=3,890)
Fair/Poor (n=1,996)
missing (n=48)

Perceived health status
Excellent (n=820)
Very good (n=1,340)
Good (n=1,464)
Fair/Poor (n=933)
missing (n=17)

38.0
41.7
40.7
40.1
4.8

[35.4,40.6]
[39.5,43.9]
[38.6,42.8]
[37.8,42.5]
[1.0,19.8]

38.4
42.3
41.8
42.0
5.1

[35.8,41.1]
[40.1,44.6]
[39.6,44.1]
[38.8,45.2]
[1.1,20.8]

35.8
38.4
37.9
41.1
13.8

[32.0,39.9]
[35.0,42.0]
[34.7,41.1]
[36.8,45.5]
[2.0,55.1]

Design-based F(3.46, 715.65) = 3.8410 Pr =
0.007*

Design-based F(3.45, 714.86) = 3.7640 Pr =
0.007

Design-based F(3.78, 781.76) = 1.2035 Pr =
0.308

Have any personal non-CRC cancer
history
No (n=12,051)
37.5 [36.2,38.9]
Yes (n=1,852)
55.5 [51.9,59.0]
missing (n=26)
26.4
[4.6,72.8]

Have any personal non-CRC cancer
history
No (n=10,456)
38.3 [36.9,39.8]
Yes (n=1,622)
56.8 [52.9,60.6]
missing (n=25)
26.4
[4.6,72.8]

Have any personal non-CRC cancer
history
No (n=3,978)
35.3 [33.4,37.2]
Yes (n=585)
54.5 [48.9,59.9]
missing (n=11)
0.0

Design-based F(1.87, 386.74) = 66.3615 Pr
= 0.000

Design-based F(1.85, 382.35) = 62.5882 Pr
= 0.000

Design-based F(1.96, 405.85) = 27.9462 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=8,838)
35.3
1 (n=2,807)
45.2
2 (n=1,320)
55.0
3+ (n=964)
53.9

[33.8,36.7]
[42.6,47.9]
[51.2,58.8]
[50.0,57.9]

Design-based F(2.91, 601.85) = 65.3284 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=8,051)
36.2
1 (n=2,268)
46.5
2 (n=1,076)
57.9
3+ (n=708)
56.0

[34.6,37.8]
[43.5,49.5]
[53.5,62.2]
[51.5,60.4]

Design-based F(2.84, 588.61) = 60.1533 Pr
= 0.000
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Quan et al.'s updated Charlson
comorbidity index
0 (n=2,919)
32.9
1 (n=943)
43.9
2 (n=417)
51.4
3+ (n=295)
53.2

[31.0,35.0]
[39.5,48.4]
[44.7,58.0]
[46.8,59.6]

Design-based F(2.88, 596.08) = 23.7676 Pr
= 0.000

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Smoking status
Non-smoker (n=10,158)
Current Smoker
(n=2,311)
missing (n=1,460)

Smoking status
Non-smoker (n=9,039)
Current Smoker
(n=1,781)
missing (n=1,283)

40.6

[38.1,43.1]

29.9
30.0

[26.2,33.9]
[24.1,36.7]

43.5

[41.9,45.1]

30.2
30.7

[27.9,32.6]
[26.8,34.8]

Design-based F(1.91, 396.20) = 49.6083 Pr
= 0.000

BMI categories
Underweight (n=141)
Normal weight (n=3,662)
Overweight (n=4,914)
Obese (n=4,748)
missing (n=464)

33.2
37.0
41.0
43.8
25.0

[23.8,44.0]
[34.9,39.2]
[39.1,42.9]
[41.7,46.0]
[19.7,31.1]

Design-based F(3.83, 793.35) = 12.7750 Pr
= 0.000

44.2

[42.5,46.0]

Smoking status
Non-smoker (n=3,328)

31.1
31.0

[28.6,33.8]
[26.9,35.5]

Current Smoker (n=754)
missing (n=492)

Design-based F(1.92, 397.39) = 42.5504 Pr
= 0.000

BMI categories
Underweight (n=106)
Normal weight (n=3,274)
Overweight (n=4,355)
Obese (n=3,952)
missing (n=416)

34.4
37.8
41.9
45.0
25.5

[23.2,47.7]
[35.5,40.2]
[39.9,43.9]
[42.7,47.4]
[19.8,32.0]

Design-based F(3.79, 783.69) = 11.9071 Pr
= 0.000

108

Design-based F(1.95, 404.46) = 11.6417 Pr
= 0.000

BMI categories
Underweight (n=54)
Normal weight (n=1,192)
Overweight (n=1,583)
Obese (n=1,579)
missing (n=166)

22.4
34.5
38.2
43.2
20.5

[11.0,40.1]
[31.4,37.8]
[35.0,41.5]
[39.9,46.6]
[14.2,28.6]

Design-based F(3.83, 791.96) = 8.0895 Pr =
0.000

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=1,851)
35.4 [32.7,38.2]
Near poor/Low income
(100-200%) (n=2,591)
34.3 [31.7,37.1]
Middle Income (200400%) (n=4,217)
36.1 [33.8,38.5]
High Income (>400%)
(n=5,270)
45.6 [43.5,47.6]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=997)
38.5 [34.6,42.7]
Near poor/Low income
(100-200%) (n=2,001)
35.6 [32.7,38.7]
Middle Income (200400%) (n=3,905)
36.5 [34.0,39.0]
High Income (>400%)
(n=5,200)
45.6 [43.5,47.7]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=632)
37.7 [32.8,42.8]
Near poor/Low income
(100-200%) (n=912)
33.1 [29.4,37.0]
Middle Income (200400%) (n=1,363)
34.4 [31.3,37.7]
High Income (>400%)
(n=1,667)
42.1 [39.1,45.1]

Design-based F(2.73, 564.10) = 27.4707 Pr
= 0.000

Design-based F(2.61, 539.82) = 20.3973 Pr
= 0.000

Design-based F(2.93, 606.05) = 7.3138 Pr =
0.000

Educational attainment
Less than a HSD
(n=2,705)
HSD/GED (n=6,593)
Bachelor's (n=2,085)
Graduate/Doctorate
Degree (n=1,232)
Other Degree (n=1,108)
missing (n=206)

31.8
38.0
44.5

[29.2,34.5]
[36.3,39.8]
[41.7,47.4]

50.7
43.4
27.2

[46.9,54.6]
[39.5,47.5]
[17.8,39.3]

Design-based F(4.72, 976.47) = 18.3436 Pr
= 0.000

Educational attainment
Less than a HSD
(n=1,957)
HSD/GED (n=5,782)
Bachelor's (n=1,975)
Graduate/Doctorate
Degree (n=1,196)
Other Degree (n=1,019)
missing (n=174)

32.6
38.8
45.0

[29.5,35.8]
[36.8,40.7]
[42.0,48.0]

50.9
43.7
28.8

[46.9,54.8]
[39.6,48.0]
[18.4,42.1]

Design-based F(4.75, 982.79) = 14.5029 Pr
= 0.000
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Educational attainment
Less than a HSD
(n=863)
HSD/GED (n=2,145)
Bachelor's (n=702)
Graduate/Doctorate
Degree (n=413)
Other Degree (n=366)
missing (n=85)

32.3
37.1
39.8

[28.0,36.8]
[34.5,39.6]
[35.6,44.1]

46.0
38.6
28.8

[39.7,52.3]
[32.5,45.1]
[15.3,47.5]

Design-based F(4.63, 957.46) = 3.2355 Pr =
0.008

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Number of months insured in survey year
1-6 (n=689)
22.6 [18.2,27.8]
7-11 (n=781)
28.4 [24.2,32.9]
12 (n=12,459)
41.6 [40.1,43.2]

Number of months insured in survey year
1-6 (n=490)
22.3 [17.2,28.4]
7-11 (n=591)
28.8 [23.9,34.3]
12 (n=11,022)
42.4 [40.8,44.1]

Number of months insured in survey year
1-6 (n=248)
18.5 [11.5,28.5]
7-11 (n=282)
36.5 [28.8,45.0]
12 (n=4,044)
39.0 [37.0,41.2]

Design-based F(1.99, 410.98) = 32.3347 Pr
= 0.000

Design-based F(2.00, 413.74) = 25.7721 Pr
= 0.000

Design-based F(1.98, 408.86) = 7.5503 Pr =
0.001

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=3,297)
15.8 [14.0,17.6]
1 (n=2,112)
29.4 [26.8,32.0]
2 (n=1,756)
37.6 [34.8,40.6]
3 (n=1,334)
40.7 [37.4,44.1]
4 (n=1,025)
46.4 [42.3,50.6]
5+ (n=4,405)
58.0 [55.7,60.3]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=2,960)
16.3 [14.5,18.3]
1 (n=1,938)
30.3 [27.6,33.1]
2 (n=1,554)
38.5 [35.4,41.7]
3 (n=1,161)
42.4 [39.0,46.0]
4 (n=904)
47.8 [43.5,52.1]
5+ (n=3,586)
60.2 [57.6,62.7]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=1,173)
14.6 [12.1,17.6]
1 (n=687)
29.3 [25.1,34.0]
2 (n=571)
31.7 [27.2,36.6]
3 (n=436)
40.7 [35.4,46.2]
4 (n=331)
39.8 [33.6,46.3]
5+ (n=1,376)
56.4 [52.9,59.8]

Design-based F(4.86, 1005.15) = 166.0569
Pr = 0.000

Design-based F(4.84, 1002.10) = 157.7673
Pr = 0.000

Design-based F(4.90, 1014.22) = 65.6746 Pr
= 0.000

Had a usual source of
care
No (n=1,893)
Yes (n=11,620)
missing (n=416)

16.8
44.1
18.2

[14.7,19.1]
[42.6,45.6]
[12.8,25.2]

Design-based F(1.86, 385.50) = 166.4117 Pr
= 0.000

Had a usual source of
care
No (n=1,639)
Yes (n=10,085)
missing (n=379)

17.3
45.1
17.7

[15.1,19.9]
[43.4,46.7]
[12.1,25.0]

Design-based F(1.89, 391.32) = 150.7793 Pr
= 0.000
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Had a usual source of
care
No (n=619)
Yes (n=3,785)
missing (n=170)

13.1
42.1
14.4

[10.1,16.8]
[40.0,44.3]
[7.2,26.7]

Design-based F(2.00, 412.99) = 64.7690 Pr
= 0.000

Table 4.3 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Year
2009 (n=4,917)
2010 (n=4,438)
2011 (n=4,574)

Year
2009 (n=4,296)
2010 (n=3,864)
2011 (n=3,943)

Year
2009 (n=0)
2010 (n=0)
2011 (n=4,574)

0.0
0.0
38.1

[36.2,40.1]

Household had a FSA
No (n=4,076)
Yes (n=317)
missing (n=181)

37.9
43.6
24.1

[35.9,40.0]
[36.6,50.9]
[14.7,37.0]

40.3
42.6
38.1

[38.2,42.4]
[40.6,44.5]
[36.2,40.1]

Design-based F(1.81, 375.35) = 5.9518 Pr =
0.004

41.1
43.6
38.9

[38.9,43.4]
[41.5,45.8]
[36.8,41.0]

Design-based F(1.86, 385.22) = 6.1986 Pr =
0.003

Insurance Features
Insurance had a DPN
No (n=6,554)
Yes (n=6,733)
missing (n=642)

[38.6,42.4]
[38.9,42.4]
[29.5,39.1]

Coverage was restricted to a DPN
No (n=9,637)
40.9 [39.2,42.5]
Yes (n=2,446)
42.7 [39.8,45.7]
missing (n=20)
49.7 [24.2,75.4]

Design-based F(1.92, 397.44) = 2.5191 Pr =
0.084*

Design-based F(1.95, 404.50) = 0.8896 Pr =
0.410

Insurance used
gatekeeping
No (n=7,854)
Yes (n=5,491)
missing (n=584)

40.5
40.6
34.1

40.2
41.0
34.2

[38.3,42.2]
[39.0,43.0]
[29.2,39.7]

Design-based F(1.82, 376.83) = 1.9186 Pr =
0.152
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Design-based F(1.98, 410.67) = 3.5037 Pr =
0.031*

Table 4.3 (cont.)
Full MEPS 2009-2011 sample
Cost-sharing categories for Aim 1
sensitivity analysis full sample
0.0% (n=887)
32.1 [28.2,36.2]
0.1 to 12.1% (n=4,006)
48.2 [46.1,50.3]
12.2 to 29.4% (n=3,455)
48.2 [45.7,50.7]
29.4 to 89.4% (n=3,451)
38.6 [36.3,41.0]
89.4 to 100% (n=634)
18.9 [15.0,23.6]
No spending in year
(n=1,496)
8.0
[6.3,10.1]
Design-based F(4.67, 965.89) = 98.0839 Pr
= 0.000
* this variable was not significant (p<0.1) after excluding the missing category
** this variable was significant (p<0.05) after excluding the missing category
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Notably, in the sensitivity analyses the Western census region had the highest
likelihood of having received screening of the four census regions in all three
samples, and there was overall significant variation in screening likelihood for the
Aim 1 sensitivity analysis full sample and the reduced sample excluding those
aged <65 with only public insurance. In the main analyses census regions did
not predict significantly varying screening likelihood and the Western census
region had the second least screening likelihood in two samples and the least in
the reduced sample of only MEPS 2011. Another notable association in the Aim
1 sensitivity analysis was that survey year 2011 significantly predicted the lowest
likelihood of previous year screening of the three survey years. In the main
analysis, 2010 and 2011 had similarly screening likelihood, which was
significantly greater than survey year 2009.
Bivariate Findings for Aim 2
In the Aim 2 sample, the patterns of bivariate associations were mostly
consistent with findings for the Aim 1 samples (Table 4.4). In the Aim 2 sample,
the screening likelihood pattern by age was consistent with Aim 1 except that the
70-75 age group had greater screening likelihood than the 65-69 group, although
differences remained non-significant.
Patterns were also similar to the Aim 1 sample for factors with greater relevance
to Aim 2 including Hispanic ethnicity and the acculturation variables. Screening
likelihood was slightly greater for non-Hispanic whites in the Aim 2 sample vs.
Aim 1 sample, 65.8 vs. 64.6%, and slightly lower for Hispanic whites, 50.2 vs.
53.1%. The covariates for survey language and for whether the respondent was
comfortable speaking English had similar screening likelihood patterns. For the
covariate incorporating US vs. foreign birth and length of time in the US for
foreign born persons, the category for foreign born, lived in the US <15 year had
a very small sample size and the estimate for screening likelihood was much
lower than in the Aim 1 sample, 13.4 vs. 33.7%, although the Aim 2 estimate had
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Table 4.4 Aim 2 Bivariate Associations with Likelihood of Being Up-to-Date with Recommended CRC Screening
for Main Analysis Samples
Full MEPS 2009-2011 sample of
Hispanic and non-Hispanic whites in
Western census region

Total (n=3,751)

%

95% CI

63.3

[60.8,65.8]

Reduced MEPS 2009-2011 sample
excluding those age 50-64 with only
public insurance

Total (n=3,375)

%

95% CI

64.8

[62.1,67.4]

[40.3,48.5]
[61.6,73.0]
[67.2,76.8]
[67.8,79.9]
[71.6,79.9]

Reduced sample of only MEPS 2011
%

95% CI

Total (n=1,272)

62.5

[58.3,66.6]

Age groups
50-54 (n=354)
55-59 (n=259)
60-64 (n=244)
65-69 (n=228)
70-75 (n=187)

41.2
64.5
70.6
72.5
80.8

[35.5,47.0]
[55.8,72.3]
[62.3,77.7]
[64.3,79.4]
[74.3,86.0]

Covariates
Age groups
50-54 (n=976)
55-59 (n=848)
60-64 (n=728)
65-69 (n=675)
70-75 (n=524)

43.9
64.6
70.0
74.3
76.0

[39.9,47.9]
[58.5,70.1]
[65.5,74.2]
[67.8,79.9]
[71.6,79.9]

Design-based F(3.03, 481.44) = 28.3963 Pr
= 0.000
Sex
Male (n=1,775)
Female (n=1,976)

64.9
61.8

[61.9,67.9]
[58.5,65.0]

Design-based F(1.00, 159.00) = 2.7558 Pr =
0.099

Age groups
50-54 (n=840)
55-59 (n=724)
60-64 (n=612)
65-69 (n=675)
70-75 (n=524)

44.4
67.5
72.3
74.3
76.0

Design-based F(3.14, 486.28) = 28.1307 Pr
= 0.000
Sex
Male (n=1,616)
Female (n=1,759)

66.4
63.2

[63.1,69.6]
[59.7,66.7]

Design-based F(1.00, 155.00) = 2.3752 Pr =
0.125
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Design-based F(3.29, 502.89) = 20.3561 Pr
= 0.000
Sex
Male (n=602)
Female (n=670)

64.6
60.6

[59.6,69.3]
[55.8,65.2]

Design-based F(1.00, 153.00) = 2.8811 Pr =
0.092

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

White/Ethnicity
non-Hispanic white
(n=2,584)
Hispanic white (n=1,167)

White/Ethnicity
non-Hispanic white
(n=2,422)
Hispanic white (n=953)

White/Ethnicity
non-Hispanic white
(n=899)
Hispanic white (n=373)

65.8
50.2

[62.9,68.6]
[45.8,54.7]

Design-based F(1.00, 159.00) = 32.3124 Pr
= 0.000
Marital status
Married (n=2,463)
Widowed (n=276)
Divorced/Separated
(n=741)
Never married (n=271)

64.8
71.9

[61.2,68.3]
[62.0,80.1]

60.0
50.1

[55.4,64.5]
[41.4,58.9]

Design-based F(2.86, 454.83) = 4.5696 Pr =
0.004
Metropolitan Statistical Area
Status
Urban (n=3,412)
63.5
Rural (n=339)
61.8

[60.8,66.2]
[55.8,67.4]

Design-based F(1.00, 159.00) = 0.2963 Pr =
0.587

66.9
52.3

[63.8,69.8]
[47.3,57.3]

Design-based F(1.00, 155.00) = 24.7308 Pr
= 0.000
Marital status
Married (n=2,294)
Widowed (n=252)
Divorced/Separated
(n=620)
Never married (n=209)

65.9
73.6

[62.1,69.5]
[63.3,81.8]

62.1
51.3

[57.0,67.0]
[41.0,61.4]

Design-based F(2.81, 436.05) = 3.7528 Pr =
0.013
Metropolitan Statistical Area
Status
Urban (n=3,081)
64.9
Rural (n=294)
64.1

[62.0,67.6]
[55.8,71.6]

Design-based F(1.00, 155.00) = 0.0343 Pr =
0.853
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64.3
53.8

[59.6,68.8]
[48.4,59.2]

Design-based F(1.00, 153.00) = 10.2973 Pr
= 0.002
Marital status
Married (n=859)
Widowed (n=81)
Divorced/Separated
(n=241)
Never married (n=91)

63.6
73.5

[58.0,68.7]
[59.5,83.9]

62.6
45.4

[53.1,71.1]
[33.1,58.3]

Design-based F(2.74, 419.21) = 2.7791 Pr =
0.046
Metropolitan Statistical Area
Status
Urban (n=1,137)
62.3
Rural (n=135)
64.2

[57.9,66.4]
[51.2,75.5]

Design-based F(1.00, 153.00) = 0.0918 Pr =
0.762

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Immigration status
US born (n=2,843)
Foreign born, lived in US
<15 years (n=66)
Foreign born, lived in US
> 15 years (n=812)
missing (n=30)

Immigration status
US born (n=2,640)
Foreign born, lived in US
<15 years (n=53)
Foreign born, lived in US
> 15 years (n=654)
missing (n=28)

Immigration status
US born (n=971)
Foreign born, lived in US
<15 years (n=28)
Foreign born, lived in US
> 15 years (n=262)
missing (n=11)

65.3

[62.5,67.9]

13.4

[3.5,40.0]

56.2
24.1

[51.0,61.2]
[9.0,50.6]

Design-based F(2.35, 373.35) = 14.2586 Pr
= 0.000
Whether comfortable
speaking English
Comfortable (n=3,277)
Not comfortable (n=374)
missing (n=100)

64.6
39.5
44.3

[62.0,67.0]
[30.8,48.9]
[30.7,58.9]

Design-based F(1.64, 260.64) = 21.5597 Pr
= 0.000
Interview Language
English (n=3,220)
Spanish, Spanish and
English, or other (n=531)

64.8

[62.2,67.2]

40.4

[32.8,48.6]

Design-based F(1.00, 159.00) = 38.3291 Pr
= 0.000

66.5

[63.5,69.4]

13.5

[3.1,43.0]

58.6
25.5

[52.8,64.2]
[9.3,53.4]

Design-based F(2.32, 360.30) = 12.0744 Pr
= 0.000
Whether comfortable
speaking English
Comfortable (n=3,019)
Not comfortable (n=271)
missing (n=85)

65.8
41.3
45.4

[63.0,68.4]
[30.3,53.2]
[30.2,61.6]

Design-based F(1.65, 256.50) = 13.7777 Pr
= 0.000
Interview Language
English (n=2,974)
Spanish, Spanish and
English, or other (n=401)

66.0

[63.3,68.7]

41.1

[32.7,50.0]

Design-based F(1.00, 155.00) = 32.9106 Pr
= 0.000
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64.6

[59.9,69.1]

14.5

[5.9,31.7]

55.1
63.1

[47.8,62.1]
[23.3,90.6]

Design-based F(2.70, 413.35) = 12.4822 Pr
= 0.000
Whether comfortable
speaking English
Comfortable (n=1,114)
Not comfortable (n=128)
missing (n=30)

63.4
44.2
68.5

[59.2,67.4]
[33.7,55.2]
[45.1,85.2]

Design-based F(2.00, 305.54) = 6.8836 Pr =
0.001
Interview Language
English (n=1,098)
Spanish, Spanish and
English, or other (n=174)

63.7

[59.5,67.8]

44.3

[33.1,56.2]

Design-based F(1.00, 153.00) = 12.0262 Pr
= 0.001

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Dental checkup
frequency
Twice a year or more
(n=1,703)
Once a year (n=837)
Less than once a year
(n=702)
Never go to dentist
(n=453)
missing (n=56)

Dental checkup
frequency
Twice a year or more
(n=1,663)
Once a year (n=766)
Less than once a year
(n=562)
Never go to dentist
(n=332)
missing (n=52)

Dental checkup
frequency
Twice a year or more
(n=576)
Once a year (n=282)
Less than once a year
(n=248)
Never go to dentist
(n=146)
missing (n=20)

72.7
61.7

[69.1,76.0]
[56.4,66.8]

50.5

[45.0,55.9]

42.6
9.0

[36.7,48.7]
[2.6,26.8]

Design-based F(3.50, 556.16) = 30.7634 Pr
= 0.000
Most recent flu shot
Within past year
(n=1,892)
Within past two years
(n=348)
More than two years
(n=354)
Never received flu shot
(n=1,046)
missing (n=111)

74.6

[72.0,77.1]

61.1

[53.6,68.2]

56.6

[50.4,62.6]

48.3
24.9

[43.5,53.2]
[15.3,37.8]

Design-based F(3.62, 576.28) = 38.8891 Pr
= 0.000

72.8
62.4

[69.1,76.1]
[56.7,67.9]

53.1

[47.1,59.0]

43.5
7.3

[36.9,50.4]
[1.7,26.7]

Design-based F(3.46, 536.66) = 25.0290 Pr
= 0.000
Most recent flu shot
Within past year
(n=1,711)
Within past two years
(n=307)
More than two years
(n=326)
Never received flu shot
(n=935)
missing (n=96)

[69.7,79.4]
[46.1,61.4]

48.9

[41.1,56.7]

42.6
0.0

[33.3,52.4]

Design-based F(3.75, 574.27) = 21.2913 Pr
= 0.000
Most recent flu shot

76.2

[73.4,78.7]

63.5

[56.2,70.3]

55.3

[48.9,61.5]

50.5
24.3

[45.2,55.8]
[14.2,38.4]

Design-based F(3.49, 541.61) = 36.5583 Pr
= 0.000
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74.9
53.8

Within past year (n=644)
Within past two years
(n=131)
More than two years
(n=109)
Never received flu shot
(n=349)
missing (n=39)

76.6

[72.9,80.0]

66.3

[53.7,76.9]

52.2

[41.5,62.6]

42.4
13.0

[34.9,50.3]
[4.2,33.5]

Design-based F(3.34, 511.74) = 25.7139 Pr
= 0.000

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Perceived health
status
Excellent (n=736)
Very good (n=1,230)
Good (n=1,064)
Fair/Poor (n=713)
missing (n=8)

Perceived health
status
Excellent (n=713)
Very good (n=1,182)
Good (n=963)
Fair/Poor (n=509)
missing (n=8)

Perceived health status
Excellent (n=253)
Very good (n=447)
Good (n=345)
Fair/Poor (n=224)
missing (n=3)

62.0
65.7
62.9
61.1
15.4

[56.5,67.1]
[61.5,69.7]
[58.3,67.3]
[56.8,65.3]
[2.7,54.6]

62.3
66.2
64.5
66.4
15.4

[56.8,67.6]
[61.9,70.2]
[59.9,68.8]
[61.0,71.4]
[2.7,54.6]

57.9
66.1
61.5
62.7
54.4

[50.3,65.2]
[59.7,72.1]
[53.1,69.3]
[55.1,69.7]
[6.8,95.1]

Design-based F(3.14, 499.29) = 1.5012 Pr =
0.212

Design-based F(3.01, 466.09) = 1.3615 Pr =
0.254

Design-based F(3.48, 532.52) = 0.9510 Pr =
0.425

Have any personal non-CRC cancer
history
No (n=3,139)
60.2 [57.6,62.7]
Yes (n=611)
77.3 [72.1,81.8]
missing (n=1)
0.0

Have any personal non-CRC cancer
history
No (n=2,801)
61.6 [58.7,64.3]
Yes (n=573)
78.4 [73.0,83.0]
missing (n=1)
0.0

Have any personal non-CRC cancer
history
No (n=1,082)
58.9 [54.7,62.9]
Yes (n=190)
81.3 [73.8,87.0]
missing (n=0)
0.0

Design-based F(1.21, 192.20) = 32.0869 Pr
= 0.000

Design-based F(1.18, 183.16) = 26.8255 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=2,419)
60.0
1 (n=709)
64.4
2 (n=391)
76.3
3+ (n=232)
72.6

[57.2,62.7]
[59.8,68.7]
[70.9,80.9]
[63.6,80.1]

Design-based F(2.76, 438.78) = 11.7138 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=2,268)
61.3
1 (n=590)
66.2
2 (n=334)
79.1
3+ (n=183)
75.1

[58.5,64.1]
[61.3,70.9]
[72.9,84.2]
[64.9,83.1]

Design-based F(2.72, 421.43) = 11.4085 Pr
= 0.000
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Design-based F(., .) = .
Pr = . **
Quan et al.'s updated Charlson
comorbidity index
0 (n=841)
57.7
1 (n=239)
66.8
2 (n=115)
83.5
3+ (n=77)
73.0

[52.9,62.4]
[59.3,73.5]
[75.3,89.3]
[61.5,82.1]

Design-based F(2.85, 435.50) = 11.2565 Pr
= 0.000

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Smoking status
Non-smoker (n=3,019)
Current Smoker (n=394)
missing (n=338)

Smoking status
Non-smoker (n=2,735)
Current Smoker (n=334)
missing (n=306)

Smoking status
Non-smoker (n=1,040)
Current Smoker (n=120)
missing (n=112)

66.1
50.7
48.8

[63.5,68.7]
[45.0,56.3]
[40.9,56.7]

Design-based F(1.98, 315.15) = 21.9931 Pr
= 0.000
BMI categories
Underweight (n=29)
Normal weight (n=1,025)
Overweight (n=1,419)
Obese (n=1,184)
missing (n=94)

44.7
59.1
63.4
68.9
44.4

[25.3,65.9]
[55.1,63.1]
[59.9,66.8]
[65.3,72.3]
[30.9,58.8]

Design-based F(3.67, 583.03) = 6.7332 Pr =
0.000

67.5
52.6
50.2

[64.8,70.1]
[46.2,59.0]
[41.9,58.5]

Design-based F(1.97, 304.65) = 19.1647 Pr
= 0.000
BMI categories
Underweight (n=22)
Normal weight (n=948)
Overweight (n=1,289)
Obese (n=1,034)
missing (n=82)

40.5
60.5
64.6
71.0
47.1

[19.7,65.3]
[56.3,64.5]
[61.1,67.9]
[67.1,74.6]
[32.7,62.0]

Design-based F(3.70, 574.27) = 7.0084 Pr =
0.000
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65.1
49.8
47.5

[61.0,69.0]
[41.2,58.3]
[33.7,61.8]

Design-based F(1.70, 259.74) = 8.3114 Pr =
0.001
BMI categories
Underweight (n=13)
Normal weight (n=341)
Overweight (n=478)
Obese (n=411)
missing (n=29)

32.4
57.6
62.7
69.3
32.3

[11.4,64.2]
[50.9,64.0]
[56.4,68.6]
[62.3,75.5]
[14.2,57.9]

Design-based F(3.55, 542.76) = 4.2589 Pr =
0.003

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=353)
51.1 [43.0,59.2]
Near poor/Low income
(100-200%) (n=606)
52.8 [46.8,58.8]
Middle Income (200400%) (n=1,107)
61.1 [57.0,65.0]
High Income (>400%)
(n=1,685)
68.3 [65.0,71.5]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=192)
58.5 [47.5,68.8]
Near poor/Low income
(100-200%) (n=478)
56.1 [49.5,62.4]
Middle Income (200400%) (n=1,035)
61.7 [57.4,65.8]
High Income (>400%)
(n=1,670)
68.3 [64.9,71.5]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=125)
57.0 [43.6,69.4]
Near poor/Low income
(100-200%) (n=219)
55.2 [45.1,64.8]
Middle Income (200400%) (n=373)
56.7 [48.7,64.4]
High Income (>400%)
(n=555)
68.1 [62.5,73.2]

Design-based F(2.79, 444.14) = 12.1090 Pr
= 0.000

Design-based F(2.90, 449.90) = 6.2798 Pr =
0.000

Design-based F(2.87, 439.12) = 3.3720 Pr =
0.020

Educational attainment
Less than a HSD
(n=714)
HSD/GED (n=1,581)
Bachelor's (n=638)
Graduate/Doctorate
Degree (n=432)
Other Degree (n=338)
missing (n=48)

48.0
60.4
66.7

[40.8,55.2]
[56.8,63.9]
[61.8,71.4]

74.2
71.7
20.0

[66.8,80.5]
[65.8,77.0]
[10.2,35.5]

Design-based F(3.85, 612.62) = 11.6172 Pr
= 0.000

Educational attainment
Less than a HSD
(n=524)
HSD/GED (n=1,462)
Bachelor's (n=608)
Graduate/Doctorate
Degree (n=420)
Other Degree (n=318)
missing (n=43)

51.6
62.0
67.1

[43.2,59.8]
[58.0,65.9]
[62.1,71.8]

74.0
71.9
21.0

[66.6,80.2]
[65.7,77.4]
[10.7,37.0]

Design-based F(3.87, 600.45) = 8.2979 Pr =
0.000
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Educational attainment
Less than a HSD
(n=224)
HSD/GED (n=509)
Bachelor's (n=240)
Graduate/Doctorate
Degree (n=172)
Other Degree (n=110)
missing (n=17)

52.1
58.4
61.5

[41.4,62.6]
[52.2,64.3]
[53.7,68.7]

73.7
76.2
24.8

[65.2,80.7]
[65.5,84.3]
[10.5,47.9]

Design-based F(3.45, 527.53) = 5.5011 Pr =
0.001

Table 4.4 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Number of months insured in survey year
1-6 (n=161)
41.1 [29.5,53.7]
7-11 (n=206)
37.2 [26.6,49.2]
12 (n=3,384)
65.4 [62.9,67.8]

Number of months insured in survey year
1-6 (n=120)
43.1 [30.3,56.8]
7-11 (n=150)
42.8 [30.0,56.6]
12 (n=3,105)
66.4 [63.7,69.0]

Number of months insured in survey year
1-6 (n=51)
41.2 [23.9,60.9]
7-11 (n=72)
44.9 [31.0,59.7]
12 (n=1,149)
64.2 [59.9,68.2]

Design-based F(2.00, 317.50) = 19.3913 Pr
= 0.000

Design-based F(1.99, 308.98) = 12.0756 Pr
= 0.000

Design-based F(1.91, 291.62) = 6.1270 Pr =
0.003

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=827)
36.9 [32.4,41.6]
1 (n=526)
56.3 [51.5,60.9]
2 (n=486)
65.2 [59.7,70.4]
3 (n=361)
67.8 [62.5,72.7]
4 (n=271)
69.8 [61.8,76.7]
5+ (n=1,280)
75.8 [72.0,79.2]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=759)
37.7 [33.1,42.5]
1 (n=497)
56.8 [51.9,61.5]
2 (n=453)
66.3 [60.8,71.5]
3 (n=337)
69.6 [64.5,74.2]
4 (n=245)
72.1 [64.1,78.9]
5+ (n=1,084)
78.8 [74.7,82.3]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=290)
37.5 [30.7,44.7]
1 (n=183)
53.8 [43.9,63.4]
2 (n=158)
61.8 [52.0,70.8]
3 (n=118)
61.5 [51.7,70.5]
4 (n=90)
69.8 [57.2,80.0]
5+ (n=433)
77.5 [72.1,82.1]

Design-based F(4.29, 682.48) = 42.3014 Pr
= 0.000

Design-based F(4.23, 655.47) = 45.3505 Pr
= 0.000

Design-based F(4.29, 655.64) = 16.9422 Pr
= 0.000

Had a usual source of
care
No (n=415)
Yes (n=3,270)
missing (n=66)

37.3
66.4
28.4

[31.1,43.9]
[63.8,69.0]
[14.0,49.0]

Design-based F(1.99, 317.08) = 49.8483 Pr
= 0.000

Had a usual source of
care
No (n=360)
Yes (n=2,954)
missing (n=61)

39.1
67.9
28.0

[32.9,45.7]
[65.0,70.7]
[13.4,49.5]

Design-based F(2.00, 309.76) = 47.8755 Pr
= 0.000
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Had a usual source of
care
No (n=136)
Yes (n=1,112)
missing (n=24)

35.2
65.7
23.2

[24.7,47.3]
[61.6,69.6]
[7.2,54.2]

Design-based F(1.96, 300.19) = 19.0388 Pr
= 0.000

Table 4.4 (cont.)
Full MEPS 2009-2011 sample
Year
2009 (n=1,283)
2010 (n=1,196)
2011 (n=1,272)

62.7
64.6
62.5

Full MEPS 2009-2011 sample
[59.6,65.8]
[61.4,67.7]
[58.3,66.6]

Design-based F(1.72, 273.78) = 0.5828 Pr =
0.534

Year
2009 (n=1,153)
2010 (n=1,084)
2011 (n=1,138)

64.3
66.0
64.0

Full MEPS 2009-2011 sample
[61.1,67.3]
[62.5,69.3]
[59.5,68.3]

Year
2009 (n=0)
2010 (n=0)
2011 (n=1,272)

0.0
0.0
62.5

[58.3,66.6]

Household had a FSA
No (n=1,130)
Yes (n=101)
missing (n=41)

62.0
71.9
39.7

[57.4,66.5]
[58.9,82.0]
[21.5,61.3]

Design-based F(1.70, 264.08) = 0.4995 Pr =
0.578

Insurance Features
Insurance had a DPN
No (n=1,596)
Yes (n=2,048)
missing (n=107)

[61.9,69.8]
[59.0,64.3]
[38.1,64.3]

Coverage was restricted to a DPN
No (n=2,469)
64.7 [61.1,68.2]
Yes (n=903)
65.1 [60.9,69.0]
missing (n=3)
0.0

Design-based F(1.86, 294.98) = 3.6761 Pr =
0.030

Design-based F(1.34, 207.11) = 0.4138 Pr =
0.579

Insurance used
gatekeeping
No (n=1,989)

66.0
61.6
51.3

64.1

[60.1,67.8]

Yes (n=1,667)

62.9

[59.1,66.5
]

missing (n=95)

50.6

[36.9,64.3]

Design-based F(1.79, 284.65) = 1.2425 Pr =
0.288
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Design-based F(1.85, 282.90) = 2.9640 Pr =
0.057*

Table 4.4 (cont.)
Full MEPS 2009-2011 sample
Cost-sharing categories for Aim 2 main
analysis full sample
0.0% (n=216)
43.2 [34.2,52.7]
0.1 to 13.9% (n=1,127)
68.6 [64.9,72.2]
14.0 to 32.3% (n=972)
72.1 [68.3,75.7]
32.3 to 88.4% (n=974)
63.5 [59.3,67.5]
88.4 to 100% (n=172)
35.2 [28.1,42.9]
No spending in year
(n=290)
27.3 [20.4,35.6]
Design-based F(4.48, 712.21) = 33.1234 Pr
= 0.000
* there was not an overall significant difference (p<0.1) for the variable after excluding the missing category
** there was an overall significant difference (p<0.05) for the variable after excluding the missing category
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Table 4.5 Aim 2 Bivariate Associations with Likelihood of Having Received CRC Screening in the Past Year
for Sensitivity Analysis Samples
Full MEPS 2009-2011 sample of those
screened in previous year and those
not up-to-date with recommended CRC
screening

Total (n=2,591)

%

95% CI

45.7

[42.8,48.5]

Reduced MEPS 2009-2011 sample
excluding those age 50-64 with only
public insurance

Total (n=2,275)

%

95% CI

47.0

[43.7,50.3]

[25.7,36.3]
[40.6,55.7]
[49.2,62.1]
[50.5,64.8]
[52.5,65.8]

Reduced sample of only MEPS 2011
%

95% CI

Total (n=848)

41.9

[37.1,46.8]

Age groups
50-54 (n=291)
55-59 (n=164)
60-64 (n=141)
65-69 (n=145)
70-75 (n=107)

27.7
41.9
46.1
55.6
62.4

[23.1,32.9]
[30.1,54.6]
[34.4,58.3]
[45.5,65.2]
[53.9,70.2]

Covariates
Age groups
50-54 (n=801)
55-59 (n=564)
60-64 (n=475)
65-69 (n=433)
70-75 (n=318)

30.6
45.0
53.8
57.8
59.3

[25.7,36.0]
[38.2,52.1]
[47.8,59.6]
[50.5,64.8]
[52.5,65.8]

Design-based F(2.80, 433.53) = 15.1307 Pr
= 0.000
Sex
Male (n=1,214)
Female (n=1,377)

47.6
43.9

[44.1,51.2]
[40.0,47.8]

Design-based F(1.00, 155.00) = 2.3592 Pr =
0.127

Age groups
50-54 (n=680)
55-59 (n=463)
60-64 (n=381)
65-69 (n=433)
70-75 (n=318)

30.7
48.1
55.8
57.8
59.3

Design-based F(2.81, 422.01) = 15.0016 Pr
= 0.000
Sex
Male (n=1,084)
Female (n=1,191)

49.1
45.0

[45.0,53.1]
[40.6,49.5]

Design-based F(1.00, 150.00) = 2.2471 Pr =
0.136
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Design-based F(3.00, 438.58) = 9.0388 Pr =
0.000
Sex
Male (n=396)
Female (n=452)

43.9
40.1

[38.4,49.5]
[34.1,46.4]

Design-based F(1.00, 146.00) = 1.2273 Pr =
0.270

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

White/Ethnicity
non-Hispanic white
(n=1,635)
Hispanic white (n=956)

White/Ethnicity
non-Hispanic white
(n=1,515)
Hispanic white (n=760)

White/Ethnicity
non-Hispanic white
(n=563)
Hispanic white (n=285)

47.6
37.1

[44.4,50.9]
[32.2,42.2]

Design-based F(1.00, 155.00) = 12.7378 Pr
= 0.000
Marital status
Married (n=1,681)
Widowed (n=175)
Divorced/Separated
(n=512)
Never married (n=223)

46.8
54.7

[42.5,51.1]
[43.0,66.0]

41.8
40.0

[36.7,47.1]
[30.2,50.7]

48.9
37.5

[45.2,52.6]
[32.1,43.3]

Design-based F(1.00, 150.00) = 11.7107 Pr
= 0.001
Marital status
Married (n=1,533)
Widowed (n=155)
Divorced/Separated
(n=419)
Never married (n=168)

47.9
56.7

[43.4,52.4]
[44.1,68.5]

42.8
41.0

[36.6,49.3]
[30.0,53.1]

43.3
35.9

[37.5,49.2]
[30.3,41.8]

Design-based F(1.00, 146.00) = 2.8524 Pr =
0.093
Marital status
Married (n=558)
Widowed (n=51)
Divorced/Separated
(n=167)
Never married (n=72)

41.7
55.6

[35.2,48.6]
[37.4,72.4]

43.7
31.7

[32.6,55.5]
[19.2,47.6]

Design-based F(2.83, 438.34) = 1.6627 Pr =
0.177

Design-based F(2.83, 424.63) = 1.5494 Pr =
0.203

Design-based F(2.75, 401.17) = 1.0634 Pr =
0.361

Metropolitan Statistical Area Status
Urban (n=2,352)
46.0 [43.0,49.1]
Rural (n=239)
43.0 [35.4,50.9]

Metropolitan Statistical Area Status
Urban (n=2,072)
47.1 [43.7,50.6]
Rural (n=203)
45.9 [36.1,56.1]

Metropolitan Statistical Area Status
Urban (n=757)
41.7 [36.8,46.7]
Rural (n=91)
43.4 [30.1,57.6]

Design-based F(1.00, 155.00) = 0.5333 Pr =
0.466

Design-based F(1.00, 150.00) = 0.0462 Pr =
0.830

Design-based F(1.00, 146.00) = 0.0554 Pr =
0.814
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Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Immigration status
US born (n=1,849)
Foreign born, lived in US
<15 years (n=60)
Foreign born, lived in US
> 15 years (n=654)
missing (n=28)

Immigration status
US born (n=1,690)
Foreign born, lived in US
<15 years (n=48)
Foreign born, lived in US
> 15 years (n=511)
missing (n=26)

Immigration status
US born (n=618)
Foreign born, lived in US
<15 years (n=24)
Foreign born, lived in US
> 15 years (n=196)
missing (n=10)

47.0

[43.6,50.4]

6.0

[1.2,25.2]

43.4
22.7

[37.2,49.8]
[7.8,50.5]

48.2

[44.4,52.1]

6.5

[1.3,27.4]

45.0
24.1

[37.3,52.9]
[8.2,53.0]

43.7

[38.1,49.6]

2.8

[0.4,18.5]

37.0
59.2

[29.5,45.2]
[18.3,90.4]

Design-based F(2.66, 412.25) = 7.1710 Pr =
0.000

Design-based F(2.62, 392.39) = 6.1250 Pr =
0.001

Design-based F(2.65, 386.92) = 6.4274 Pr =
0.001

Whether comfortable speaking English
Comfortable (n=2,186)
46.8 [43.6,50.0]
Not comfortable (n=316)
26.7 [20.6,33.9]
missing (n=89)
38.3 [26.3,52.0]

Whether comfortable speaking English
Comfortable (n=1,979)
47.9 [44.4,51.5]
Not comfortable (n=221)
25.9 [18.5,35.1]
missing (n=75)
39.5 [26.7,53.8]

Whether comfortable speaking English
Comfortable (n=724)
42.6 [37.5,47.7]
Not comfortable (n=99)
25.8 [17.6,36.2]
missing (n=25)
61.1 [37.1,80.7]

Design-based F(1.84, 284.59) = 12.4500 Pr
= 0.000

Design-based F(1.78, 267.67) = 10.4856 Pr
= 0.000

Design-based F(1.98, 289.58) = 5.2244 Pr =
0.006

Interview Language
English (n=2,136)
Spanish, Spanish and
English, or other (n=455)

47.0

[43.9,50.2]

28.6

[22.8,35.2]

Design-based F(1.00, 155.00) = 22.0192 Pr
= 0.000

Interview Language
English (n=1,939)
Spanish, Spanish and
English, or other (n=336)

48.2

[44.7,51.8]

27.3

[21.0,34.6]

Design-based F(1.00, 150.00) = 23.5169 Pr
= 0.000
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Interview Language
English (n=713)
Spanish, Spanish and
English, or other (n=135)

43.3

[38.2,48.5]

22.8

[16.1,31.1]

Design-based F(1.00, 146.00) = 15.9766 Pr
= 0.000

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Reduced MEPS 2009-2011 sample

Reduced sample of only MEPS 2011

Dental checkup
frequency
Twice a year or more
(n=1,074)
Once a year (n=580)
Less than once a year
(n=518)
Never go to dentist
(n=366)
missing (n=53)

Dental checkup
frequency
Twice a year or more
(n=1,043)
Once a year (n=517)
Less than once a year
(n=400)
Never go to dentist
(n=265)
missing (n=50)

Dental checkup
frequency
Twice a year or more
(n=345)
Once a year (n=195)
Less than once a year
(n=178)
Never go to dentist
(n=110)
missing (n=20)

57.6
42.2

[52.4,62.7]
[37.0,47.6]

30.3

[25.5,35.7]

27.9
1.1

[23.4,33.0]
[0.1,8.0]

Design-based F(2.81, 435.37) = 32.4849 Pr
= 0.000
Most recent flu shot
Within past year
(n=1,215)
Within past two years
(n=226)
More than two years
(n=249)
Never received flu shot
(n=803)
missing (n=98)

59.9

[56.5,63.1]

42.7

[34.5,51.3]

36.7

[28.8,45.5]

30.4
11.1

[25.4,35.8]
[4.3,25.6]

Design-based F(3.65, 565.00) = 27.7441 Pr
= 0.000

57.6
42.6

[52.3,62.8]
[36.9,48.6]

30.9

[25.5,36.9]

28.9
1.2

[23.6,34.8]
[0.2,8.2]

Design-based F(2.95, 443.22) = 28.1272 Pr
= 0.000
Most recent flu shot
Within past year
(n=1,070)
Within past two years
(n=190)
More than two years
(n=232)
Never received flu shot
(n=699)
missing (n=84)

[49.6,65.7]
[23.8,40.5]

26.3

[19.1,35.1]

20.0
0.0

[14.2,27.3]

Design-based F(3.24, 472.92) = 16.4994 Pr
= 0.000
Most recent flu shot

61.5

[57.8,65.0]

45.3

[36.3,54.6]

36.5

[28.1,45.8]

31.9
8.4

[26.5,37.8]
[2.1,28.5]

Design-based F(3.47, 521.01) = 23.5668 Pr
= 0.000
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57.9
31.6

Within past year (n=392)
Within past two years
(n=75)
More than two years
(n=79)
Never received flu shot
(n=266)
missing (n=36)

59.7

[55.0,64.3]

40.2

[24.0,58.7]

35.3

[23.5,49.2]

22.2
5.8

[16.5,29.2]
[1.3,22.0]

Design-based F(3.44, 502.74) = 17.7983 Pr
= 0.000

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Perceived health
status
Excellent (n=467)
Very good (n=838)
Good (n=751)
Fair/Poor (n=527)
missing (n=8)

Perceived health
status
Excellent (n=447)
Very good (n=800)
Good (n=665)
Fair/Poor (n=355)
missing (n=8)

Perceived health status
Excellent (n=172)
Very good (n=286)
Good (n=231)
Fair/Poor (n=156)
missing (n=3)

41.6
48.5
46.3
44.4
15.4

[34.8,48.6]
[43.9,53.1]
[41.7,51.1]
[39.4,49.5]
[2.7,54.6]

41.9
49.1
47.7
48.6
15.4

[35.1,49.0]
[44.4,53.8]
[42.7,52.7]
[41.6,55.6]
[2.7,54.6]

39.2
43.4
40.3
45.2
54.4

[31.0,48.1]
[36.2,51.0]
[31.0,50.4]
[34.9,55.9]
[6.8,95.1]

Design-based F(3.14, 487.29) = 1.4754 Pr =
0.219

Design-based F(3.11, 466.78) = 1.6063 Pr =
0.185

Design-based F(3.48, 507.44) = 0.3121 Pr =
0.845

Have any personal non-CRC cancer
history
No (n=2,221)
41.9 [39.1,44.8]
Yes (n=369)
64.0 [57.8,69.8]
missing (n=1)
0.0

Have any personal non-CRC cancer
history
No (n=1,938)
43.1 [39.9,46.4]
Yes (n=336)
65.1 [58.3,71.4]
missing (n=1)
0.0

Have any personal non-CRC cancer
history
No (n=748)
38.4 [34.1,42.8]
Yes (n=100)
64.5 [51.1,75.9]
missing (n=0)
0.0

Design-based F(1.32, 204.22) = 45.0785 Pr
= 0.000

Design-based F(1.28, 192.69) = 38.0901 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=1,679)
40.8
1 (n=500)
47.9
2 (n=267)
65.8
3+ (n=145)
56.4

[37.5,44.2]
[43.3,52.5]
[57.9,73.0]
[46.7,65.6]

Design-based F(2.51, 389.08) = 16.8927 Pr
= 0.000

Quan et al.'s updated Charlson
comorbidity index
0 (n=1,546)
42.2
1 (n=399)
49.4
2 (n=221)
68.8
3+ (n=109)
58.8

[38.7,45.8]
[44.0,54.9]
[59.1,77.1]
[47.3,69.5]

Design-based F(2.50, 374.92) = 14.2369 Pr
= 0.000
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Design-based F(., .) = . Pr = .
**
Quan et al.'s updated Charlson
comorbidity index
0 (n=574)
36.5
1 (n=166)
49.0
2 (n=64)
68.5
3+ (n=44)
53.0

[31.7,41.5]
[40.7,57.3]
[53.8,80.2]
[35.8,69.6]

Design-based F(2.64, 385.35) = 8.8260 Pr =
0.000

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Smoking status
Non-smoker (n=2,045)
Current Smoker (n=281)
missing (n=265)

Smoking status
Non-smoker (n=1,802)
Current Smoker (n=237)
missing (n=236)

Smoking status
Non-smoker (n=676)
Current Smoker (n=84)
missing (n=88)

48.8
31.3
33.3

[45.5,52.2]
[25.3,38.1]
[25.5,42.0]

Design-based F(1.98, 307.20) = 13.9238 Pr
= 0.000
BMI categories
Underweight (n=20)
Normal weight (n=701)
Overweight (n=974)
Obese (n=823)
missing (n=73)

20.4
40.5
46.3
52.3
24.4

[9.8,37.7]
[35.5,45.7]
[42.4,50.3]
[47.9,56.6]
[13.0,41.1]

Design-based F(2.97, 459.73) = 7.1376 Pr =
0.000

50.0
32.7
34.4

[46.3,53.7]
[26.2,40.0]
[26.2,43.6]

Design-based F(1.97, 295.34) = 12.6360 Pr
= 0.000
BMI categories
Underweight (n=16)
Normal weight (n=634)
Overweight (n=862)
Obese (n=701)
missing (n=62)

16.1
41.5
47.1
54.7
26.6

[4.3,45.0]
[36.2,47.0]
[42.8,51.5]
[49.7,59.6]
[14.2,44.3]

Design-based F(3.11, 466.48) = 6.7012 Pr =
0.000
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44.4
28.8
32.7

[39.6,49.2]
[19.7,39.9]
[18.6,50.9]

Design-based F(1.80, 262.13) = 3.3220 Pr =
0.043
BMI categories
Underweight (n=10)
Normal weight (n=220)
Overweight (n=321)
Obese (n=274)
missing (n=23)

19.7
35.1
41.9
51.1
10.2

[4.1,58.3]
[28.8,42.1]
[34.4,49.7]
[41.6,60.4]
[2.3,35.3]

Design-based F(3.04, 443.26) = 3.9143 Pr =
0.009

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=277)
37.0 [29.9,44.8]
Near poor/Low income
(100-200%) (n=472)
37.6 [31.5,44.1]
Middle Income (200400%) (n=780)
43.0 [37.9,48.2]
High Income (>400%)
(n=1,062)
50.6 [45.8,55.4]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=143)
41.4 [29.7,54.2]
Near poor/Low income
(100-200%) (n=362)
40.3 [32.9,48.2]
Middle Income (200400%) (n=719)
43.3 [38.0,48.7]
High Income (>400%)
(n=1,051)
50.7 [45.9,55.5]

Household income as a percentage of the
federal poverty level
Poor/Negative (<100%)
(n=93)
39.6 [27.8,52.6]
Near poor/Low income
(100-200%) (n=157)
35.3 [24.5,47.7]
Middle Income (200400%) (n=260)
36.2 [27.6,45.6]
High Income (>400%)
(n=338)
47.4 [39.7,55.2]

Design-based F(2.92, 453.25) = 5.5083 Pr =
0.001

Design-based F(2.95, 442.35) = 2.9773 Pr =
0.032

Design-based F(2.82, 412.20) = 1.8679 Pr =
0.138

Educational attainment
Less than a HSD
(n=583)
HSD/GED (n=1,095)
Bachelor's (n=403)
Graduate/Doctorate
Degree (n=247)
Other Degree (n=217)
missing (n=46)

31.6
43.0
48.3

[26.1,37.7]
[38.5,47.6]
[41.5,55.2]

56.8
57.5
17.8

[47.5,65.6]
[49.8,64.8]
[8.0,35.2]

Design-based F(3.96, 613.72) = 7.1938 Pr =
0.000

Educational attainment
Less than a HSD
(n=413)
HSD/GED (n=996)
Bachelor's (n=382)
Graduate/Doctorate
Degree (n=240)
Other Degree (n=203)
missing (n=41)

33.6
44.3
48.7

[27.0,40.9]
[39.2,49.6]
[41.7,55.8]

56.4
57.5
18.7

[47.0,65.3]
[49.0,65.6]
[8.3,36.7]

Design-based F(3.99, 597.76) = 5.1157 Pr =
0.000
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Educational attainment
Less than a HSD
(n=168)
HSD/GED (n=346)
Bachelor's (n=157)
Graduate/Doctorate
Degree (n=94)
Other Degree (n=68)
missing (n=15)

26.3
38.5
41.2

[18.3,36.1]
[32.5,45.0]
[32.7,50.2]

52.1
61.7
16.1

[39.4,64.6]
[47.7,74.0]
[3.0,54.3]

Design-based F(4.24, 619.35) = 4.8126 Pr =
0.001

Table 4.5 (cont.)
Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Full MEPS 2009-2011 sample

Number of months insured in survey year
1-6 (n=125)
22.9 [13.9,35.5]
7-11 (n=169)
20.9 [12.1,33.7]
12 (n=2,297)
48.1 [44.9,51.3]

Number of months insured in survey year
1-6 (n=88)
24.4 [13.9,39.1]
7-11 (n=119)
24.5 [13.3,40.7]
12 (n=2,068)
48.9 [45.3,52.6]

Number of months insured in survey year
1-6 (n=38)
18.7
[6.2,44.5]
7-11 (n=54)
18.5
[7.2,39.8]
12 (n=756)
44.0 [39.0,49.1]

Design-based F(1.98, 306.56) = 13.7066 Pr
= 0.000

Design-based F(1.97, 295.69) = 8.4935 Pr =
0.000

Design-based F(2.00, 291.59) = 4.7499 Pr =
0.009

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=674)
19.3 [14.8,24.8]
1 (n=376)
37.8 [32.2,43.8]
2 (n=322)
46.4 [38.9,54.0]
3 (n=232)
51.4 [43.7,58.9]
4 (n=181)
54.6 [43.4,65.4]
5+ (n=806)
61.4 [56.8,65.7]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=614)
20.1 [15.3,25.8]
1 (n=353)
38.7 [32.9,44.9]
2 (n=294)
47.7 [39.8,55.8]
3 (n=211)
53.3 [45.8,60.7]
4 (n=157)
56.4 [44.7,67.5]
5+ (n=646)
64.7 [59.3,69.8]

Number of outpatient provider visits in
year including physicians PAs and NPs
0 (n=233)
20.1 [14.3,27.5]
1 (n=132)
36.9 [26.4,48.7]
2 (n=108)
39.5 [29.7,50.2]
3 (n=74)
41.1 [28.9,54.5]
4 (n=59)
49.0 [33.6,64.6]
5+ (n=242)
59.3 [50.8,67.3]

Design-based F(4.17, 645.97) = 28.2297 Pr
= 0.000

Design-based F(4.17, 626.12) = 29.1859 Pr
= 0.000

Design-based F(4.34, 633.99) = 9.9258 Pr =
0.000

Had a usual source of
care
No (n=336)
Yes (n=2,195)
missing (n=60)

19.3
49.4
16.4

[14.4,25.3]
[46.4,52.3]
[4.4,45.2]

Design-based F(1.77, 273.70) = 30.6188 Pr
= 0.000

Had a usual source of
care
No (n=286)
Yes (n=1,933)
missing (n=56)

20.2
50.8
16.9

[15.0,26.7]
[47.3,54.2]
[4.6,46.2]

Design-based F(1.80, 269.50) = 28.5074 Pr
= 0.000
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Had a usual source of
care
No (n=106)
Yes (n=721)
missing (n=21)

16.2
45.5
8.8

[8.6,28.3]
[40.6,50.4]
[1.1,45.6]

Design-based F(1.95, 285.39) = 12.3316 Pr
= 0.000

Table 4.5 (cont.)
Full MEPS 2009-2011 sample
Year
2009 (n=925)
2010 (n=818)
2011 (n=848)

47.4
47.6
41.9

Full MEPS 2009-2011 sample
[42.6,52.2]
[43.5,51.8]
[37.1,46.8]

Design-based F(1.61, 248.92) = 2.1301 Pr =
0.131

Year
2009 (n=811)
2010 (n=725)
2011 (n=739)

48.9
48.8
43.1

Full MEPS 2009-2011 sample
[43.8,54.0]
[44.3,53.3]
[37.7,48.8]

Year
2009 (n=0)
2010 (n=0)
2011 (n=848)

0.0
0.0
41.9

[37.1,46.8]

Household had a FSA
No (n=759)
Yes (n=58)
missing (n=31)

41.7
49.7
20.4

[36.7,47.0]
[33.0,66.5]
[8.1,42.7]

Design-based F(1.66, 248.66) = 1.8588 Pr =
0.165

Insurance Features
Insurance had a DPN
No (n=1,040)
Yes (n=1,468)
missing (n=83)

[40.8,50.1]
[42.9,49.7]
[22.6,48.0]

Coverage was restricted to a DPN
No (n=1,621)
44.7 [40.4,49.0]
Yes (n=651)
53.1 [47.5,58.6]
missing (n=3)
0.0

Design-based F(1.75, 270.70) = 1.1566 Pr =
0.311

Design-based F(1.32, 197.29) = 4.2290 Pr =
0.030

Insurance used
gatekeeping
No (n=1,290)
Yes (n=1,228)
missing (n=73)

45.4
46.3
34.2

42.5
49.9
32.9

[37.8,47.4]
[45.4,54.4]
[21.0,47.5]

Design-based F(1.61, 249.64) = 3.6949 Pr =
0.035
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Design-based F(1.70, 247.75) = 1.7669 Pr =
0.178

Table 4.5 (cont.)
Full MEPS 2009-2011 sample
Cost-sharing categories for Aim 2
sensitivity analysis full sample
0.0% (n=156)
24.9 [16.7,35.5]
0.1 to 13.0% (n=759)
54.3 [50.0,58.4]
13.1 to 32.3% (n=647)
56.0 [51.0,60.8]
32.3 to 93.1% (n=659)
43.0 [37.9,48.2]
93.1 to 100% (n=116)
14.5
[8.7,23.1]
No spending in year
(n=254)
11.7
[7.6,17.7]
Design-based F(4.55, 705.07) = 28.8871 Pr
= 0.000
** there was an overall significant difference (p<0.05) for the variable after excluding the missing category
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a very wide confidence interval (3.5 to 40.0%).
Some variables that had significant variation, but of a small difference, in the Aim
1 sample were not significant in the Aim 2 sample, which had about one-sixth the
sample size as the full Aim 1 sample 3,751 vs. 21,085. In the Aim 2 full sample
and both reduced samples, screening likelihood did not significantly vary
depending on urban vs. rural MSA designation, perceived health status, or
survey year.
Bivariate associations for the Aim 2 sensitivity analysis for the binary outcome of
had received any CRC screening in the previous year vs. was not up-to-date with
recommended screening were generally consistent with the main analysis
findings (Table 4.5). Notably, in the sensitivity analyses marital status no longer
predicted significant variation in screening likelihood as it had in the main
analyses. In the sensitivity analyses, foreign born persons who had lived in the
US for less than 15 years were predicted to have a 6.0% likelihood of having
received screening in the previous year in the full sample for the Aim 2 sensitivity
analysis, and only a 2.8% likelihood in the reduced sample of only MEPS 2011.
Those estimates were 13.4 and 14.5% for the same samples of the main
analyses, respectively. In the Aim 2 sensitivity analysis, the overall significance
tests for the bivariate associations for the insurance features switched from the
findings for the main analyses’ samples. In the sensitivity analyses’ samples,
having a DPN was no longer significant, while each having insurance that used
gatekeeping and having insurance with coverage that was restricted to a DPN
was significant.

Multivariate Logistic Regression Model Specifications

Covariate Effects
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In the first part of the multivariate logistic regression procedure, the covariates
from the bivariate analyses were fit into blocks of substantively related variables,
with a separate model fitting for each unique sample used in the main and
sensitivity analyses for Aims 1 and 2. Although generally similar overall (Table
4.6), the covariates included in each block varied some across the 10 analytic
samples. The prevention history and health care access blocks were consistent
across the samples, while the education and income block was consistent except
for the two Aim 2 sensitivity analysis samples, which dropped the income
variable. In all samples, the health/lifestyle block included all covariates minus
perceived health status, except for two samples that did not drop perceived
health status. The sociodemographics block had the most variation in included
covariates: MEPS interview language was dropped from the block in all
samples; census regions were dropped in four of the six applicable Aim 1
samples; and urban vs. rural residence and whether comfortable speaking
English were dropped in five and six of the ten samples, respectively. For the
covariates that remained following the first step of the multivariate logistic
regression procedure, collinearity diagnostics indicated no collinearity, so no
covariates were excluded due to collinearity. The collinearity diagnostics
revealed that there were no Western Hispanics who had an FSA in MEPS 2011,
so the FSA variable was not assessed for the Aim 2 main or sensitivity analyses.
Table 4.7 reports multivariate-adjusted screening likelihoods across the levels of
covariates for the full set of covariates controlled for in the analyses of each of
the full samples (the full sample is the first row for each Aim’s main and
sensitivity analyses in Table 4.6). For centered age (age minus 50) and squared
centered age the predicted continuous change in screening likelihood for each
one year of age or squared age change is reported. Covariates that are blank in
the table were dropped from the covariate block as either noted in Table 4.6 or
were not applicable to a particular analysis (census region and race/Hispanic
ethnicity for Aim 2 and Hispanic ethnicity for Aim 1).
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Table 4.6 Covariates Included/Dropped in Blocks for each Multivariate Logistic Regression Analysis

Analyses

Sample and
Insurance
Features
Analyzed

Sociodemographics
Included

Aim 1 main
analyses

Full MEPS
2009-2011
Sample:
Whether
insurance had
DPN; Whether
insurance used
gatekeeping;
and Costsharing
categories

Age and Age2; Sex;
Race/Hispanic
ethnicity; Urban vs.
rural residence;
Marital status;
Immigration
categories; and
Whether comfortable
speaking English

Aim 1
Sensitivity
Analyses
with
previous
year CRC
screening
outcome

Full MEPS
2009-2011
Sample:
Whether
insurance had
DPN; Whether
insurance used
gatekeeping;
and Costsharing
categories

Age and Age2; Sex;
Race/Hispanic
ethnicity; Marital
status; Census
regions; Urban vs.
rural residence;
Marital status;
Immigration
categories; and
Whether comfortable
speaking English

Dropped

Census
regions*; and
MEPS interview
language

MEPS interview
language
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Covariate Blocks†
Education and income
Included
Dropped

Educational
attainment and
FPL categories

Educational
attainment and
FPL categories

Health/lifestyle
Included
Dropped

-

Charlson
comorbidity
index;
Perceived
health status;
Whether ever
had non-CRC
cancer
diagnosis;
Smoking
status; and
BMI categories

-

-

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Perceived
health status*

Table 4.6 (cont.)
Analyses

Aim 1 main
analyses

Aim 1
Sensitivity
Analyses
with
previous
year CRC
screening
outcome

Sample
Reduced MEPS
2009-2011
Sample
excluding
those age 50-64
with only
public
insurance:
Whether
insurance
restricted
coverage to
DPN
Reduced MEPS
2009-2011
Sample
excluding
those age 50-64
with only
public
insurance:
Whether
insurance
restricted
coverage to
DPN

Sociodemographics
Included

Age and Age2; Sex;
Race/Hispanic
ethnicity; Urban vs.
rural residence;
Marital status;
Immigration
categories; and
Whether comfortable
speaking English

Age and Age2; Sex;
Race/Hispanic
ethnicity; Marital
status; Census
regions; Urban vs.
rural residence;
Immigration
categories; and
Whether comfortable
speaking English

Education and income

Dropped

Census
regions*; and
MEPS interview
language

MEPS interview
language*
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Included

Educational
attainment and
FPL categories

Educational
attainment and
FPL categories

Dropped

Health/lifestyle
Included

Dropped

-

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Perceived
health status*

-

Charlson
comorbidity
index;
Perceived
health status;
Whether ever
had non-CRC
cancer
diagnosis;
Smoking
status; and
BMI categories

-

Table 4.6 (cont.)
Analyses

Sample

Sociodemographics
Included

Education and income

Dropped

Included

Dropped

Health/lifestyle
Included

Reduced MEPS
2011 Sample:
Whether
respondent had
FSA in 2011

Age and Age2; Sex;
Race/Hispanic
ethnicity; Marital
status; and
Immigration
categories

Census
regions*; Urban
vs. rural
residence*;
Whether
comfortable
speaking
English; and
MEPS interview
language

Educational
attainment and
FPL categories

-

Aim 1
Sensitivity
Analyses
with
previous
year CRC
screening
outcome

Reduced MEPS
2011 Sample:
Whether
respondent had
FSA in 2011

Age and Age2; Sex;
Race/Hispanic
ethnicity; Marital
status; Urban vs.
rural residence; and
Immigration
categories

Census
regions*;
Whether
comfortable
speaking
English; and
MEPS interview
language*

Educational
attainment and
FPL categories

-

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories
Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Aim 2 main
analyses**

Full MEPS
2009-2011
Sample:
Whether
insurance had
DPN; Whether
insurance used
gatekeeping;
and Costsharing
categories

Age and Age2; Sex;
and Immigration
categories

Urban vs. rural
residence;*
Marital status;
Whether
comfortable
speaking
English; and
MEPS interview
language

-

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Aim 1 main
analyses
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Educational
attainment and
FPL categories

Dropped

Perceived
health status*

Perceived
health status*

Perceived
health status*

Table 4.6 (cont.)
Analyses

Aim 2
Sensitivity
Analyses
with
previous
year CRC
screening
outcome

Aim 2 main
analyses**

Sample
Full MEPS
2009-2011
Sample:
Whether
insurance had
DPN; Whether
insurance used
gatekeeping;
and Costsharing
categories
Reduced MEPS
2009-2011
Sample
excluding
those age 50-64
with only
public
insurance:
Whether
insurance
restricted
coverage to
DPN

Sociodemographics
Included

Education and income

Dropped

Age and Age2; Sex;
and Immigration
categories

Marital status;
Urban vs. rural
residence;
Whether
comfortable
speaking
English; and
MEPS interview
language

Age and Age2; Sex;
and Immigration
categories

Urban vs. rural
residence;*
Marital status;
Whether
comfortable
speaking
English; and
MEPS interview
language
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Included

Educational
attainment

Educational
attainment and
FPL categories

Dropped

Health/lifestyle
Included

Dropped

FPL
categories

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Perceived
health status*

-

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Perceived
health status*

Table 4.6 (cont.)
Analyses

Aim 2
Sensitivity
Analyses
with
previous
year CRC
screening
outcome

Sample
Reduced MEPS
2009-2011
Sample
excluding
those age 50-64
with only
public
insurance:
Whether
insurance
restricted
coverage to
DPN

Sociodemographics
Included

Age and Age2; Sex;
and Immigration
categories

Education and income

Dropped

Marital status;
Urban vs. rural
residence;
Whether
comfortable
speaking
English; and
MEPS interview
language

Included

Educational
attainment

Dropped

FPL
categories

Health/lifestyle
Included

Dropped

Charlson
comorbidity
index; Whether
ever had nonCRC cancer
diagnosis;
Smoking
status; and
BMI categories

Perceived
health status*

†The prevention history block consistently included the same two variables: dental checkup frequency and time since most recent flu shot. The
health care access block consistently included the same three variables: survey year insurance duration; Number of outpatient provider visits;
and Whether had a usual source of care.
* Covariate was dropped after having non-significant (p<0.1) bivariate association with CRC screening outcome and was not included in
multivariate analyses
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Table 4.7 Multivariate Adjusted Predicted Effects and Likelihoods of CRC Screening for Fully Adjusted Models
Including All Covariates Without Insurance Features
Covariates

Table 4.7a: Aim 1
Main Analysis

Table 4.7b: Aim 1
Sensitivity Analysis
Predicted
continuous
change in
likelihood
of Having
Received
CRC
screening
in the
95%
Previous
Confidence
Year
Interval

Predicted
continuous
change in
likelihood
of being
up-to-date
with CRC
screening

95%
Confidence
Interval

Centered age

2.68%*

2.26% to 3.10%

2.10%*

Squared centered
age

-0.08%*

-0.09% to 0.06%

-0.05%*

Predicted
likelihood
of being
up-to-date
with CRC
screening

95%
Confidence
Interval

Predicted
likelihood
of having
received
CRC
screening
in previous
year

62.50%

61.3% to 63.8%

40.30%

Full Sample

Table 4.7c: Aim 2
Main Analysis

Table 4.7d: Aim 2
Sensitivity Analysis
Predicted
continuous
change in
likelihood
of Having
Received
CRC
screening
in the
95%
Previous
Confidence
Year
Interval

Predicted
continuous
change in
likelihood
of being
up-to-date
with CRC
screening

95%
Confidence
Interval

1.58% to 2.63%

3.16%*

1.98% to 4.34%

2.87%*

1.30% to 4.45%

-0.08% to 0.03%

-0.09%*

-0.14% to 0.04%

-0.08%*

-0.15% to 0.02%

95%
Confidence
Interval

Predicted
likelihood
of being
up-to-date
with CRC
screening

95%
Confidence
Interval

Predicted
likelihood
of having
received
CRC
screening
in previous
year

95%
Confidence
Interval

39.0% to 41.7%

63.30%

60.8% to 65.8%

45.70%

42.8% to 48.5%
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Table 4.7 cont.)

Aim 1 Main Analysis

Aim 1 Sensitivity Analysis

Aim 2 Main Analysis

Aim 2 Sensitivity Analysis

Sex
Male
Female

65.4%*

63.8% to 66.9%

44.0%*

42.2% to 45.9%

66.7%*

63.6% to 69.7%

49.7%*

46.1% to 53.3%

60.00%

58.4% to 61.5%

37.20%

35.6% to 38.9%

60.20%

57.1% to 63.2%

42.20%

38.3% to 46.2%

60.8% to 63.7%

39.20%

37.6% to 40.8%

58.4% to 64.7%

42.40%

38.7% to 46.2%

66.7% to 70.8%

51.1%*

48.5% to 53.7%

50.3% to 58.8%

32.3%*

27.6% to 37.0%

54.1% to 65.1%

35.20%

29.9% to 40.6%

64.10%

61.3% to 66.8%

46.00%

43.2% to 48.8%

59.70%

54.3% to 65.1%

44.10%

37.8% to 50.4%

Race/Hispanic Ethnicity
REF: Non-Hispanic
white
62.30%
Hispanic white
61.60%
Non-Hispanic black
68.7%*
Non-Hispanic Asian
54.6%*
Other
59.60%
Hispanic ethnicity
REF: Non-Hispanic
white
Hispanic white
Census region
REF: Northeast
Midwest
South
West
MSA Designation
Urban
Rural

38.80%

36.2% to 41.5%

38.10%

35.6% to 40.6%

39.70%

37.5% to 41.9%

44.6%*

42.4% to 46.8%

63.1%*

61.7% to 64.5%

40.9%*

39.4% to 42.4%

60.10%

57.5% to 62.7%

37.60%

34.7% to 40.4%
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Table 4.7 cont.)
Marital Status
REF: Married
Widowed
Divorced/Separated
Never married
Immigration Status
REF: US born
Foreign born, lived
in the US <15 years
Foreign born, lived
in the US >15 years
missing

Aim 1 Main Analysis

Aim 2 Main Analysis

Aim 2 Sensitivity Analysis

63.20%

61.6% to 64.7%

40.90%

39.3% to 42.6%

64.90%

62.0% to 67.9%

42.90%

39.4% to 46.4%

61.60%

59.6% to 63.6%

38.90%

36.8% to 41.1%

57.0%*

54.0% to 60.0%

36.1%*

32.6% to 39.5%

62.80%

61.4% to 64.1%

40.20%

38.7% to 41.7%

63.80%

61.1% to 66.5%

45.50%

42.1% to 48.8%

50.1%*

43.1% to 57.2%

29.1%*

21.6% to 36.5%

32.9%*

6.1% to 59.7%

15.3%*

-2.2% to 32.8%

62.40%

59.2% to 65.6%

42.90%

39.0% to 46.7%

62.80%

57.7% to 67.9%

49.00%

42.5% to 55.5%

63.10%

48.8% to 77.4%

44.70%

24.2% to 65.2%

55.60%

5.4% to 105.8%

42.50%

-19.1% to
104.2%

40.40%

39.0% to 41.8%

38.60%

33.4% to 43.8%

38.60%

29.8% to 47.4%

Whether comfortable speaking English
REF: Comfortable
62.60%
61.3% to 63.8%
Not comfortable
61.60%
56.7% to 66.5%
missing
62.40%
55.9% to 69.0%
Educational attainment
Less than a HSD
REF: HSD/GED
Bachelor's
Graduate/Doctoral
degree
Other Degree
missing

Aim 1 Sensitivity Analysis

57.9%*

54.9% to 60.9%

36.4%*

33.3% to 39.4%

59.80%

53.6% to 66.0%

38.2%*

31.3% to 45.1%

61.90%

60.3% to 63.4%

39.80%

38.1% to 41.5%

62.50%

59.3% to 65.7%

46.00%

42.0% to 50.1%

64.8%*

62.7% to 67.0%

41.80%

39.3% to 44.4%

63.00%

58.6% to 67.4%

44.20%

38.3% to 50.1%

65.3%*

62.3% to 68.3%

42.80%

39.3% to 46.4%

65.50%

58.8% to 72.2%

47.50%

40.1% to 54.9%

63.30%

60.5% to 66.2%

41.50%

37.9% to 45.1%

69.30%

63.3% to 75.2%

52.70%

44.8% to 60.7%

64.30%

55.7% to 72.9%

43.90%

34.3% to 53.5%

43.4%*

29.9% to 56.8%

36.40%

19.1% to 53.7%
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Table 4.7 cont.)

Aim 1 Main Analysis

Household Income as a % of the FPL
Poor/Negative
(<100%)
61.60%
58.7% to 64.4%
Near poor/Low
income (100-200%)
58.5%*
56.1% to 60.9%
Middle Income
(200-400%)
61.70%
59.9% to 63.4%
REF: High Income
(>400%)
64.30%
62.7% to 65.9%
Charlson Comorbidity Index
REF: 0
62.50%
1
62.50%
2
62.60%
3+
63.30%

Perceived Health Status
REF: Excellent
64.10%
Very good
63.50%
Good
61.7%*
Fair/Poor
60.3%*
missing
31.2%*

46.50%

Aim 2 Main Analysis

Aim 2 Sensitivity Analysis

39.00%

36.0% to 41.9%

61.00%

54.5% to 67.5%

37.1%*

34.2% to 40.0%

56.8%*

51.2% to 62.4%

39.00%

36.6% to 41.3%

64.40%

60.9% to 67.9%

42.30%

40.5% to 44.1%

64.70%

61.7% to 67.7%

61.1% to 63.9%

40.00%

38.3% to 41.7%

63.50%

60.6% to 66.4%

45.30%

41.9% to 48.7%

60.2% to 64.7%

40.40%

38.1% to 42.8%

62.00%

58.2% to 65.8%

44.40%

40.1% to 48.6%

59.7% to 65.5%

41.70%

38.4% to 45.0%

64.20%

58.4% to 70.1%

49.80%

41.9% to 57.7%

59.9% to 66.6%

41.00%

37.5% to 44.5%

63.20%

54.8% to 71.7%

45.50%

37.6% to 53.5%

39.70%

38.3% to 41.1%

62.80%

60.2% to 65.4%

45.20%

42.3% to 48.0%

43.8%*

40.6% to 47.0%
-15.2% to
90.9%

66.00%

59.8% to 72.2%

48.20%

41.7% to 54.7%

62.1% to 66.0%
61.8% to 65.3%
60.1% to 63.3%
57.9% to 62.7%
14.8% to 47.7%

Whether ever had any non-CRC cancer diagnosis
REF: No
62.00%
60.7% to 63.3%
Yes
65.7%*
62.9% to 68.6%
missing

Aim 1 Sensitivity Analysis

-4.2% to 97.2%

37.8%
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Table 4.7 cont.)
Smoking status
REF: Non-smoker
Current Smoker
missing
BMI categories
Underweight
REF: Normal weight
Overweight
Obese
missing

Aim 1 Main Analysis

63.40%

62.1% to 64.7%

Aim 1 Sensitivity Analysis

Aim 2 Main Analysis

41.10%

39.6% to 42.6%

64.20%

61.7% to 66.8%

Aim 2 Sensitivity Analysis

46.90%

43.8% to 49.9%

59.3%*

56.9% to 61.6%

37.2%*

34.6% to 39.7%

59.80%

54.0% to 65.6%

37.6%*

30.6% to 44.6%

60.70%

57.6% to 63.9%

38.70%

35.0% to 42.5%

58.3%*

51.9% to 64.7%

43.90%

36.1% to 51.8%

61.00%

53.0% to 69.1%

37.60%

27.8% to 47.5%

52.10%

30.5% to 73.7%

25.60%

5.9% to 45.3%

61.40%

59.7% to 63.2%

39.30%

37.4% to 41.2%

59.80%

56.3% to 63.3%

42.00%

38.1% to 46.0%

62.90%

61.3% to 64.5%

40.50%

38.7% to 42.2%

63.10%

59.7% to 66.4%

45.80%

42.4% to 49.3%

63.5%*

61.9% to 65.1%

41.40%

39.5% to 43.4%

67.4%*

64.3% to 70.6%

49.7%*

45.2% to 54.2%

55.3%*

49.9% to 60.7%

34.70%

28.6% to 40.8%

57.60%

47.1% to 68.0%

36.50%

25.8% to 47.1%

67.1% to 70.3%

47.70%

45.7% to 49.7%

69.40%

66.1% to 72.7%

53.50%

48.7% to 58.2%

59.9% to 64.4%

39.8%*

37.0% to 42.5%

63.6%*

59.2% to 68.1%

44.5%*

39.3% to 49.7%

54.3% to 58.7%

31.8%*

29.5% to 34.2%

54.6%*

49.9% to 59.3%

34.5%*

29.8% to 39.1%

50.0% to 54.7%

31.4%*

29.0% to 33.7%

47.5%*

42.3% to 52.7%

30.9%*

25.7% to 36.1%

10.9% to 29.8%

8.3%*

2.6% to 14.1%

28.1%*

-0.2% to 56.3%

4.6%*

-5.4% to 14.6%

Dental checkup frequency
REF: Twice a year
or more
68.70%
Once a year
62.1%*
Less than once a
year
56.5%*
Never go to dentist
52.4%*
missing
20.3%*
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Table 4.7 cont.)
Time since last flu shot
REF: Within past
year
Within past two
years
More than two
years
Never received flu
shot
missing

Aim 1 Main Analysis

Aim 1 Sensitivity Analysis

Aim 2 Main Analysis

Aim 2 Sensitivity Analysis

67.50%

66.2% to 68.8%

46.10%

44.4% to 47.9%

68.00%

65.1% to 70.9%

51.10%

47.8% to 54.4%

62.2%*

59.4% to 65.0%

40.1%*

36.8% to 43.5%

64.00%

58.0% to 70.1%

45.10%

37.6% to 52.6%

59.3%*

56.5% to 62.1%

36.8%*

32.9% to 40.7%

61.6%*

55.9% to 67.3%

42.90%

34.6% to 51.2%

56.2%*

54.2% to 58.2%

32.3%*

30.2% to 34.3%

56.6%*

52.3% to 61.0%

38.1%*

32.9% to 43.3%

45.5%*

38.3% to 52.8%

21.4%*

13.9% to 28.9%

48.0%*

33.1% to 62.8%

29.60%

8.1% to 51.2%

35.40%

30.1% to 40.6%

58.40%

49.1% to 67.7%

38.60%

27.4% to 49.9%

40.40%

35.6% to 45.1%

54.0%*

43.3% to 64.7%

34.7%*

22.9% to 46.5%

40.50%

39.1% to 41.9%

64.00%

61.5% to 66.4%

46.40%

43.5% to 49.3%

23.20%

20.8% to 25.6%

48.70%

43.7% to 53.8%

29.50%

23.1% to 35.8%

32.2%*

29.8% to 34.6%

58.5%*

53.8% to 63.2%

40.1%*

35.2% to 44.9%

38.0%*

35.3% to 40.7%

64.5%*

59.4% to 69.5%

46.7%*

39.7% to 53.6%

39.4%*

36.3% to 42.5%

66.6%*

62.4% to 70.9%

49.6%*

43.6% to 55.6%

43.0%*

39.2% to 46.7%

66.3%*

58.7% to 74.0%

49.9%*

38.4% to 61.4%

51.5%*

49.3% to 53.7%

70.7%*

67.2% to 74.3%

53.8%*

49.4% to 58.2%

29.30%

26.2% to 32.4%

55.80%

49.7% to 61.8%

35.50%

27.8% to 43.3%

41.5%*

40.1% to 42.9%

64.2%*

61.6% to 66.8%

46.7%*

43.8% to 49.7%

38.8%*

30.2% to 47.4%

52.60%

34.2% to 71.0%

33.70%

10.9% to 56.5%

Duration insured during survey year
1-6 months
60.40%
56.2% to 64.6%
7-11 months
60.40%
56.5% to 64.3%
REF: Full year
62.70%
61.4% to 64.0%

Number of Outpatient Provider visits in Survey year
REF: 0
46.60%
44.2% to 49.0%
1
56.1%*
54.0% to 58.2%
2
61.3%*
59.0% to 63.5%
3
63.0%*
60.3% to 65.7%
4
65.2%*
62.3% to 68.0%
5+
71.6%*
69.9% to 73.3%
Whether had a Usual Source of Care
REF: No
49.80%
46.7% to 52.9%
Yes
64.0%*
62.7% to 65.2%
missing
57.90%
50.4% to 65.5%
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Table 4.7 cont.)
Survey Year
REF: 2009
2010
2011

Aim 1 Main Analysis

Aim 1 Sensitivity Analysis

Aim 2 Main Analysis

Aim 2 Sensitivity Analysis

61.10%

59.6% to 62.7%

40.40%

38.4% to 42.4%

63.20%

60.3% to 66.2%

46.90%

42.3% to 51.5%

63.1%*

61.6% to 64.7%

42.00%

40.1% to 43.8%

63.70%

60.7% to 66.8%

46.50%

42.6% to 50.5%

63.3%*

61.5% to 65.1%

38.60%

36.7% to 40.5%

63.00%

59.2% to 66.7%

43.50%

39.4% to 47.6%

* covariate level was significantly different (p<0.05) than the referent level (REF:) in the multivariate logistic
regression
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Some covariates were included in all analyses and had consistent multivariateadjusted effects including age, sex and immigration status for the
sociodemographics block, Quan et al.’s Charlson comorbidity index for the
health/lifestyle block, dental checkup frequency for the prevention history block,
and count of outpatient provider visits in the survey year and having a usual
source of care for the health care access block. Increasing age significantly
increased screening likelihood with a decreasing rate of increase, which was
indicated by a positive 2.10-3.16% point increase in screening likelihood for each
year increase of the centered age variable and a negative 0.05-0.09% point
change in screening likelihood for each squared year increase. The net effect of
the two age variables, for example, for a person aged 75 years in the Aim 2 main
analysis is 3.16*25 – 0.09*(25^2)= 79 - 56.25 = a 22.75% points predicted
greater likelihood of being up-to-date with recommended CRC screening than a
person aged 50 years. In comparison to females, males’ predicted likelihood of
CRC screening was 5.4-7.5% points higher across all analyses. For immigration
status, US-born persons consistently had significantly higher screening likelihood
than foreign-born persons who had lived in the US less than 15 years, although
screening likelihood was not significantly lower for foreign-born person who had
lived in the US more than 15 years. The disparity between recent immigrants
and US-born persons increased from ~10% points in the Aim 1 analyses to ~30%
points in the Aim 2 analyses. The Charlson comorbidity index was included in all
analyses and there were no significant differences in any analyses for having a
positive value (1, 2, or 3+) vs. having an index score of zero. More frequent
dental checkups and a greater number of outpatient provider visits in the survey
year each significantly predicted higher screening likelihood in a dose-response
fashion in all analyses. Reporting having a usual source of care significantly
predicted higher screening likelihood in all analyses.
Some covariates were included in all analyses and had inconsistent effects
including educational attainment for the education and income block; having any
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non-CRC cancer diagnosis, smoking status, and BMI categories for the
health/lifestyle block; most recent flu shot for the prevention history block;
duration of time insured in the survey year for the health care access block; and
survey year. For educational attainment, having a HSD/GED predicted
significantly higher screening likelihood than having less than a HSD/GED and
significantly lower screening likelihood than those with a Bachelor’s degree or
Graduate/Doctoral degree in the Aim 1 main analyses. Educational attainment
did not significantly predict screening likelihood in the Aim 2 main analysis and in
both sensitivity analyses was only significant for having a HSD/GED predicting
higher screening likelihood than having less than a HSD/GED. Ever having a
non-CRC cancer diagnosis vs. not predicted higher screening likelihood and was
statistically significant in the Aim 1 analyses, while in the Aim 2 analyses,
differences with the same direction and similar magnitude were not significant.
Being a current smoker vs. non-smoker predicted lower screening likelihood,
although the effect did not reach significance for the Aim 2 main analysis. For
BMI categories, being normal weight predicted significantly lower screening
likelihood than being obese, although did not predict significantly different
screening likelihood in comparison to being overweight or underweight. There
was not a significant difference between being obese vs. normal weight in the
Aim 1 sensitivity analysis. A more recent last flu shot usually predicted
significantly higher screening likelihood, although in both the Aim 2 main and
sensitivity analyses, having received a flu shot within the past year did not predict
significantly different screening likelihood than having last received a flu shot
between one and two years ago. Duration of time insured in the survey year
generally was not a significant predictor, although for the Aim 2 main and
sensitivity analyses, having been insured for 7-11 months predicted lower
screening than having been insured for the full year, although there was not a
significant difference for being insured for 1-6 months compared to the full year.
In the Aim 1 main analysis, survey years 2011 and 2010 each predicted higher
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screening likelihood than survey year 2009, although there were not significant
differences between survey years in the other analyses.
Some variables had consistent effects, but were not included in all analyses
including race/Hispanic ethnicity, census region, marital status, and whether a
person was comfortable speaking English for the sociodemographics block;
household income as a percentage of FPL categories for the education and
income block; and perceived health status for the health/lifestyle block. By
design, Aim 1 analyses had a race/Hispanic ethnicity category, while Aim 2 only
had a Hispanic ethnicity indicator. For race/Hispanic ethnicity groups in the Aim
1 analyses, non-Hispanic whites had significantly lower screening likelihood of
both CRC screening outcomes than non-Hispanic blacks and significantly higher
screening likelihood than non-Hispanic Asians, although screening likelihood did
not significantly differ between non-Hispanic and Hispanic whites. In the Aim 1
analyses, Hispanic whites had slightly higher predicted screening likelihood than
non-Hispanic whites for screening in the previous year 42.4 vs. 39.4%, while
non-Hispanic whites had slightly higher screening likelihood for being up-to-date
with recommended screening, 62.3 vs. 61.6%. For the Aim 2 analyses,
screening likelihood also did not significantly differ between non-Hispanic and
Hispanic whites, although non-Hispanic whites had higher screening likelihood
for both the primary outcome (64.1 vs. 59.7% up-to-date with recommended
screening) and for having had any screening in the previous year (46.0 vs.
44.1%). By design, census region was only applicable to the Aim 1 analyses and
ultimately was non-significant in the main analysis, although was included in the
Aim 1 sensitivity analysis. Screening likelihood was similar in the Northeast,
Midwest, and South, although was significantly higher in the Western census
region. Respondents residing in Urban areas had significantly higher screening
likelihood than rural residents in the Aim 1 main analysis by 3.0% points
(p=0.049) and in the sensitivity analysis sample by 3.3% points (p=0.042),
although urban vs. rural residence was dropped from the Aim 2 analyses. Marital
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status was dropped from the Aim 2 analyses, and in the Aim 1 analyses, those
who were married had significantly higher screening likelihood than those who
were never married, although there was no significant difference compared to
widowed or divorced/separated persons. Whether a person was comfortable
speaking English was only included in the Aim 1 analyses and was nonsignificant. Income was included in all analyses except the Aim 2 sensitivity
analyses, and being high income consistently predicted higher screening
likelihood than being near poor/low income, but did not predict significantly
different screening than being middle income or being poor/having negative
income. Perceived health status was only included in the Aim 1 main analyses
and having Excellent health predicted significantly greater screening likelihood,
64.1%, than having Good health, 61.7%, or Fair/Poor health, 60.3%.

Aim 1 Multivariate Findings for Binary Insurance Features

Aim 1 Main and Sensitivity Analyses
Figures 4.1-8 report the Aim 1 main multivariate logistic regression and sensitivity
analysis findings for binary insurance features. The insurance feature main
effect is reported as the multivariate-adjusted percentage change in the predicted
likelihood of CRC screening and the 95% confidence interval if a respondent had
a binary insurance feature vs. not. Each figure reports the insurance feature
effect and confidence interval for eight models: the unadjusted effect (adjusting
only for survey year), five models adjusting separately for each of the covariate
blocks, the full model with all covariate blocks, and a reduced full model without
the prevention history and health care access covariates. If controlling for a
covariate block or set of blocks increases an insurance feature effect, the change
suggests that the unadjusted insurance feature effect was confounded downward
by not having adjusted for the covariates, meaning the respondents with the
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insurance feature in aggregate have values of the covariates that are less
favorable to their screening likelihood. If controlling for a covariate block
decreases an insurance feature effect, the change suggests the opposite is true:
the covariates confound upward the insurance feature effect by not having
adjusted for the covariates, so respondents with the insurance feature in
aggregate have values of the covariates that are more favorable to their
screening likelihood.
Figure 4.1 reports the findings for whether a respondent had insurance with a
DPN in the Aim 1 main analyses. In the unadjusted model, having a DPN
predicted a non-significant 1.4% point reduction (95% CI: -3.4 to 0.6%) in the
likelihood of being up-to-date with recommended CRC screening. The adjusted
changes in predicted screening likelihood for the separate covariate block
models ranged from a high estimate of a significant increase of 3.1% points (95%
CI: 0.9 to 5.3%) in screening likelihood if a person had a DPN after controlling for
the sociodemographics block (a 4.5% point increase from the effect in the
unadjusted model suggesting that respondents who had insurance with a DPN
had unfavorable sociodemographics characteristics in aggregate compared to
those who did not have insurance with a DPN) to a low estimate of a significant
negative 3.6% point reduction (95% CI: -5.6 to -1.6%) in screening likelihood
after controlling for the education and income block (a 2.2% point decrease from
the effect in the unadjusted model suggesting that respondents who had
insurance with a DPN had favorable education and income values in aggregate
compared to those who did not have insurance with a DPN). In the fully-adjusted
model and the full reduced model without the prevention history and health care
access blocks, having insurance with a DPN predicted small non-significant
increases in screening likelihood, 0.5% points (95% CI: -1.4 to 2.4%) and 1.8%
points (95% CI: -0.3 to 3.9%). In total, the findings suggest whether a person’s
insurance had a DPN did not strongly influence screening likelihood.
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Figure 4.2 reports the findings for whether a respondent had insurance that used
gatekeeping in the Aim 1 main analyses. In the unadjusted model, having
insurance
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Figure 4.1

Aim 1 Main Analyses: Change in Predicted Likelihood of Being Up-To-Date with
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Figure 4.2

Aim 1 Main Analyses: Change in Predicted Likelihood of Being Up-To-Date with
CRC Screening if Insurance Used Gatekeeping
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1.8%

that used gatekeeping predicted a significant 2.9% point reduction in screening
likelihood (95% CI: -5.1 to -0.6%). The adjusted changes in predicted screening
likelihood for the separate covariate block models ranged from a high estimate of
a non-significant 1.9% point increase in screening likelihood (95% CI: -0.4% to
4.1%) after adjusting for the sociodemographics block to a low estimate of a
significant reduction in screening likelihood of 3.1% points (95% CI: -0.9 to 5.2%) after adjusting for the education and income block. In the fully adjusted
model and the full reduced model, having insurance that used gatekeeping
predicted small non-significant increases in screening likelihood, 1.0% (95% CI: 1.1 to 3.0%) and 1.8% (95% CI: -0.4 to 4.0%), respectively. In total, the findings
suggest that whether a person’s health plan used gatekeeping did not strongly
influence screening likelihood, and that the significant negative unadjusted effect
for gatekeeping is confounded by those who have insurance with gatekeeping
tending to have less favorable other characteristics that predict lower screening
likelihood.
Figure 4.3 reports the findings for whether a respondent had a health plan that
restricted coverage to a DPN in the Aim 1 main analyses. In the unadjusted
model, having coverage restricted to a DPN predicted a non-significant 1.8%
point reduction in screening likelihood (95% CI: -4.5 to 0.9%). The adjusted
changes in predicted screening likelihood for the separate covariate block
models ranged from a high estimate of a non-significant 2.0% point increase
(95% CI: -0.6 to 4.7%) in screening likelihood if coverage was restricted to a DPN
after controlling for the sociodemographics block to a low estimate of a nonsignificant negative 2.6% point reduction (95% CI: -5.4 to 0.1%) in screening
likelihood after controlling for the education and income block. In the fully
adjusted model and the full reduced model, having insurance that restricted
coverage to a DPN predicted small non-significant increases in screening
likelihood, 1.2% points (95% CI: -1.2 to 3.7%) and 1.6% points (95% CI: -1.1 to
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Figure 4.3

Aim 1 Main Analyses: Change in Predicted Likelihood of Being Up-To-Date with
CRC Screening if Insurance Restricted Coverage to a DPN
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1.2%

1.6%

4.2%). In total, the findings suggest whether a person’s insurance restricted
coverage to a DPN did not influence screening likelihood.
Figure 4.4 reports the findings for whether a respondent’s household had a FSA
in the Aim 1 main analyses. In the unadjusted model, having a FSA predicted a
significant 6.8% point increase in screening likelihood (95% CI: 1.7 to 11.8%).
The adjusted changes in predicted screening likelihood for the separate covariate
block models ranged from a high estimate of a significant 9.7 % point increase
(95% CI: 4.9 to 14.4%) after controlling for the sociodemographics block to a low
estimate of a null effect, 0.1% point increase (95% CI: -5.0 to 5.2%), after
controlling for the prevention history block. In the fully adjusted model, having an
FSA predicted a no longer significant increase in screening likelihood of 2.6%
points (95% CI: -2.0 to 7.2%). In the full reduced model without the prevention
history and health care access blocks, having an FSA still had a significant
positive effect, 7.2% points (95% CI: 2.2 to 12.2%). In total, the findings suggest
that having an FSA may have predicted a small increase in CRC screening
likelihood. Since the FSA effect was adjusted downward after controlling for
each the prevention history block and the education and income block, but did
not change after adjusting for the health/lifestyle covariate block, having an FSA
may be a marker of being generally more health aware, but not substantively
healthier.
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Figure 4.4

% Point Change (95% CI)

Aim 1 Main Analyses: Change in Predicted Likelihood of Being Up-To-Date with
CRC Screening if Respondent's Household Had a FSA
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Aim 1 Sensitivity Analyses for Binary Insurance Features
In the Aim 1 sensitivity analyses (Figures 4.5-8), the binary insurance feature
effects followed the same pattern across the eight models as in the main
analyses, although the overall pattern was shifted upward or downward. The
insurance feature effects in the Aim 1 sensitivity analyses were greater than in
the main analyses for the organizational insurance features. In the main
analyses, the unadjusted effects had been negative and non-significant (except
having insurance that used gatekeeping was significant (Figure 4.2)), and the
effects in the fully adjusted and full reduced models were positive and nonsignificant. In the sensitivity analyses, the organizational features’ unadjusted
effects were slightly positive and still non-significant, although the effects in the
fully adjusted and full reduced models were positive and usually significant.
Having insurance with a DPN was non-significant in the fully adjusted model
(Figure 4.5) (a 1.6% point increase in likelihood of screening in the previous year
(95% CI: -0.5 to 3.7%)), although in the full reduced model, significantly predicted
3.2% points greater likelihood of screening in the previous year (95% CI: 0.8 to
5.6%). In the fully adjusted and full reduced models, having insurance with
gatekeeping (Table 4.6) significantly predicted greater likelihood of screening in
the previous year, respectively, by 3.6% points (95% CI: 1.1 to 6.0%) and 4.6%
points (95% CI: 1.9 to 7.4%), respectively. In the fully adjusted and full reduced
models, having insurance that restricted coverage to a DPN (Figure 4.7)
significantly predicted greater likelihood of screening in the previous year by
3.4% points (95% CI: 0.7 to 6.2%) and 4.0% points (95% CI: 0.9 to 7.0%),
respectively. In total, the sensitivity analysis findings suggest that having
insurance with a DPN, having insurance with a gatekeeper, and having insurance
that restricted coverage to a DPN more strongly predicted recent CRC screening
in the previous year than predicted being up-to-date with recommended
screening according to the USPSTF recommended time intervals for different
techniques.
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Figure 4.5

Aim 1 Sensitivity Analyses: Change in Predicted Likelihood of
Previous-Year CRC Screening if Insurance Defined a Provider Network
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Figure 4.6

Aim 1 Sensitivity Analyses: Change in Predicted Likelihood of
Previous-Year CRC Screening if Insurance Used Gatekeeping
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4.6%

% Point Change (95% CI)

Figure 4.7

Aim 1 Sensitivity Analyses: Change in Predicted Likelihood of
Previous-Year CRC Screening if Insurance Restricted Coverage to a DPN
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3.4%

4.0%

For having an FSA, in contrast to the other binary insurance features, the pattern
of the change in the sensitivity analysis across the eight models was shifted
down in comparison to the pattern in the main analysis (Figure 4.8). In the main
analysis unadjusted model, having an FSA predicted positive and significantly
greater likelihood of being up-to-date with recommended screening (Figure 4.4),
and the effects in the fully adjusted and full reduced models were positive and
significant for the full reduced model, although non-significant for the fully
adjusted model. In the sensitivity analysis, having an FSA in the unadjusted
model predicted smaller positive increase in screening likelihood than the main
analysis that did not reach significance, 5.6% points (95% CI: -1.7 to 12.8%), and
the fully adjusted and full reduced models also had positive non-significant
effects 0.1% points (95% CI: -6.3 to 6.5%) and 7.0% points (95% CI: -0.3% to
14.2%). In total, the sensitivity analysis findings suggest that having an FSA less
strongly predicted recent CRC screening in the previous year than being up-todate with recommended screening.
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Figure 4.8
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Aim 1 Sensitivity Analyses: Change in Predicted Likelihood of
Previous-Year CRC Screening if Respondent's Household had a FSA
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Aim 2 Multivariate Findings for Binary Insurance Features

Aim 2 Main and Sensitivity Analyses
The Aim 2 main analysis findings for the three binary features (excluding whether
a person had an FSA because no Western Hispanic whites had an FSA) reveal
consistent patterns of the effects of having each feature for and between
Hispanic and non-Hispanic whites (Figures 4.9a, 4.10a, and 4.11a). Four
patterns were consistent for each of the three insurance features in all eight
models: Hispanic whites that did not have the insurance feature had the lowest
predicted likelihood of being up-to-date with recommended CRC screening;
Hispanic whites that had an insurance feature had greater screening likelihood
than Hispanic whites that did not have the feature; non-Hispanic whites with and
without the insurance feature had similar screening likelihood; and Hispanic and
non-Hispanic whites with the insurance feature had similar screening likelihood in
the fully adjusted and full reduced models, which had changed from non-Hispanic
whites with the insurance feature having higher predicted screening than
Hispanic whites with the insurance feature in the unadjusted estimates and in the
five models adjusted for each covariate block individually.
Figures 4.9b, 10b, and 11b report five contrast tests of selected comparisons of
Hispanic vs. non-Hispanic whites and of those with the insurance feature vs. not.
These figures and subsequent figures of contrast tests present a set of contrast
tests that were repeated in multiple models. On the horizontal axis, a label
indicates the covariates adjusted for in each model. Above the model label, the
contrast tests performed are numbered, and the legend notes which contrast test
each number corresponds to. In figures 4.9b, 10b, and 11b, each of the eight
models has the same pattern of point estimates and confidence intervals for the
five contrast tests. Tests 1 and 2 are estimates of the disparity in predicted
screening likelihood for Hispanics compared to the non-Hispanics in the
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subsamples of those without the insurance feature (Test 1) and those with the
feature (Test 2). Tests 3 and 4 are estimates of the change in predicted
screening likelihood due to having the insurance feature vs. not for non-Hispanic
whites (Test 3) and for Hispanic whites (Test 4). Test 5 estimated the double
difference contrast, the difference between the marginal effect of Hispanic whites
having a feature vs. not and the marginal effect of non-Hispanic
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Figure 4.9a

Likelihood (95% CI)

Aim 2 Main Analyses: Predicted Likelihood of Being Up-To-Date with CRC Screening if
Insurance Defined a Provider Network for Western US Hispanic and non-Hispanic whites
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Figure 4.9b

Aim 2 Main Analyses: Tests of Differences Between Selected Findings
for Having a DPN in Figure 4.9a
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Figure 4.10a
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Aim 2 Main Analyses: Predicted Likelihood of Being Up-To-Date with CRC Screening if
Insurance Used Gatekeeping for Western US Hispanic and non-Hispanic whites
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Figure 4.10b

Aim 2 Main Analyses: Tests of Differences Between Selected Findings
for Having Gatekeeping in Figure 4.10a
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Likelihood (95% CI)

Figure 4.11a
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Figure 4.11b

Aim 2 Main Analyses: Tests of Differences Between Selected Findings
for Having Restricted Coverage in Figure 4.11a
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whites having a feature vs. not (i.e. Test 4 minus Test 3).
Tests 1 and 2 show that each Hispanic whites with and without the insurance
features were predicted to have significantly lower screening likelihood than their
non-Hispanic white counterparts who also had or did not have the feature, and
the disparity was larger for Hispanic whites without the insurance feature. For
having insurance with a DPN and having insurance that used gatekeeping,
Hispanic whites that did not have the feature had significantly lower screening
likelihood than non-Hispanic whites without the feature by more than 20% points
in every model, and Hispanic whites who had the feature had significantly lower
screening likelihood than non-Hispanic whites with the feature by around 10%
points across the models. For having insurance that restricted coverage to a
DPN, Hispanic whites that did not have restricted coverage had significantly
lower screening likelihood than non-Hispanic whites without restricted coverage
by more than 15% points in every model, and Hispanic whites who did have
restricted coverage had lower screening likelihood than non-Hispanic whites with
restricted coverage by 7.3 to 11.9% points across the models, although the
disparity did not reach significance in the full or full reduced model.
The third test estimated the difference in predicted screening likelihood for nonHispanic whites who had the feature vs. those that did not. For whether a person
had insurance with a DPN (Figure 4.9b), non-Hispanic whites with a DPN
significantly predicted 5.3-6.1% points lower screening likelihood than nonHispanic whites without a DPN across the eight models. For whether a person
had insurance that used gatekeeping and whether a person’s insurance was
restricted to a DPN, there were not significant differences in screening likelihood
for non-Hispanic whites.
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The fourth test estimated the difference in predicted screening likelihood for
Hispanic whites who had the feature vs. those that did not. Hispanic whites who
had any of the features had higher predicted screening likelihood, although the
difference was non-significant for having insurance with a DPN (Figure 4.9b) and
having insurance that restricted coverage to a DPN (Figure 4.11b). For whether
a persons’ insurance used gatekeeping (Figure 4.10b), Hispanic whites had
higher screening likelihood by 8.8 to 13.8% points, and the difference was
significant in all models except the fully adjusted model.
The fifth test suggests the impact that having the insurance feature vs. not had
on the total disparity in CRC screening among Hispanics. The double difference
contrast was positive (favorable for Hispanic whites) for all three features and
was 10% points or more and consistently significant for two variables, whether a
person had insurance with a DPN and whether a person had insurance that used
gatekeeping. For whether a person had insurance that restricted coverage to a
DPN, the double difference contrast was positive and ranged from 3.9 to 11.3%
points. Test 5 did not reach significance in the unadjusted model and five of the
adjusted models, although the effect was significant in the full reduced model and
nearly significant in the fully adjusted model with a predicted increase in
screening likelihood of 9.8% points (95% CI: -0.3 to 19.9%).
Overall, the contrast tests and observed patterns suggest that having the
insurance features predicted higher screening likelihood for Hispanic whites, but
no change or a reduction in screening likelihood for non-Hispanic whites. The
double difference contrasts suggest that these features affect or are associated
with other insurance features that affect or predict reduced CRC screening
disparities for Western US Hispanic whites vs. non-Hispanic whites.
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Aim 2 Sensitivity Analyses for Binary Insurance Features
In the sensitivity analyses for Aim 2 (4.12, 4.13, and 4.14), the patterns of
predicted screening likelihood for having had any screening in the previous year
appear similar to the main analyses, although the sensitivity analyses have some
notable differences in magnitude and significance of effects.
First, in the sensitivity analyses, the magnitude of the disparity between Hispanic
and non-Hispanic whites’ predicted screening likelihood usually decreased for
both those with and without the insurance feature. For those without the
insurance feature, the Hispanic disparity decreased, although remained
significant for all three insurance features. For those with the insurance feature,
the change in the interpretation for each insurance feature was slightly differently.
For those who had insurance with a DPN, the Hispanic disparity from the main
analysis decreased and changed from being significant in all models to being
non-significant in all sensitivity analysis models. For those with insurance that
used gatekeeping, the Hispanic disparity decreased and changed from being
significant in all models to not reaching significance in most models, although
remained significant in the fully adjusted model. For those with insurance that
restricted coverage to a DPN, the range of the point estimates did not change
from the main analysis to the sensitivity analysis, although those differences had
been significant in some of the main analysis models, but were not significant in
any of the sensitivity analysis models (the no-longer significant difference likely
reflects the reduced sample size).
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Likelihood (95% CI)

Figure 4.12a

Aim 2 Sensitivity Analyses: Predicted Likelihood of Previous-Year CRC Screening if
Insurance Defined a Provider Network for Western US Hispanic and non-Hispanic whites
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Figure 4.12b

Aim 2 Sensitivity Analyses: Tests of Differences Between Selected Findings
for Having a DPN in Figure 4.12a
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All covariates
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Figure 4.13a

Likelihood (95% CI)

Aim 2 Sensitivity Analyses: Predicted Likelihood of Previous-Year CRC Screening if
Insurance Used Gatekeeping for Western US Hispanic and non-Hispanic whites
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Figure 4.13b

Aim 2 Sensitivity Analyses: Tests of Differences Between Selected Findings
for Having Gatekeeping in Figure 4.13a
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All covariates
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Figure 4.14a

Likelihood (95% CI)

Aim 2 Sensitivity Analyses: Predicted Likelihood of Previous-Year CRC Screening if
Insurance Restricted Coverage to a DPN for Western US Hispanic and non-Hispanic whites
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Figure 4.14b

Aim 2 Sensitivity Analyses: Tests of Differences Between Selected Findings
for Having Restricted Coverage in Figure 4.14a
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Next, for each Hispanic and non-Hispanic whites, having the insurance feature
vs. not predicted a more positive change in screening likelihood in the sensitivity
analysis than had been found in the main analysis. The positive change from the
main analysis to the sensitivity analysis was usually accompanied by a change in
significance toward a positive and significant effect for having the feature. For
non-Hispanic whites in the main analysis, having insurance with a DPN predicted
a significant reduction in screening likelihood, and in the sensitivity analysis,
there was still a reduction, but it was much smaller and consistently nonsignificant. For non-Hispanic whites in the main analysis, having insurance that
used gatekeeping vs. not predicted a non-significant reduction in screening
likelihood, but predicted a significant increase in screening likelihood in the
sensitivity analysis. For non-Hispanic whites in the main analysis, having
insurance that restricted coverage to a DPN vs. not predicted a negligible nonsignificant change in screening likelihood, while in the sensitivity analysis, the
magnitude of the change increased, but did not quite reach significance.
Similar changes were found for Hispanic whites in the sensitivity analyses. For
Hispanic whites in the main analysis, having insurance with a DPN predicted a
non-significant increase in screening likelihood, although the change was greater
and significant in the sensitivity analysis. For Hispanic whites in the main
analysis, having insurance that used gatekeeping vs. not predicted a positive and
usually significant (except for the fully adjusted model) change in screening
likelihood, and in the sensitivity analysis, the predicted change in screening
likelihood was greater and always significant. For Hispanic whites, having
insurance that restricted coverage to a DPN vs. not predicted a positive, although
non-significant change in screening likelihood in the main analysis, and in the
sensitivity analysis, that effect was larger and sometimes significant including the
fully adjusted and full reduced models.
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Last, two features had a change in the double difference contrast in the
sensitivity analysis, while one did not. In the sensitivity analysis, the double
difference contrast was essentially unchanged for having insurance with a DPN,
so it was still positive and significant in the sensitivity analysis. The double
difference contrast decreased and was less often significant in the sensitivity
analyses for having insurance that used gatekeeping (a change from being
always significant in the main analysis to sometimes significant or nearly
significant in the sensitivity analysis) and having insurance that restricted
coverage to a DPN (a change from sometimes significant in the main analysis to
always non-significant in the sensitivity analysis). The reductions in the double
difference contrasts reflects the greater changes in predicted screening likelihood
from the main analysis to the sensitivity analysis for non-Hispanic whites than
Hispanic whites.

Multivariate Findings for Cost-Sharing Categories

Aim 1 main and sensitivity analyses
Figure 4.15 reports the Aim 1 main analysis findings of the predicted screening
likelihoods across the cost-sharing categories. In the unadjusted analysis,
predicted screening likelihood is highest and similar for the three internal tertiles
of the cost-sharing distribution; is lower for those with 0% cost-sharing; is lower
for those in the top 5th percentile of cost-sharing, which overlaps the confidence
interval for the 0% cost-sharing group; and is much lower among those with no
spending in the survey year. In three of the covariate block models
(sociodemographics, education and income, and health/lifestyle), the pattern of
the cost-sharing categories is very similar to the unadjusted model, suggesting
that those factors did not substantively correlate with the cost-sharing categories.
In the prevention history block model, predicted screening likelihood for the first
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five cost-sharing categories did not change very much from the unadjusted
model, although screening likelihood increased noticeably for those with no
spending in the survey year by ~10% points suggesting that those people tend to
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Figure 4.15

Aim 1 Main Analyses: Predicted Likelihood of
Being Current with Recommended Screening Across Cost-sharing Categories

Predicted Screening LIkelihood (95% CI)

70%

0.0%

60%

0.1 to 13.0%
50%

13.1 to 29.8%
29.8 to 85.8%

40%

85.8 to 100%

No spending in
year

30%

20%

10%

Model Specifications: covariate block + cost-sharing category
184

have an unfavorable history of having received the preventive services
covariates, which consistently were strong predictors of screening likelihood. In
the health care access model, predicted screening likelihood for the first four
cost-sharing categories did not change very much from the unadjusted model,
although screening likelihood increased substantially for the top 5th percentile of
cost-sharing by >10% points and for the no spending category by >20% points.
After adjusting for the health care access factors, the top fifth percentile category
had a predicted screening likelihood that was slightly greater than the 0% costsharing category and the overlapping confidence interval indicates that it was not
significantly different from the 0% cost-sharing category and the first and third
internal tertiles of the cost-sharing distribution. The change in the HC access
block model is consistent with the known inverse relationship between costsharing and health care utilization.
The patterns in the fully adjusted and full reduced models are consistent with the
changes in the individual covariate block models. In the fully adjusted model,
controlling for all covariates balanced predicted screening likelihood across the
cost-sharing categories. The five cost-sharing categories have overlapping
confidence intervals, while the no-spending group overlaps with the top fifth
percentile of cost-sharing category. In contrast, the full reduced model retains
the pattern of the unadjusted model and the covariate block models controlling
for each the sociodemographics, education and income, and health/lifestyle
blocks.
Predicted Screening Likelihood Depending on Cost-Sharing Categories for
Aim 1 Sensitivity Analysis
The sensitivity analysis findings for Aim 1 (Figure 4.16) are consistent with the
main analysis findings. One noticeable difference is that the third tertile of the
internal part of the cost-sharing distribution had consistently lower predicted
screening likelihood than the first and second tertiles in the sensitivity analysis,
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Figure 4.16
Aim 1 Sensitivity Analysis: Predicted Likelihood of
Screening in the Previous Year Across Cost-sharing Categories
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although three internal tertiles had similar predicted screening likelihood in all
models of the main analysis.
Predicted Screening Likelihood Depending on Cost-Sharing Categories for
Aim 2
In the Aim 2 analysis of the cost-sharing variable, Hispanic and non-Hispanic
whites had distinct patterns of predicted screening likelihood over the costsharing categories (Figure 4.17). The pattern for non-Hispanic whites was
consistent with the pattern observed in the Aim 1 analysis. For Hispanic whites,
the predicted screening likelihoods were less for the internal tertiles of the costsharing distribution and for the no-spending group than for the same categories
for non-Hispanic whites, while the ends of the cost-sharing distribution (0% costsharing and the top fifth percentile of cost-sharing) had greater point estimates
than the same categories for non-Hispanic whites. The Aim 2 individual
covariate block adjustments had similar effects as in the Aim 1 analyses. For
both Hispanic and non-Hispanic whites, the prevention history block model
predicted noticeably higher screening likelihood for the no-spending group than
was predicted in the unadjusted model. For each Hispanic and non-Hispanic
whites, the health care access block model predicted substantially increased
screening likelihood for the top fifth percentile group and the no spending group
than was predicted in the unadjusted model. The Aim 2 fully adjusted and full
reduced cost-sharing models (Figure 4.17b) changed the pattern of predicted
screening likelihood in comparison to the unadjusted model similar to the change
in the Aim 1 analyses. The fully adjusted model balanced the predicted
screening likelihoods across cost-sharing categories for both Hispanic and nonHispanic whites. The full reduced model did not substantially change the pattern
of predicted screening likelihoods compared to the unadjusted model.
Because the Aim 2 cost-sharing analysis had a much smaller sample size than
the Aim 1 analysis, confidence intervals are large for most estimates and it is not
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Figure 4.17a

Aim 2 Main Analyses: Predicted Likelihood of
Being Current with Recommended Screening Across Cost-sharing Categories (Graph 1)
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Figure 4.17b

Aim 2 Main Analyses: Predicted Likelihood of
Being Current with Recommended Screening Across Cost-sharing Categories (Graph 2)
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Figure 4.17c

Aim 2 Main Analyses: Tests of Differences Between Selected Findings
for Cost-Sharing Categories in Figures 4.17a and b
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clear if Hispanic and non-Hispanic whites significantly differed in screening
likelihood across cost-sharing categories. Figure 4.17c reports the contrast tests
for the difference between the predicted screening likelihoods for Hispanic and
non-Hispanic whites in each cost-sharing category. For the internal tertiles of the
cost-sharing distribution, Hispanic whites consistently had significantly lower
predicted screening likelihood than their non-Hispanic white counterparts in each
tertile. Differences between Hispanic and non-Hispanic whites for the other costsharing categories were non-significant in all models except that in the fully
adjusted model, Hispanics in the no spending category had 19.5% points
significantly lower predicted screening likelihood than non-Hispanic whites.
Hispanics with no spending in the survey year had lower predicted screening
likelihood than non-Hispanics in all the other models, although the differences did
not reach significance. Although also never a significant difference, Hispanics in
the top fifth percentile of cost-sharing category consistently had higher predicted
screening likelihood than non-Hispanic whites in the top fifth percentile of costsharing. For the 0% cost-sharing category, Hispanic whites sometimes had
higher and sometimes lower predicted screening likelihood than non-Hispanic
whites.
In total, these findings suggest that Hispanics with some cost-sharing (including
most of the cost-sharing distribution) had decreased predicted screening
likelihood than non-Hispanic whites with equivalent cost-sharing, although there
are not differences in screening likelihood for Hispanic and non-Hispanic whites
at the extremes of the cost-sharing distribution. Hispanics with no spending likely
have lower screening likelihood than their non-Hispanic white counterparts.
Aim 2 Sensitivity Analysis Findings
The Aim 2 sensitivity analysis findings for the cost-sharing variable overall exhibit
very similar patterns to the main analysis of screening likelihood across the
categories and between Hispanic and non-Hispanic whites (Figure 4.18). Figure
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Figure 4.18a

Aim 2 Sensitivity Analyses: Predicted Likelihood of
Screening in the Previous Year Across Cost-sharing Categories (Graph 1)
80%

Predicted Screening LIkelihood (95% CI)

70%
0.0%
60%

0.1 to 13.0%

50%

13.1 to 32.3%
32.3 to 93.1%

40%
93.1 to 100%
30%

No spending
in year

20%
10%
0%
nonHispanic
nonHispanic
nonHispanic
nonHispanic
nonHispanic
nonHispanic
Hispanic white
Hispanic white
Hispanic white
Hispanic white
Hispanic white
Hispanic white
white
white
white
white
white
white
Unadjusted

Sociodemographics

Education and
Income

Health/Lifestyle

Prevention history

HC Access

Model Specifications: covariate block + Hispanic ethnicity*cost-sharing categories
192

Figure 4.18b

Aim 2 Sensitivity Analyses: Predicted Likelihood of
Screening in the Previous Year Across Cost-sharing Categories (Graph 2)
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Figure 4.18c

Aim 2 Main Analyses: Tests of Differences Between Selected Findings
for Cost-Sharing Categories in Figures 4.17a and b

Screening LIkelihood % Point Change (95% CI)

40%

30%
20%
10%
0%
-10%
-20%

-30%
-40%
Hispanics vs. non-Hispanics who had ... 0) 0% cost-sharing; 1) 0.1-13.9% cost-sharing 2) 14.0-32.3% costsharing; 3) 32.4-88.4% cost-sharing; 4) 88.5-100% cost-sharing; 5) no spending in survey year

-50%
0 1 2 3 4 5

0 1 2 3 4 5

0 1 2 3 4 5

0 1 2 3 4 5

0 1 2 3 4 5

0 1 2 3 4 5

0 1 2 3 4 5

Unadjusted

Sociodemographics

Education and
Income

Health/lif estyle

Prevention
history

HC Access

All covariates

Repeated Tests for Each Covariate Block Model
194

0 1 2 3 4 5
Full Reduced

4.18c reports the contrast tests for the difference between the predicted
likelihood of any screening in the previous year for Hispanic and non-Hispanic
whites in each cost-sharing category. The estimated differences are more
positive across all models than in the main analysis and only Hispanics vs. nonHispanics in the third tertile of cost-sharing still had a consistent significant
disparity in screening likelihood. The difference consistently did not reach
significance for the first tertile, and only reached significance in three of eight
models for the second tertile, which included significant differences for the fully
adjusted and full reduced models. For the 0% cost-sharing category and the top
fifth percentile, the differences are more favorable to Hispanics, although did not
reach significance. Hispanics may have higher predicted screening likelihood for
screening in the previous year than non-Hispanic whites at the extremes of the
cost-sharing distribution.
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Chapter 5
Discussion
This section contains a discussion of key findings, limitations, policy issues, and
the conclusion.

Key Findings

This study investigated the influence of a person’s health insurance features,
including organizational and financial features, on whether they obtain CRC
screening and whether there is a difference in insurance feature effects for
Western US Hispanic whites vs. non-Hispanic whites. The analyses found that
the multiple insurance features studied predicted varying use of CRC screening,
which suggests insurance design may have public health importance for CRC
screening. If insurance features even modestly affect CRC screening use, the
population health implications would be large considering that more than 75
million Americans are eligible for CRC screening and only around 60% of eligible
persons are up-to-date with recommended CRC screening. To the best of my
knowledge, this is the first study to assess these potential relationships, which is
relevant to insurers’, providers’ and policymakers’ efforts to increase use of
recommended CRC screening, a notably underused highly effective cancer
screening, and is relevant to efforts to increase use of other preventive services.
This section discusses the key findings for each analysis, relevant evidence from
other studies, and implications of the findings. Notable limitations and policy
issues are discussed before concluding.
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Aim 1 Organizational Insurance Features
Two of the three organizational features (using gatekeeping and restricting
coverage to a DPN) predicted significantly greater CRC screening in the
previous-year in the sensitivity analyses after controlling for covariates, although
none of the three features significantly predicted being up-to-date with
recommended CRC screening in the main analyses. The sensitivity analysis
findings may support the hypothesis that an insurer will achieve greater
screening use if they have a greater capacity to communicate appropriate CRC
screening to providers and enrollees. Whether a person had insurance with a
DPN may not have been significant in both analyses because it did not
substantially increase an insurer’s capacity to communicate appropriate
screening, in contrast to the seemingly greater administrative controls of
restricting coverage to a DPN and using gatekeeping. The significant sensitivity
analyses findings and non-significant main analyses findings supports the
rationale for the sensitivity analyses: insurers may be less able or not able to
influence being up-to-date with recommended screening because enrollees could
be up-to-date with CRC screening due to having been screened prior to gaining
their current insurance. Overall, these findings indicate that certain
organizational insurance features may support increasing use of CRC screening
and that further research is needed particularly with study designs that are able
to estimate a causal effect of the significant associations found here.
The same organizational features were assessed in Tye et al.’s evaluation of
insurance features as predictors of having received mammography in the
previous two years using 1996 MEPS data. Tye et al. found that women who
had insurance with a DPN had a multivariate adjusted predicted probability of
screening of 78%, in comparison to 75% for women with plans that did not have
a DPN (OR: 1.21, 95% CI = 1.07-1.36). Tye et al. also found that women whose
insurance used gatekeeping had a multivariate adjusted predicted probability of
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screening of 78% vs. 75% for women with insurance that did not use
gatekeeping (OR: 1.18, 95% CI = 1.03-1.36). No other health insurance features
significantly predicted mammography use including whether coverage was
restricted to a DPN, which was also assessed here, and several financial
features that were not available to be evaluated in this study. While the studies
are not comparable in many ways (including outcomes, the year(s) of data and
sample sizes, covariates controlled for, and eligibility criteria), Tye et al.’s
significant findings for two organizational features are consistent with this study’s
sensitivity analysis findings suggesting a potential modest positive influence of
certain insurance organizational features on likelihood of having recently
received cancer screening.
Other studies provide evidence regarding the influence of types of insurance and
features on use of CRC screening, although the findings are not easily
comparable or relatable to this study’s findings. Pertaining to types of insurance,
HMOs have consistently achieved higher screening use than PPOs on the
HEDIS CRC screening measure since they were first measured for both
insurance types in 2005 (National Committee for Quality Assurance 2013), which
may be partially attributable to favorable organizational features including the
ones here that more commonly occur in HMOs than PPOs. O’Malley et al. found
that Medicare beneficiaries who had specialists available when the patient
thought they were needed had a higher likelihood of recent CRC screening,
which may be inconsistent with the positive effects for this study’s organizational
features including using gatekeepers and restricting coverage to a DPN. These
conjectures comparing this study’s findings to other evidence reflect the
fundamental difficulties that inhibit comparing and making connections between
studies of insurance effects on CRC screening use and studies of insurance
effects on health services use more generally.
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Aim 1 Financial Insurance Features
Regarding the Aim 1 findings for financial insurance features, the evaluated
financial features (whether a person’s household had a FSA and categories of
cost-sharing) had substantial unadjusted differences in predicted screening
likelihood, which mostly did not remain significant in fully adjusted analyses.
Whether a person had a FSA may have been a proxy for being health aware,
since adjusting for the education and income covariate block and the prevention
history block each pushed downward the estimated change in predicted
screening likelihood due to having an FSA. In order to have a FSA, the
respondent or someone in the respondent’s household had to have been
employed. If people with a FSA were employed and therefore generally younger,
this employment criterion may have biased downward the effect of having an
FSA since younger people tend to have a lower screening likelihood and if being
employed creates a barrier to a person having the time to seek CRC screening.
Ultimately, whether a person has an FSA does not seem to be an independently
significant predictor of CRC screening and it is not clear what proxy effects it
represents.
Cost-sharing levels may be proxies for adequacy of health care access and
inclination to seek needed care, although may not be independently significant
factors, since significant unadjusted differences for these variables were largely
mitigated after adjusting for the prevention history and health care access
covariate blocks. The effect of categories of cost-sharing on use of CRC
screening may be mediated by health care access factors (e.g. number of
outpatient provider visits), so it may be inappropriate to include health care
access factors as covariates in the model. In addition, although dental checkup
frequency or time of most recent flu shot would not seem to mediate the
influence of cost-sharing on CRC screening use, those prevention history
variables may be correlated with other factors on the causal pathway, which
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would make it also inappropriate to control for the prevention history covariate
block. The Aim 1 sensitivity analysis for the cost-sharing categories was
essentially equivalent to the main analysis findings.
Notably, respondents with 0% cost-sharing had lower screening likelihood than
respondents from the three internal tertiles of the cost-sharing distribution
(greater than 0% and less than the 95th percentile). When the distribution of
cost-sharing values was broken up into 20 approximately equally populated
quantiles (respondents with 0% cost-sharing are the first quantile), the finding
remained: 0% cost-sharing had lower likelihood of screening than every quantile
except the highest, 95th to 100th. Even in comparison to respondents in the
quantile with the smallest non-zero cost sharing (0.1-2.1%), who would be
expected to be similar to the 0% subgroup, the 0% subgroup had substantially
lower likelihood of being up-to-date with recommended screening, 54.0 vs.
66.3%.
A comparison of respondent characteristics revealed that the 0% and 0.1-2.1%
cost-sharing subgroups were similar for many characteristics (socioeconomics,
acculturation, the organizational health insurance features and some other health
care access factors), although had notable differences. The 0% subgroup was
significantly >1.3 years younger, more male, more likely Hispanic or nonHispanic Black and was more likely from the Western Census region than the
South or Midwest. The 0% cost-sharing group was significantly healthier than
the 0.1-2.1% cost-sharing subgroup across many health measures including
having a lower rate of obesity, lower Charlson comorbidity index scores, better
perceived health status and less personal non-CRC cancer history. The 0%
subgroup also had significantly lower health services utilization across multiple
measures including having last received a flu shot further in the past, having
fewer outpatient provider visits in the survey year, and being less likely to have a
usual source of care. Source of health insurance was similar except for the 0%
cost-sharing subgroup had a larger composition of persons aged <65 years with
any private insurance 42.5% vs. 36.0% in the 0.1-2.1% subgroup (although both
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subgroups have a substantially smaller proportion of the subgroup aged <65
years with private insurance than the full sample, 62.5%).
The different characteristics in the 0% and 0.1-2.1% cost-sharing subgroups
suggest that relatively good health and less interaction with the health care
system result in the 0% subgroup avoiding out-of-pocket health care expenses
and also not obtaining CRC screening. The increased likelihood of CRC
screening for someone with 0.1-2.1% cost-sharing could plausibly be the result of
someone with 0% cost-sharing having a sudden health shock or electively
deciding to seek care, and as a result, both incurring out-of-pocket costs and
have increased probability of obtaining CRC screening due to increased
interaction with the health care system.
In total, the Aim 1 cost-sharing findings indicate further research is needed
particularly with study designs that are able to eliminate residual confounding in
order to estimate a causal effect of level of cost-sharing on CRC screening use.
Cost-sharing categories may be a useful unadjusted proxy in other data sources
such as administrative data that do not include detailed personal characteristics
to adjust as covariates.
Aim 2 Organizational Features
The Aim 2 findings indicated that organizational insurance features might
influence screening use differently for Hispanic whites than non-Hispanic whites
in the Western US. The main analyses found that having the organizational
features predicted decreased or unchanged screening likelihood for non-Hispanic
whites, while Hispanic whites had unchanged or increased predicted screening
likelihood. Hispanic whites had more positive effects of having an organizational
insurance feature vs. not than non-Hispanic whites, and the differences of the
effect for Hispanic whites minus the effect for non-Hispanic whites were usually
significant, which suggests that some insurance features may contribute to
reducing disparate screening among Hispanic whites. In the Aim 2 sensitivity
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analyses compared to the main analyses, Hispanics whites did not benefit as
much due to having two of the organizational features (insurance with
gatekeeping or coverage restricted to a DPN) in comparison to non-Hispanic
whites, and the differences of the effect for Hispanic whites minus the effect for
non-Hispanic whites were less likely to be significant in the sensitivity analysis,
which suggests organizational features may affect reduced disparities in being
up-to-date with recommended CRC screening although not reduce disparities for
having been screened in the previous year. In the Aim 2 sensitivity analysis,
whether a person had a DPN equally predicted a reduced screening disparity for
Hispanics in the sensitivity analysis as in the main analysis. The Aim 2 main and
sensitivity analysis findings largely agree and contradict the hypothesis that
Hispanic whites would benefit less due to having the insurance features than
non-Hispanic whites. The organizational features may mitigate an access
deficiency that is more of an issue for Hispanic whites than non-Hispanic whites
(Singal 2013).
Aim 2 Financial Insurance Features
For the cost-sharing variable in the Aim 2 main analyses, non-Hispanic whites
had a pattern of predicted screening likelihoods across the cost-sharing
categories that was similar to the Aim 1 findings for the cost-sharing variable.
Hispanic whites had a less varied pattern in a narrower range than non-Hispanic
whites did. Variation in predicted screening likelihood was essentially eliminated
for Hispanic whites and largely mitigated for non-Hispanic whites in the fullyadjusted model. Hispanic whites in the internal tertiles of the cost-sharing
distribution usually had significantly lower predicted screening likelihood than
non-Hispanic whites by greater than 10% points in most models. For those who
had no spending in the survey year, those with 0% cost-sharing and those in the
top fifth percentile of the cost-sharing distribution, Hispanic and non-Hispanic
whites did not have significantly differing screening likelihood. In the sensitivity
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analysis, findings were similar although there were no longer significant
differences for Hispanics vs. non-Hispanics in the first internal tertile of the costsharing distribution. There is not an obvious explanation for why cost-sharing
categories predicted less variation in screening likelihood for Hispanic whites
than non-Hispanic whites or why Hispanic whites in the internal tertiles of the
cost-sharing distribution had lower predicted screening likelihood than nonHispanic whites. Since there was not a significant difference for Hispanic whites
vs. non-Hispanic whites among those who had no spending in the survey year,
those with 0% cost-sharing and those in the top fifth percentile of the costsharing distribution, the most disadvantaged Hispanic whites may not have
disparate CRC screening use compared to their non-Hispanic white counterparts.

Limitations

The study has some notable limitations. First, estimates of insurance feature
effects may be biased by unobserved differences between those with and without
the insurance features (i.e. residual confounding/endogeneity (Levy and Meltzer
2008)) as is a potential threat in all cross-sectional studies of observational
studies where the independent variable of interest is not known to vary randomly.
By adjusting for a broad set of covariates in eight models for each analysis, this
study made a substantial effort to mitigate residual confounding. In addition, the
threat of residual confounding may be small for the evaluated organizational
insurance features because those administrative features would prima facie only
weakly have any association with other personal characteristics that influence
use of CRC screening including health care access factors and other
predisposing and enabling factors. On the other hand, the financial features,
categories of cost-sharing and whether a person has an FSA, may more strongly
reflect a person’s other health care access factors and other predisposing and
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enabling factors, so the threat of residual confounding may be greater. The
range of estimates generated in each analysis provide valuable evidence
regarding how certain clusters of covariates and larger groups of covariates were
correlated with and influenced estimates of insurance feature effects.
A study design that isolates the exogenous effect of insurance features on CRC
screening use is needed to estimate an unbiased causal effect. Suitable study
designs could include a natural or quasi-experiment where some exogenous
event results in variation in insurance coverage and suitable analyses are
performed such as difference-in-difference estimation or instrumental variables,
or could use a randomized controlled experiment where insurance features are
randomly assigned to a sample. Substantial challenges impede carrying out
these study designs. A natural experiment may be feasible in the context of a
large employer that randomly varied insurance design for some of its employees,
although such a study would likely exclude retired persons aged 65-75 who are
eligible for CRC screening. A state-level policy that constrained insurance
design could possibly permit comparing those in the state to those in a
neighboring state without the insurance design constraint, although again it may
be unlikely such a situation would apply to those aged 65-75 who are almost
completely federally insured by Medicare. To date, the RAND Health Insurance
Experiment (Manning 1987) and the Oregon Medicaid lottery (Baicker and
Finkelstein 2011) are the only true social experiments where insurance plans
were randomly allocated to individuals. A true randomized experiment would be
an expensive and in other ways resource-intensive undertaking, and it is highly
unlikely that such an undertaking would be worthwhile solely to identify the
effects of insurance features on CRC screening use. It is possible that a larger
experiment of insurance design could be worthwhile including CRC screening as
one of several outcomes. Future research should use natural and quasiexperiments to generate evidence regarding insurance feature effects on use of
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CRC screening and other health services, which would likely need to focus on
either the 50-64 year age group or the 65-75 year age group considering the
notable difference in insurance provision before and after Medicare eligibility.
A second notable limitation is the data limitations of the evaluated insurance
features including known inaccuracies in the MEPS source variables, how the
variables were constructed in this study, and the features’ limited capacity to
measure meaningful variation in insurance design. The source MEPS managed
care variables are known to be biased by respondent error in household-reported
information, which, for instance, results in MEPS overestimating the number of
persons in HMOs in comparison to estimates from industry sources (Agency for
Healthcare Research and Quality 2013b). In addition, a person’s insurance
features reported in MEPS correspond to the last insurance held by a person,
although the person could have had different insurance at an earlier point in the
interview period.
In addition to the limitations of MEPS’s source variables, the construction of the
insurance features for this study has a potential for bias. First, two of the
organizational features, whether a person’s insurance had a DPN and whether a
person’s insurance used gatekeeping, had overlapping definitions, since a
person was identified as having either of those two features by having been
enrolled in an HMO (either a private HMO or a Medicaid HMO) in addition to
unique criteria for each variable using MEPS variables that directly asked if the
respondent’s insurance used gatekeeping or if the respondents’ insurance
defined a provider network. The overlapping constructions mean that the two
variables are partially evaluating the same effect of being enrolled in an HMO.
There was also a limitation for the construction of the variable of whether a
person’s insurance restricted coverage to a DPN as was noted in the Methods
section. MEPS only had specific information to construct the variable for persons
with private insurance. Medicare beneficiaries without any private insurance
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(16.7% of the full Aim 1 sample) were assumed not to have coverage restricted
to a DPN. This assumption may be somewhat inaccurate. Lower payment rates
for Medicare than the commercial market inherently restricts coverage to a DPN,
since Medicare beneficiaries can only see providers who are willing to accept
those lower payment rates. This issue may be more salient for some
beneficiaries than others. The local panel of providers who will see Medicare
beneficiaries might be large and offer a large amount of provider choice in some
places, but not others. For instance, such a discrepancy may occur in urban vs.
rural areas or suburban vs. inner city areas. Last, as noted in the methods, those
under age 65 with only public insurance were excluded from the analysis of
whether a person’s insurance restricted coverage to a DPN. A large portion of
those under age 65 with only public insurance may have had restricted coverage
by having Medicaid or other public insurance that is directly administered by
managed care organizations or may have de facto restricted coverage to the
providers that are willing to accept lower payment rates from public insurance.
The aforementioned data construction limitations have a potential to bias the
evaluated effects of the organizational insurance features and indicate a need for
better information about insurance characteristics in publically available datasets.
Last, the evaluated insurance features had limited capacity to measure
meaningful variation in insurance design in several ways. Insurance features
were evaluated in this study rather than insurance types to avoid the problem of
evaluating binary categorizations of health insurance types that are too general
to have precise meaning and yield actionable evidence. Ideally, features that
directly pertained to use of CRC screening would have been studied although
none were available. Of the available measures, the organizational insurance
features were very general with a breadth of possible meanings for each having
a DPN, having gatekeeping insurance, and having insurance that restricted
coverage to a DPN, so they suffer from the same problem as binary categories of
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health insurance types. The financial features are specific constructs related to a
person’s health insurance and health care experience, although are only proxies
for more suitable variables. Whether or not a person has a FSA relates to a
specific health savings account that is tied to employment, although persons may
have other types of savings accounts for medical expenses. Categories of costsharing are a proxy for burden of health care expenses, although they do not
specifically reflect cost-sharing for CRC screening. Thus, the limited relevance of
the evaluated insurance features also indicates a need for better information
about insurance characteristics in publically available datasets.
A third limitation is the accuracy of self-reported CRC screening history in MEPS,
which may be inaccurate with respect to type of screening used and time since
last screening. Meta-analysis findings have found that cancer-screening
prevalence estimates from national health surveys are likely overestimated and
that differences in reporting accuracy between whites, blacks, and Hispanics
likely bias estimates of disparities in screening use (Rauscher 2008). The metaanalysis findings suggested that Hispanics might tend to underreport CRC
screening history while African Americans tend to over-report CRC screening
history. A key reason for over-reporting of CRC screening use for all
respondents in study’s using survey data is non-response bias, since nonresponders are less likely to have been screened (Schneider 2008a). Indeed,
the aggregate estimate of the proportion of the population up-to-date with
recommended CRC screening was 62.5% in this study for the full US population
from 2009-2011. That estimate is less than the estimate for the 2010 BRFSS
(Joseph 2012), 64.5%, which has a lower response rate than MEPS, and is
greater than the estimate for the 2010 NHIS (Shapiro 2012), 58.3%, which has a
higher response rate than MEPS. Another issue affecting the accuracy of selfreported CRC screening history is question phrasing. Comparing the EARTH
study of an AIAN sample and the Alaska BRFSS, it was noted that question
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phrasing might have contributed to overestimates of screening use in the Alaska
BRFSS (Schumacher 2008). The EARTH study asked respondents “how old
were you at your last screening”, while BRFSS asks “how long has it been since
your last test”, which people tend to underestimate, thereby making persons
noted as up-to-date with screening when they were not. MEPS uses the same
phrasing as BRFSS. National health surveys should strive to optimize response
rates to yield accurate estimates of health services use and accurately estimate
disparities.
A fourth limitation is that the study does not explore varying use of the distinct
CRC screening techniques. In the summary of univariate counts and
percentages (Table 4.1), the Aim 2 sample of Western US Hispanic and nonHispanic whites had lower use of colonoscopy within the past ten years than the
Aim 1 sample 56.2 vs. 58.8%, higher use of FSIG in the past five year with FOBT
in the past three years 5.1% vs. 2.7%, and higher use of FOBT in the previous
year 16.7 vs. 12.2%. Higher use of FSIG and FOBT resulted in the Aim 2
sample having a higher percentage of respondents up-to-date with screening by
any technique despite having a lower rate of colonoscopy, 63.3 vs. 62.5%. The
differences in screening by specific technique between the full US Aim 1 sample
and the Western US Aim 2 sample suggest regional differences in screening
preferences that are driven by the preferences of providers, of persons receiving
screening, and of insurers.
With respect to insurers’ preferences, if certain insurance features correlated with
a preference for a particular screening technique, those preferences could
influence estimates of aggregate screening use differently for the different
screening outcomes in the main and sensitivity analyses. Indeed, a previous
study noted in the literature review found that Medicare managed care plans
predicted greater FOBT use (Schneider 2008b). Having each of the
organizational insurance features did not significantly predict being up-to-date
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with recommended screening in the fully adjusted main analyses, although If
insurers having a certain organizational insurance feature corresponded with a
greater preference for low cost FOBT, persons with insurance with the
organizational feature would seem to have greater screening likelihood in the
sensitivity analysis for the outcome of any screening in the previous year. This
situation could explain that discrepant significance between the Aim 1 main and
sensitivity analysis findings for organizational insurance features.
Differential preference for screening techniques may also potentially alter the
influence of financial insurance features on the different outcomes in the main
and sensitivity analyses. Having an FSA had a reduced effect in the sensitivity
analysis compared to the main analysis, which could reflect less preference for
FOBT among FSA holders than non-holders. For the cost-sharing categories,
the main and sensitivity analysis findings are similar and do not suggest a
differential preference for distinct screening techniques across the cost-sharing
categories. Future research could evaluate an alternative sensitivity analysis
outcome of only colonoscopy in the previous year (in comparison to a main
analysis of colonoscopy within the past ten years), which would eliminate the
threat of bias due to a correlation between organizational insurance features and
screening technique preference.
Last, the study’s analytic strategy has notable limitations. A repeated
regressions approach with separate analyses for each insurance feature was
employed in order to isolate effects of distinct insurance features, although that
strategy does not reflect the reality of many insurance features operating
simultaneously in concert. In a study evaluating the effects of managed care
characteristics on health services use among children with special healthcare
needs, principal components analysis was used to cluster managed care
characteristics into managed care indices, although the authors noted the
limitation that the findings did not identify specific influential features (Shenkman
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2003). Ultimately, isolating insurance feature effects and modeling reality as fully
as possible are opposing interests that it may not be possible to reconcile.
Another important pair of analytic limitations was the decision not to conduct
analyses stratified by gender and age. Stratified analyses have shown that many
covariates have different effects for females compared to males (Gonzales
2012), which likely applies to this study and possible to the insurance feature
effects. Also, Medicare eligibility at age 65 meaningfully divides the population
that is eligible for CRC screening, so stratified analyses of those aged 50-64 and
those aged 65-75 would have likely yielded different covariate effects and
possibly insurance feature effects. In the interest of preserving sample size to
permit modest insurance feature effects to be identified as significant, stratified
analyses were not conducted. As noted before, more rigorous natural and quasiexperimental study designs of insurance features are needed. Studies focusing
on subpopulations or conducting stratified analyses may be necessary.

Policy Issues

CRC screening insurance coverage had a major change when the ACA
mandated that private insurers cover all services recommended by the USPSTF
with an “A” or “B” recommendation with zero cost-sharing, which includes CRC
screening at guideline-consistent time intervals (Pollitz 2013). Although the rule
was implemented September 23, 2010, grandfathered plans were (and are still)
not required to comply with the rule and patients supposedly in plans with the
rule were (and are still) not assured a zero cost-sharing screening because
certain circumstances negate the rule including screening for diagnostic
purposes and screening that becomes therapeutic if a polyp is removed. For
Medicare beneficiaries as well, cost-sharing is not waived in the case that a polyp
is removed. Ultimately, full financial coverage for CRC screening is not assured
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for either Medicare beneficiaries or privately insured persons and is uncertain
before the procedure is completed. Considering the highly invasive nature of the
colonoscopy and FSIG procedures, gaps in insurance coverage and uncertainty
about whether one’s insurer will waive cost-sharing mean that substantial
financial barriers to CRC screening persist. The potentially large expense of
cost-sharing may inhibit people from receiving screening and particularly may
dissuade low income persons from receiving screening and therefore widen
disparities. This barrier may be eliminated soon as existing legislation before
Congress would truly eliminate cost-sharing for CRC screening <sup>122</sup>.
In light of uncertainty about cost-sharing being waived, other aspects of
insurance design are still relevant factors to study in order to understand the
myriad influences on whether people receive CRC screening.

Conclusion

This study found that insurance features sometimes modestly predicted
significantly varied use of CRC screening, which sometimes was mitigated by
adjusting for covariates and depended on whether the outcome was being up-todate with recommended CRC screening or was having recently received CRC
screening in the previous year. In the analyses pertaining to the study’s first aim,
the organizational insurance features did not predict significantly different
likelihood of being up-to-date with recommended CRC screening in the main
analyses, although in the sensitivity analyses, having insurance that used
gatekeeping and having insurance that restricted coverage to a DPN each
predicted a greater than 3% point increase in likelihood of having received CRC
screening in the previous year. For the financial features, effects for each having
an FSA and categories of cost-sharing were each largely mitigated after
adjusting for covariates, although such financial features may be valuable proxies
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in other studies. In the analyses pertaining to the study’s second aim, findings
suggest that having each of the three organizational features predicted increased
likelihood of being up-to-date with recommended screening for Hispanic whites,
although did not change or decreased screening likelihood for non-Hispanic
whites. In total, the organizational insurance features may have the effect of
reducing disparate screening use among Western US Hispanic whites. In the
Aim 2 sensitivity analysis, having insurance with a DPN suggested the same
reduced disparity as in the main analysis, although for each having insurance
that used gatekeeping and having insurance that restricted coverage to a DPN,
the effect was smaller and less likely to be significant. For the Aim 2 main and
sensitivity analyses of cost-sharing, screening likelihood for Hispanic whites
varied less than for non-Hispanic whites, and Hispanics whites had significantly
lower screening likelihood than non-Hispanic whites for some cost-sharing
categories.
The findings of this study suggest a potentially meaningful, modest influence of
specific insurance features on use of CRC screening although do not provide
strong enough evidence to support any action by insurers or through policy to
change insurance design in the interest of increasing CRC screening use.
Sufficient evidence for such an administrative or policy change would require
experimental evidence and in consideration of any change’s influence on use of
other health services. Modifying insurance design in a targeted way that is
specific to CRC screening would probably be a better approach for specifically
increasing CRC screening use. MEPS has a limited offering of insurance
features, so it was not possible to evaluate any features that pertained directly to
CRC screening. Despite that limitation, the modest predicted 3% point increase
in predicted screening likelihood for some insurance features is still notable. If
such an insurance feature was adopted by the entire eligible population and
increased screening use by a few percentage points, it could correspond to more
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than a million additional persons having received screening and a substantial
reduction in CRC incidence, morbidity, and mortality.
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Appendix National Cancer Institute’s Cancer Topic Search for “Digestive
System Cancer: Screening and Prevention” Modified to Exclude NonColorectal Cancers
(((digestive system neoplasms/prevention[majr] OR (digestive system
neoplasms[mesh] AND (mass screening[mesh] OR preventive medicine[mesh]
OR preventive health services[mesh] OR chemoprevention[mesh] OR cancer
vaccines[mesh]))) AND human[mh] AND english[la]) OR ((intestine[ti] OR
intestines[ti] OR intestinal[ti] OR bowel[ti] OR bowels[ti] OR duodenal[ti] OR
duodenum[ti] OR ileal[ti] OR ileum[ti] OR jejunal[ti] OR jejunum[ti] OR
colorectal[ti] OR colon[ti] OR colonic[ti] OR rectal[ti] OR rectum[ti] OR
rectosigmoid[ti] OR anal[ti] OR anus[ti] OR perianal[ti]) AND (cancer*[ti] OR
carcinoma*[ti] OR adenocarcinoma*[ti] OR malignan*[ti] OR tumor*[ti] OR
tumour*[ti] OR neoplasm*[ti]) AND (prevention[ti] OR prevent[ti] OR screen[ti] OR
screening[ti] OR chemoprevent*[ti] OR surveillance[ti])))
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